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Frequently used abbreviations –  
 
PK Penetrating Keratoplasty 
EK Endothelial Keratoplasty 
DMEK Descemet Membrane Endothelial Keratoplasty 
DSAEK Descemet Stripping Automated Endothelial Keratoplasty 
ALK Anterior Lamellar Keratoplasty 
HCECs Human Corneal Endothelial Cells 
LK Lamellar Keratoplasty 
DM Descemet‘s Membrane 
AFM Atomic Force Microscope 
TCM Tissue Culture Medium 
TM Transport Medium 
OC Organ Culture 
FSS Fish Scale Scaffolds 
rHSA Recombinant Human Serum Albumin 
FCS Foetal Calf Serum 
GMP Good Manufacturing Practices 
FBOV Fondazione Banca degli Occhi del Veneto Onlus 
EEBA European Eye Bank Association 
EBAA Eye Bank Association of America 
PBS Phosphate Buffered Saline 
TBPC Trypan Blue Positive Cells 
TB Trypan Blue 
MEM Minimum Essential Medium 
ECL Endothelial Cell Loss 
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ECD Endothelial Cell Density 
BSE Bovine Spongiform Encephalopathy 
EDTA Ethylenediaminetetraacetic acid 
CECs Corneal Endothelial Cells 
HCEPs Human Corneal Endothelial Progenitor Cells 
CEM Corneal Endothelial Medium 
ESC-CM Embryonic Stem Cell-Conditioned Medium 
ZO-1 Zonula Occludens -1 
MSCs Mesenchymal Stem Cells 
HAF Human Amniotic Fluid 
ROCK Rho-associated protein kinase 
iPSCs Induced Pluripotent Stem Cells 
PFA Paraformaldehyde 
RT Room Temperature 
IOL Intra Ocular Lens 
PAS Periodic acid–Schiff 
DAPI 4,6-diamidino-2-phenylindole 
DALK Deep Anterior Lamellar Keratoplasty 
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La cornea è quel tessuto trasparente che riveste la superficie anteriore dell'occhio, e che 
consente di avere una visione ottimale e chiara. La trasparenza di questo tessuto è 
fondamentale e non può essere compromessa. La cornea umana è costituita da più 
strati,tra cui lo strato posteriore o ―endotelio‖ è responsabile della trasparenza della 
cornea. L‘ endotelio è un monostrato di cellule che permettono agli ioni ed ai soluti di 
essere trasportati dall‘ umor acqueo alla cornea e viceversa, e che a sua volta mantiene la 
trasparenza della cornea conservando l'omeostasi tra la cornea anteriore e posteriore. 
L‘endotelio non possiede capacità rigenerative. Attualmente, l'unico metodo di trattamento 
è la sostituzione dell'endotelio danneggiato con l'endotelio di un donatore sano. La 
cheratoplastica perforante, che prevede trapianti di cornea a tutto spessore,rappresentava 
l'unica soluzione terapeuticafino ad un decennio fa. Tuttavia, con i nuovi progressi nel 
campo dei trapianti di cornea, sono state identificate specifiche tecniche chirurgiche, come 
DMEK e DSAEK, che sostituiscono solo una parte (o uno strato) della cornea. Sono I 
risultati ottenuti, in termini di riabilitazione visiva, si sono rivelati vantaggiosi grazie 
all‘utilizzo di queste procedure chirurgiche specifiche. Tuttavia, la DMEK è più 
impegnativarispetto alla DSAEK in quanto non è ancora completamente standardizzata. 
La DMEK ha diversi vantaggi in termini di tasso di riabilitazione e risultati visivi post-
operatori e quindi è necessario standardizzare questa tecnica per una maggiore diffusione 
di tali interventi e anche considerando che questo è l'unico trattamento possibile per la 
cura di pazienti affetti da disfunzioni endoteliali. Sebbene il trapianto di cornea sia in fase 
avanzata, a causa di una quantità limitata di cornee da donatori ai fini di trapianto, 
approcci alternativi come la coltura di endotelio corneale in vitro svolgono un ruolo 
importante. La coltura di endotelio non è l'unico problema nel trapianto di endotelio 
(EK)dal momento che trapiantare un innesto di 20 micron di spessore all'interno 
dell'occhio destinatario rappresenta una sfida ulteriore. Inoltre, la disponibilità dei donatori 
per la coltura di endotelio corneale è inferiore, rendendo questa strategia ulteriormente più 
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complicata. La tesi è quindi strutturata in modo da mettere in evidenza due questioni 
molto importanti nell‘ attuale scenario della cheratoplastica endoteliale, 1) trapianto di 
cornea posteriore o EK, che è l'attuale metodo di trattamento per la cheratoplastica 
endoteliale e 2) coltura delle cellule endoteliali della cornea umana, che rappresenta il 
futuro della cheratoplastica endoteliale. 
Il Capitolo 1 è un'introduzione sul mondo dell‘ Eye Banking, sulle sue caratteristiche 
attuali, sullo sviluppo nel mondo moderno e sul supporto per i chirurghi, non solo in termini 
di nuove tecniche, ma anche di dispositivi per interventi selettivi. Si evidenzia anche la 
conservazione dei tessuti corneali, che è un elemento importante nel campo dell‘Eye 
Banking. Le banche degli occhi svolgono un ruolo significativo nel settore dei trapianti di 
cornea, dal momento cheraccolgono le cornee umane e le analizzano per ilsuccessivo 
trapianto. Le cornee non idonee per il trapianto possono essere utilizzate per la ricerca e 
quindi lo sviluppo dell‘Eye Bankinge la ricerca possono influenzare il campo del trapianto 
di cornea. Il Capitolo 2 introduce l‘argomento delle colture cellulari corneali e le tecniche 
attuali che sono utilizzate per la coltura ed il trapianto di cellule coltivate. 
Per capire il motivo e l'esigenza dell‘ingegnerizzazione dei tessuti, è importante studiare la 
cornea umana, la sua matrice extracellulare ed il suo comportamento in diversi mezzi di 
coltura. Il comportamento biomeccanico di un tessuto sottile (DM) in condizioni diverse 
rappresenta una parte rilevante di questo studio per la futura ingegnerizzazione,che viene 
descritta nel Capitolo 3. E‘ inoltre importante standardizzare il trattamento attualmente 
disponibile allo scopo di ridurre in futuro  l‘onere di pazienti con endotelio compromesso 
ed evitare danni o sprechi di tessuto, che attualmente avvengono nelle sale chirurgiche, 
fornendo tessuti standardizzati in terreni di  conservazione validati, come descritto nel 
Capitolo 4. La DMEK è considerata il futuro della cheratoplastica endoteliale, dal 
momento che presenta vantaggi quali la velocità dei tempi di riabilitazione ed i risultati 
visivi. Il Capitolo 5 mette in evidenza l'importanza della nuova tecnica che consiste 
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nell‘arrotolare il tessuto DMEK per consentire un facile inserimento per poi dispiegarlo 
nell'occhio ricevente, rispetto alla tecnica attualmente utilizzata con endotelio arrotolato in 
senso opposto. Attualmente, i tessuti DMEK sono o preparati in sala operatoria o allestiti 
in Banca degli Occhi e spediti ai chirurghi. Tuttavia, non vi è alcuna procedura 
standardizzata che possa contribuire ad ottenereun lembo endoteliale validato  prima 
dell'intervento e fornire un innesto ready-to-use ai chirurghi. Il Capitolo 6 descrive una 
nuova tecnica di pre-caricamento di un lembo endoteliale in una cartuccia IOL disponibile 
in commercio che può essere utilizzato come dispositivo di conservazione, trasporto e 
trapianto. Questa tecnica consentirà di ridurre ulteriormente gli sprechi nei trapianti e 
fornirà ai chirurghi un innesto pre-convalidato,riducendo ulteriormente il tempo 
complessivo in sala operatoria edi relativi costi. Quindi nella prima fase della tesi, sono 
stati analizzati i diversi approcci per standardizzare la tecnica DMEK. 
Le HCECs sono attualmente coltivate usando cornee di donatori giovani. Ci sono due 
aspetti importanti, in primo luogo la disponibilità di tessuti di donatori giovani è minore 
rispetto a quella di donatori anziani, ed in secondo luogo non vi è, ad oggi, alcun metodo 
standardizzato di coltura delle HCECs. Pertanto, per ridurre la domanda di tessuti a livello 
mondiale, vi è una forte necessità di coltivare leHCECsderivanti da cornee di donatori 
anziani, che sono meno proliferative e meno resistenti in natura, ma per le quali vi è una 
elevata disponibilità della fonte donatrice. Il Capitolo 7 descrivelo studio sull'isolamento 
delle HCECs e la successiva coltura di tali cellule ottenute da cornee di donatori anziani. 
Una volta stabilito il protocollo, è stato eseguito uno studio completocon un alto 
campionamento, per dimostrare la coerenza di questa tecnica,come evidenziato nel 
Capitolo 8. Nel frattempo si è anche osservato che le cellule da donatori anziani  possono 
essere coltivate utilizzando l‘inibitore ROCK in combinazione con acido  ialuronico (HA). 
HA induce una forza meccanica alle cellule per far sì che siano saldamente attaccate alla 
base e consentire così una maggiore proliferazione,come descritto nel Capitolo 9. La 
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seconda parte della tesi indaga quindi la tecnica di coltura delle HCECs da cornee di 
donatori anziani. Tuttavia, una volta che le cellule sono coltivate, un'altra sfida è 
trapiantarle nella camera anteriore dell'occhio. Ciò può essere eseguito utilizzando due 
strategie: la prima è quella di ad impiantare le cellule in forma di sospensione nella 
camera anteriore, tecnica che è già stata proposta, ma che non ha ancora fornito 
un‘evidenza clinica; la secondaè quella di sviluppare un substrato per il trasporto delle 
cellule coltivate. Nel Capitolo 10, si identifica la colla di pesce (FSS)come una grande 
fonte di collagene e quindi come un potenziale scaffold da utilizzare per la cultura HCECs 
e successivo trapianto. E‘ inoltre importante capire le norme che regolano gli studi 
scientifici ed il loro uso nelle applicazioni cliniche. Pertanto, nel Capitolo 11, viene 
descritta l‘identificazione dell‘ rHSA come sostitutodell‘ FCS per la conservazione di 
cornee umane. Questo contribuirà anche a creare un terreno di coltura sintetico che 
potrebbe essere utilizzato per la cultura HCECs in condizioni GMP in futuro. 
In conclusione, si è osservato che il pre-caricamento di tessuti con endotelio rivolto verso 
l'interno e conservati in un terreno con destrano, potrebbe rappresentare una possibile 
soluzione per fornire un lembo per DMEK validato e standardizzato per il trattamento delle 
disfunzioni endoteliali. Le banche degli occhi svolgono un ruolo importante nello sviluppo 
di queste tecniche chirurgiche e relativi dispositivi, che potranno cambiarele modalità del 
trapianto di cornea in futuro. Una tecnica alternativa come la coltura di HCECs ha in sèil 
potenziale per il trattamento di disturbi endoteliali e substrati come FSS potrebbero essere 
utilizzati per la coltura edil trapianto di queste cellule. Tuttavia, l'efficacia di queste cellule 
potrà essere  validata solo dopo uno studio clinico. Considerando le questioni regolatorie, 
il terreno sintetico potrebbe aiutare le banche degli occhi sia per la conservazione delle 
cornee e dei i nuovi prodotti come DMEK pre-caricati sia, in futuro, per le colture. 
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Cornea is the front transparent window of the eye which is responsible for optimal and 
clear vision. Transparency of this tissue is highly inevitable and cannot be compromised. 
Human cornea is made up of multiple layers out of which the posterior layer ‗endothelium‘ 
is responsible for the transparency of the cornea. Endothelium is a monolayer of cells that 
allow the ions and solutes to transport from aqueous humour to the cornea and back 
which in turn maintains the transparency of the cornea by preserving the homeostasis 
between the anterior and posterior cornea. Earlier, it was observed that the endothelium 
had non regenerating capability however; recent studies have shown that these cells could 
be proliferated in vitro. Currently, the only method of treatment is the replacement of the 
diseased endothelium with the healthy donor endothelium. Penetrating keratoplasty which 
transplants a full thickness cornea was the only solution a decade ago. However, with the 
new advancements in the field of corneal transplants, specific surgical techniques like 
DMEK and DSAEK which replace only a part of the cornea have been identified. DSAEK 
replaces a part of the stroma along with the Descemet‘s membrane and endothelium 
whereas DMEK only replaces the Descemet‘s membrane and the endothelium and does 
not involve stroma. The results in terms of visual rehabilitation and outcomes have been 
found to be advantageous in these specific surgical procedures. However, DMEK is more 
challenging then DSAEK as DMEK is not yet a widespread technique, associated with 
steep learning curves and difficult donor tissue preparation. Despite DMEK is a 
challenging procedure it is becoming more popular because of the significant advantages 
in term of faster visual recovery, less postoperative astigmatism and reduced risk of 
transplant rejection, as compared to the other EK procedures. DMEK has several 
advantages in terms of rehabilitation rate and post-operative visual outcomes and 
therefore it is necessary to further refine this technique for a higher uptake of such 
surgeries and also considering that this is the only possible treatment for treating the 
patients suffering from endothelial dysfunctions. Although the corneal transplantation is 
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well advanced, due to a limited supply of donor corneas for the transplantation purposes, 
alternative approaches like culturing corneal endothelium in vitro play an important role. 
Culturing the endothelium is not the only problem in EK but transplanting a 20 micron thick 
graft inside the recipient eye is another challenge. Moreover, the donor availability for 
culturing the corneal endothelium is less, making this strategy further more complicated. 
The thesis is therefore structured to highlight two significantly important issues in current 
scenario of endothelial keratoplasty, 1) posterior corneal transplantation or EK which is the 
on-going method of treatment for EK and 2) Human corneal endothelial cell culture which 
is the future of EK.  
Chapter 1 is an introduction to the world of eye banking, its current nature and 
development in the modern world and as a support to the surgeons not only in terms of 
new techniques but also devices for selective surgeries. It also highlights the preservation 
of the corneal tissues which is an important element in the field of eye banking. Eye banks 
play a significant role in the field of corneal transplants as they collect the human corneas 
and process them for transplantation. The corneas that are rejected for transplantation 
can be used for research and therefore development of eye banking and its research can 
change the field of corneal transplantation. Chapter 2 introduces the field of corneal cell 
culture and current techniques that are followed for culturing and possible transplantation 
of the cultured cells.  
To understand the reason and requirement of tissue engineering, it is important to study 
the human cornea, its extracellular matrix and its behaviour in different media. The 
biomechanical behaviour of the thin tissue i.e. the DM in different conditions becomes a 
relevant part of this study for future engineering which is studied in chapter 3. It is also 
important to standardize the currently available treatment options to reduce the burden of 
endothelial compromised patients in the future and avoid damages or tissue wastage that 
is currently occurring in the surgical theatres by providing standardized tissues in validated 
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preservation medium which is studied in chapter 4. DMEK promises to become a more 
popular technique for the replacement of unhealthy corneal endothelium as it shows 
advantages like early rehabilitation rate and visual outcomes. Chapter 5 highlights the 
importance of new technique in rolling the DMEK tissue for easy insertion and unfolding in 
the recipient eye compared to the currently used technique with endothelium rolled in 
opposite direction. Presently, the DMEK tissues are either prepared in the surgical theatre 
or are stripped in the eye bank and shipped to the surgeons. However, there is no 
standardized procedure that could help validate a graft before surgery and provide a 
ready-to-use graft to the surgeons. Chapter 6 describes about a new technique of pre-
loading a graft in a commercially available IOL cartridge which can be used as a 
preservation, transportation and transplantation device. This technique will further reduce 
graft wastage and will provide the surgeons a pre-validated graft further reducing the 
overall time in the surgical theatre and related costs. Thus different approaches for 
standardizing the DMEK technique were studied in the first phase of the thesis.  
 
HCECs are currently being cultured using young donor corneas. There are two major 
issues, firstly, the availability of the young donor corneas is less compared to the old donor 
corneas and secondly, there is no standard method of culturing the HCECs obtained so 
far. Therefore, to reduce the global tissue demand, there is a strong need to culture the 
HCECs from the old donor corneas which are less proliferative and less robust in nature 
but with high availability of the donor source. Chapter 7 is a study on isolation of HCECs 
and further culture of these cells from old donor corneas. Once the protocol was obtained, 
a full length study was performed with high sample size to prove the consistency of this 
technique which is highlighted in chapter 8. Meanwhile it was also noted that cells from old 
donors can be cultured using ROCK inhibitor in combination with Hyaluronic Acid (HA). 
HA induces mechanical force to the cells attaching them forcefully on the base and allows 
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a higher proliferation of old donor cells which was studied in chapter 9. The second part of 
the thesis therefore investigates the culturing technique of HCECs from old donor 
corneas. However, once the cells are cultured, another challenge is to transplant them in 
the anterior chamber of the eye. This can be performed using two strategies, first, to 
implant the cells as suspension in the anterior chamber which is already been proposed, 
but the clinical evidence is still not confirmed yet, and second, to develop a carrier to 
transport the cultured cells. In chapter 10, we identified fish scales as a great source of 
collagen and therefore have investigated it as a potential scaffold to be used for HCECs 
culture and transplant in the future. It is also important to understand the regulations that 
govern the scientific studies and its use for clinical applications. Therefore, we also 
identified rHSA as a source to replace FCS for preserving human corneas in chapter 11. 
This will also help to create a synthetic media that could be used for GMP purposes for 
HCECs culture in the future.  
 
In conclusion, it was observed that pre-loading the tissues with endothelium-flapped 
inwards and preserved in dextran based medium could be a potential solution for 
providing a validated and standardized DMEK graft for the treatment of current endothelial 
dysfunction. Eye banks play a major role in the development of these surgical techniques 
and related devices which will change the face of corneal transplantation in the future. 
Alternatives like HCECs culture has a potential for the treatment of endothelial disorders 
and carriers like FSS could be used for culturing and transplanting these cells. However, 
the efficacy of these cells will only be validated after the clinical study. Considering the 
regulatory issues, synthetic medium would help both, the eye banks for preserving the 
corneas and its new products like pre-loaded DMEK and for cell culture in the future. 
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Human eye is a fascinating organ that reacts to light and provides vision to an individual. 
Its systematic organization allows the light to pass from the surrounding through cornea, 
lens, vitreous, retina, choroid, optic nerve and brain. This pathway is responsible for clear 
vision. Damage to either component may reduce vision or acquire blindness. Human 
cornea is the transparent front part of the eye that covers the anterior chamber. As cornea 
is directly exposed to the external environment it also acts as a primary protection against 
external living or non-living elements and does not allow any entry of foreign particles in 
the eye globe. It refracts the light from the surrounding to the lens and retina to hit the 
optic nerve. The cornea is supposed to account for approximately two-thirds of the eye‘s 
total optical power. The refractive power of the cornea is around 43 dioptres.  
 
Transparency of the cornea is of primary importance. Human cornea is an avascular 
tissue (no blood vessels) which helps in reducing any immune rejection of the graft. It 
receives the oxygen directly through the air by dissolving in tears and diffusing it further. It 
receives nutrients from two parts, a) diffusion from the tear fluid through the outer surface 
and b) aqueous humour from the inside. Neutrophins supply nutrients via nerve fibres that 
innervate it. A normal human cornea has a diameter of around 11.5 mm with thickness of 
around 0.5-0.6 mm in the center and 0.6-0.8 mm in its periphery. The thickness may 
increase if the cornea is swollen. Transparency, avascularity, presence of immature 
resident immune cells, and immunologic privilege makes the cornea a very important and 
interesting tissue to study. The cornea borders with the sclera by the corneal limbus.  
 
Human cornea has a highly organized structure to maintain the transparency of the tissue 
and is well determined by its functional layers as shown in figure 1.  
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Figure 1: Anatomy of human eye globe showing different parts of the eye and schematic 
representation and structure of human cornea showing specific layers of the tissue.  
The layers include -  
a) Corneal epithelium: it is a multicellular epithelial tissue layer (non-keratinized 
stratified squamous epithelium). The epithelium has a regenerative capability and it 
can renew itself with the help of limbal stem cells which reside in the Palisades of 
Vogt. Damage or edema of the epithelium reduces the smoothness of the air/tear-
film interface which is the most important part of the refractive power hence 
minimizing the visual acuity.  
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b) Bowman’s layer: this is the basal membrane of the corneal epithelium which 
protects the stroma.  
c) Stroma: it is a thick and transparent layer which is arranged with collagen fibres 
along with sparsely distributed keratocytes. Keratocytes are responsible for the 
general repair and maintenance. This middle layer of the cornea consists of up to 
90% of the total corneal thickness. The arrangements of the collagen fibrils in the 
stroma are supposed to be responsible for the overall transparency of the human 
cornea. The collagen fibrils in the stroma are also responsible for the polarization 
patterns of the cornea. Just anterior to Descemet‘s membrane, a very thin and 
strong layer, the Dua‘s layer, 15 µm thick has been proposed recently. 
d) Descemet’s membrane: this membrane is a thin acellular layer that serves as the 
basement membrane of the corneal endothelium. This layer is composed mainly of 
collagen type IV fibrils, less rigid than collagen type I fibrils, and is around 5-20 µm 
thick, depending on the age of an individual. Corneal endothelium: simple 
squamous or cuboidal cells. These cells form a monolayer, approx 5 µm thick that 
is rich in mitochondria. These cells are responsible for regulating fluid and solute 
transport between the aqueous and corneal stromal compartments. The corneal 
endothelium is flushed continuously by aqueous humor, not by blood or lymph, and 
has a very different origin, function and appearance from vascular endothelia. 
Unlike the corneal epithelium, the cells of the endothelium do not regenerate (this is 
still a hypothesis). Instead, they stretch out to compensate for dead cells which 
reduce the overall cell density of the endothelium further affecting the fluid 
regulation. If the endothelium does not maintain a proper fluid balance, stromal 
swelling due to excess fluids and subsequent loss of transparency will occur and 
this may cause corneal edema and interference with the transparency of the cornea 
and thus impairing vision.  
22 
 
Histological images of human cornea are shown in figure 2.  
 
Figure 2: Histological analysis of human corneal tissue. A) All the layers can be seen 
precisely with stromal folds, b) epithelium, stroma and keratocytes, c) stroma and 
endothelium and d) epithelium and stroma.  
 
Human corneal endothelium -  
The posterior layer of the cornea is the endothelium which is a physiologically important 
monolayer of cells. HCECs play a major role in maintaining the corneal transparency, 
thickness and hydration [1,2].  
 
The cornea takes in fluid from the aqueous humour and the small blood vessels of the 
limbus, but the pump function in the HCECs eject the fluid immediately once entered. The 
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pump may fail when the energy is deficient, or may work too slowly to compensate. This 
further causes swelling of the cornea which could arise at death. A dead eye can although 
be placed in a warm chamber in combination with sugar and glycogen that can keep the 
cornea transparent for at least 24 hours. The endothelium controls this pumping action, 
and as discussed above, damage thereof is more serious, and may increase opacity and 
swelilng. When a cornea is needed for transplant from an eye bank, the best procedure is 
to remove the cornea from the eyeball, preventing the cornea from absorbing the aqueous 
humour.  
 
It is noted that the total number of donated corneas in 2015 distributed by US eye banks 
was 79,306 [Eye Bank Association of America (EBAA) statistical report 2015]. Of these, 
39,554 were destined for full thickness PK and 30,710 for EK (14,472 for Fuchs‘ 
Dystrophy and 3,208 other causes of endothelial dysfunction). This signifies that nearly 
40% of corneal transplantations were carried out for endothelial dysfunction. Endothelial 
keratoplasty has been the most commonly performed keratoplasty procedure in the United 
States in the last four years and continues to increase. This means that endothelial 
diseases are the main indication for corneal transplantation in the United States.Although 
EK has a high success rate in terms of visual rehabilitation and post-op visual outcomes, 
shortage of donor corneas still remain a global challenge [3].  
 
Due to the non-regenerative capability of the HCECs, its preservation and maintenance 
becomes a critical issue. It is noted that the HCECs have a low tendency to proliferate in 
vivo, as they are arrested in the G1 phase, and therefore these cells spread out to replace 
the deceased cells, thus maintaining the functional integrity and corneal deturgescence 
[4,5].  
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Accidental or surgical trauma can result into acute corneal endothelial dysfunction which 
results in the inability of the pumping function of the endothelium which is necessary for 
the drainage of excess fluids. This causes critical anomalies like stromal edema, loss of 
transparency and most importantly the visual acuity which usually leads to the clinical 
condition of bullous keratopathy. The corneal endothelium is assumed to be originated 
from the neural crest cells [6]. It has already been described that the neural crest cells 
migrate and differentiate during the developmental phases of the cornea. Periocular 
mesenchymal cells are originated from the neural crest cells and are responsible for the 
development of the corneal epithelium and the synthesis of the primary stroma. These 
cells further migrate to the periphery of the optic cup eventually moving between the lens 
and the corneal epithelium for the development of the trabecular meshwork and the 
corneal endothelium. Further, in the second phase of the development, the neural crest 
cells occupy the primary stroma and differentiate into corneal keratocytes [7].  
 
HCECs are metabolically active and continuously functions as a fluid pump for the 
movement of fluid from the stroma and the anterior chamber. Thus, as described earlier, 
the endothelial layer plays a significant role, but lacks the capacity to regenerate and 
hence its viability should be maintained. Currently, surgical replacement of the diseased 
endothelium by a healthy donor tissue using corneal transplantation is the only solution to 
restore vision caused due to endothelial dysfunction.  
 
The function of the endothelium is compromised if the cell density falls below a critical 
threshold of 500 cells/mm
2
. Recently, surgical procedures such as DSAEK have focused 
on the transplantation of corneal endothelium, yielding better clinical results, yet the 
shortage in donor tissue remains a main issue. Various other methods have been 
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attempted to treat endothelial dysfunctions, and in recent years DMEK have also been 
employed [8].  
 
However, the availability and quality of corneas are main concerns; more than 40% of the 
donated corneas to our institute, the Veneto Eye Bank Foundation (FBOV – Venice, Italy) 
are rendered unsuitable for transplantation. Additionally, more than 60% of the donors are 
over 60 years and due to the low endothelial cell density that most of the grafts from these 
age groups have, most of the grafts become unsuitable for transplantation in the 
preliminary phase of evaluation. Isolation, culturing of the cells and tissue engineering, 
thus, can play a vital role and serve as an alternative in the treatment of endothelial 
dysfunction. It has been observed that the HCECs at the periphery possess a higher 
density of precursors which have a strong proliferation capability, as compared to the 
central endothelium and can be differentiated into neural or mesenchymal cells. A mass 
production of HCECs can be achieved through young donors, which could ultimately 
reduce the waiting lists of the patients requiring endothelial keratoplasty. The current 
treatment available for the restoration of the corneal endothelium is keratoplasty, which 
represent more than 22% of the corneal tissues supplied by FBOV in 2012 but has been 
increasing ever since.  
 
DMEK has evolved over the years since it was first introduced by Dr. Melles in 2006. 
Various preparation and implantation techniques have been addressed so far. However, 
there has not been a standard technique for DMEK. Eye banks are confronted with new 
requirements from corneal surgeons as DMEK is gaining popularity in terms of early 
rehabilitation and better visual outcome. DMEK validation and standardization both in 
terms of preparation and implantation is thus becoming essential. At FBOV, we have seen 
a gradual increase in the demand of tissues for specific purposes like pre-cut DSAEK 
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since 2012. FBOV has also received requests for pre-cut DMEK tissues and we have 
seen an upcoming interest in these tissues since 2014. In 2015, we reported pre-loaded 
tissues for DSAEK using a commercial device, iGlide (Eurobio, France), which has the 
capability to transport and transplant a pre-cut DSAEK tissue [Figure 3] [9]. In 2016 we 
reported a ‗proof of concept‘ for pre-loading DMEK tissues and introduced a modified 
design for a surgical device that will help to preserve, transport and transplant a DMEK 
graft with less manipulation [10]. Pre-loading DMEK, as we assume, will also be useful to 
standardize and validate DMEKs with advantages like reduced primary graft failure rates 
due to de-oriented grafts, lowering high surgical skills quotient, high rehabilitation rate with 
better visual acuity, low surgical time, costs and logistic requirements. 
 
 
 
Figure 3: Number of corneal tissues prepared for specific keratoplasties between 2012 
and 2015 at FBOV, Venice, Italy. A consistent decrease in the request for PK has been 
noticed since 2012 where as tissues for DSAEK and DMEK prepared in the eye banks 
have shown increased popularity.  
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However, these relatively new procedures still face some obstacles, such as the worldwide 
shortage of transplantable donor corneas, continuing cell loss after transplantation, 
technical difficulty, and primary graft failure. In order to address the worldwide shortage of 
donor corneas, the idea of one donor cornea for each patient has been challenged, and 
the concept of using one donor cornea for treating multiple patients has yet to be widely 
accepted. Such a timely goal prompts researchers to establish optimum technologies for 
isolation and cultivation of HCECs. Testing several cultivation methods and scaffolds will 
eventually lead to better transplantation outcomes. With mark of stem cells and 
regenerative medicine, the next ambitious goal would be the identification and 
amplification of corneal endothelial stem cells to treat endothelial disorders reducing 
invasiveness of clinical interventions. Although, maintenance of the undifferentiated stem 
cell nature, promotion, amplification, molecular mechanisms and differentiation are still the 
key issues to learn, with the on-going studies, cultured endothelial cells for transplantation 
in humans seems to be a possible option in the near future. 
 
The emerging strategies in the field of cell biology and tissue cultivation of corneal 
endothelial cells aim at the production of transplantable endothelial cell sheets. Cell 
therapy focuses on the culture of corneal endothelial cells retrieved from the donor 
followed by transplantation into the recipient. This strategy likely poses multiple 
advantages over the conventional PK and most certainly, EK, as it has evolved over the 
past 15 years and has become the treatment of choice for endothelial diseases. The 
advantages include reduction in post-operative complications like irregular astigmatism, 
wound leakage, corneal infection, neovascularisation and epithelial defects. Recently, the 
focus is on overcoming the challenge of harvesting human corneal endothelial cells and 
the generation of new bio-membranes to be used as cell scaffolds in surgical procedures. 
Current results represent important progress in the development of new strategies based 
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on alternative sources of tissue for the treatment of corneal endotheliopathies. Similarly, 
multiple techniques have been described in the literature [11]. Human corneal 
endothelium is a physiologically important monolayer of cells, with a simple, but crucial, 
role to maintain corneal clarity.  
 
In conclusion, corneal transplantation is a popular choice of treatment for many corneal 
disorders. However, the shortage in availability of donor tissues limits the amount of 
corneal transplantation around the globe. Continuous increase in the number of patients 
has boosted the need for clinical grade tissues or a reasonable substitute to overcome this 
issue. Alternatives include cell, tissue or bio-engineering, cell culture in vitro, the potential 
use of stem cells or other related therapies. The current treatment measure to overcome 
the corneal disorders is transplantation of a healthy donor corneal graft with a diseased 
patient‘s cornea. There is a rapid advancement in the field of endothelial keratoplasty as it 
has advantages being a less-sutured surgery with quicker rehabilitation and better post 
operative visual outcomes. Thus, to overcome the necessity of donor tissues for selective 
keratoplasty, the endothelial reconstruction or regeneration is currently studied.  
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CHAPTER 1 
  
EYE BANKING – AN OVERVIEW 
 
Derived from published book chapter 
Mohit Parekh, Stefano Ferrari and Diego Ponzin. Eye Banking: An Overview. In: Mohit 
Parekh, Stefano Ferrari and Diego Ponzin. Eye Banking: Changing Face of Corneal 
Transplantation. Pages 1-18. 
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Corneal transplantation mainly referring to PK is performed to replace the central part of a 
cornea which has lost its physiologic curvature and/or transparency. LK refers to a 
selective surgery which is aimed at replacing the corneal stroma i.e. ALK OR the posterior 
corneal stroma with the Descemet‘s membrane-endothelium complex i.e. EK. The 
paradigm shifts in corneal transplantation encouraged by recent advances in LK is having 
a tremendous impact in the daily routine of eye banks. In particular, the field of EK has 
shown a dramatic impact in current eye banking and corneal transplantation procedures. 
The speed of adoption and implementation of this new form of selective tissue 
replacement is making a mark in the field of EK, and most eye banks are now pre-cutting, 
pre-bubbling or pre-stripping the corneal tissues for DSAEK, DMEK and DALK to improve 
the surgical feasibility.  
 
Earlier, the role of eye banks was to recover, evaluate and store donor corneas and other 
ocular tissues for surgical use. However, in the recent years, eye banks are satisfying the 
demands of the clinics in terms of pre-evaluated pre-prepared grafts. If the next of kin of 
the donor consents, then the tissues could also be used for research purpose which is 
equally important to understand the mechanism and behavior of the human tissues both in 
vitro and in vivo. Tissue removal and tissue processing in an eye bank should be carried 
out with sterile instruments by operators wearing personal protective clothing and 
observing strict aseptic techniques. The morphologic and functional status of the 
endothelium is the most important indicator of donor corneal suitability for transplantation.  
 
Various preservation media have been identified to preserve the integrity and functional 
mechanism of the corneal endothelium under varied temperature and conditions. 
Hypothermic storage at 2-6°C and organ culture at 30-37°C are the two storage practices 
for the cornea that are practiced around the world in wide-range. For keratolimbal 
32 
 
allografts, the donor limbal epithelium must be protected from trauma and desiccation, 
and a conjunctival rim of 3-4 mm should be left [1]. Donor sclera is prepared from ocular 
tissue following excision of the corneo-scleral button, or from the donor ocular globes.  
 
Recent advances in the fields of eye banking, ophthalmology and regenerative medicine 
are challenging the traditional activities of eye banks. Serum-free media are being 
evaluated for corneal storage, autologous serum eye-drops, amniotic membrane 
transplantation and ex-vivo expanded limbal stem cells are being offered as 
complementary remedies for ocular surface disorders. 
 
Screening of donors   
Transplantation of human cornea requires additional care and involves potential risks of 
transmission of host disease to recipient. In order to ensure safety, a set of 
contraindication has been established, after retrospective discoveries of transmission of 
disease, or on a cautionary basis (theoretical or significant risk of transmission). Other 
contraindications have also been set to improve the quality of the graft so making the 
criteria for donor screening a little more stringent for penetrating than for lamellar grafts. 
 
Diseases with the potential risk of transmission by corneal transplantation comprise 
infections (local and/or systemic), hematologic malignancies, prion diseases and corneal 
disorders, the latter being more related to quality than to safety issues. Metastatic 
neoplasia do not exclude from donation and transplantation. The EEBA [2] and EBAA [3] 
have established Minimum Medical Standards and Medical Standards, respectively 
(details can be found at www.europeaneyebanks.org or www.restoresight.org). The 
contraindications comprise a group of systemic disorders (including the death of unknown 
cause), intrinsic eye diseases and prior intraocular or anterior segment surgery. 
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In Europe, the contraindication have been listed in the Directive 2004/23/EC that, together 
with Directive 2006/17/EC and Directive 2006/86/EC, set the standards for safety and 
quality of tissue transplantation. As set by the Directives, the serological screening for 
HBV, HCV, HIV and syphilis must be performed for every tissue that has been donated. 
Besides the search for antibodies of antigens, some nations require the execution of 
nucleic acid testing (NAT), a molecular technique developed to shorten the window period 
(the time between the infection and when a positive antibody/antigen can be revealed). 
Because of the window period, also the behaviors that may have put the donors at risk, 
such as intravenous drug use, must be evaluated. Post mortem blood can be obtained 
from direct heart puncture or accessible blood vessels, within 24 hours from death. 
Despite the low incidence, transmissible spongiform encephalopathies, such as 
Creutzfeldt-Jakob disease, have been transmitted via corneal transplantation. The disease 
is progressive and fatal. For which, any donor who died with neurological symptoms, or 
degenerative neurological conditions, must be excluded from donation. Theoretically 
lymphoproliferative disorders including leukemias, lymphomas and lymphosarcomas pose 
the greatest risk of transfer from donor to host, because they may invade the cornea. 
However, there is no report of a systemic malignancy transmission following keratoplasty. 
The source of information (pathologist, medical records, attending medical and nursing 
staff, family members or other relevant persons close to the deceased, family doctor, post-
mortem report) is another important documentation to be noted. Transmission of local 
corneal disorders is a further risk of corneal transplantation. Early stage anterior and 
posterior membrane dystrophies, and keratoconus, may escape detection. A thorough 
tissue evaluation in the eye bank may minimize these events. Age criteria for cornea 
donors are not well defined and vary between eye banks and surgeons. The diameter of 
the infant cornea stops growing after 2 years of age, and the curvature probably reaches 
adult dimension during the second 6 months of life. The small diameter, thinness and 
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elasticity of the infant cornea may cause technical problem for the surgeon. In general, the 
diagnosis of the recipient and the surgeon‘s experience are more important than donor 
age in determining the long-term graft clarity. Ocular tissues should be recovered as soon 
as possible after death. A short post mortem interval warrants a higher yield of suitable 
corneas and limits endothelial loss during storage. 
 
Ocular tissue removal -  
The removal of ocular tissue for surgical use must minimize the endothelial cell loss and 
contamination, maximize the number and quality of cells that are ultimately grafted, and 
should not alter the appearance of the donor. After the physical inspection of the donor, 
the enucleator, with the aid of a penlight, should examine the periorbital and orbital 
tissues, and the anterior segment of the eye, for pathologic findings such as mucopurulent 
material, congenital or acquired corneal abnormalities or signs of intraocular surgery. 
 
The donor‘s head must be kept elevated for the whole length of the ocular tissue removal, 
in order to prevent bleeding. The eyelids must be gently opened to allow a thorough 
irrigation of the cornea and conjunctival sac of each eye with sterile phosphate-buffered 
saline, then with iodine solution, followed by phosphate-buffered saline, to prevent corneal 
toxicity. Then, a preparation of the operative area using sterile gauze moistened in the 
iodine solution should be performed, starting at the medial can thus of the upper closed 
eyelid and moving out, around and below the lid, over the bridge of the nose, in an ever-
widening circular pattern. Finally, the donor is draped to create a sterile field at the 
operative site. The upper eyelid of the donor‘s right eye is gently opened with sterile gauze 
and the closed lid-speculum is inserted, taking care not to touch the cornea. The 
conjunctiva is grasped with the forceps, near the lateral edge of the cornea at the limbus, 
and cut using the microsurgery scissors, continuing 360° all the way around the cornea, 
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removing the conjunctiva as far as possible. Closed, straight scissors are inserted under 
the conjunctiva, and a blunt dissection is performed by gently opening the blades. This will 
separate any adhesions between the conjunctiva and the anterior globe. The remaining 
conjunctiva is removed by carefully scraping from the limbus with a scalpel blade. 
 
Enucleation -  
Using a muscle hook, the rectus muscles are exposed and severed where they meet the 
sclera. The lateral rectus must be severed last, leaving a 5 mm stump on the sclera. The 
stump is gasped with a hemostat and the globe is lifted upwards with the aid of 
enucleation scissors. The optic nerve is identified and severed with the enucleation 
scissors, leaving a 5-10 mm stump. The globe is then lifted from the socket with the 
hemostat clamped to the lateral rectus muscle, while cutting away any remaining 
connective tissue. The globe is wrapped in sterile gauze with the cornea facing up and a 
small amount of PBS is poured over the cornea to moisten it. The globe is then placed in 
the eye jar, carefully inserting at least four rectangular, sterile ophthalmologic tampons 
between the gauze and the sides of the container. Once moistened, they will swell, 
keeping the globe in position. 
 
In situ corneo-scleral rim excision -  
Without perforating the choroid, a scleral incision is performed using a scalpel, 
approximately 4 mm from and parallel to the limbus. The incision is extended 360° with 
microsurgery scissors, taking care to remain at least 4 mm from the limbus and avoid 
perforating the underlying uveal tissue. The tips of the scissor blades must not enter the 
anterior chamber and the corneas‘ normal curvature must be maintained. If the incision 
has been performed correctly, the corneo-scleral rim adheres to the ciliary bodies only at 
the scleral spur. An air bubble will appear in the anterior chamber if it is entered in the 
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chamber correctly. The removal is completed using one pair of small forceps to hold the 
scleral rim, and a second set of forceps, to push the ciliary body-choroid downward and 
away from the corneo-scleral button. The remaining adhesions can now be gently 
separated from the corneo-scleral button, avoiding distortion of the cornea shape with 
excessive traction. The posterior chamber of the donor eye must be examined to check 
the presence of the natural crystalline lens. 
 
Donor reconstruction -  
After enucleation, a moistened piece of gauze, rolled into a ball of the approximate 
dimensions of the globe, can be placed in the socket and covered with a plastic eye cap or 
a plastic prosthesis. The conjunctival remains are used for overall covering. Following in 
situ corneal excision, a plastic eye cap can be placed between the remains of the 
conjunctiva and the globe, covering part of the eye cap with the remains of the 
conjunctiva. The eyelids will be closed and gently manipulated to restore the donor‘s 
appearance. The donor‘s head should be left elevated, verifying the absence of bleeding. 
It is recommended to ask the mortuary staff to check the conditions of the donor later. The 
process is illustrated in figure 1.  
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Figure 1: In situ corneo-scleral rim excision and donor reconstruction. a) The globe is 
exposed using eye speculum to keep the eye lashes out of the corneal retrieval field, b 
and c) conjunctival remnants are cut, d) the scleral incision is performed with a scalpel 
blade and microsurgery scissors extended to 360
o
, e) the corneo-scleral rim is excised, f) 
a plastic cap is placed back and the conjunctival remains are used for overall covering of 
the eye to retain the donor eye characteristics.  
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Tissue processing 
All eye bank manipulations are carried out in sterility using a laminar flow cabinet, placed 
in a defined and monitored environment. Prior to any manipulation or evaluation, the 
ocular tissues and solutions should be allowed to reach normal room temperature, 
avoiding multiple repeated warming/cooling cycles. 
 
Decontamination of donor eyes -  
The eyes are rinsed with sterile PBS, then immersed in sterile polyvinylpyrrolidone-iodine, 
sodium thiosulfate in PBS, and rinsed again in PBS, where they are left until the corneal 
excision is performed. This procedure has been reported to reduce the percentage of 
contaminated eyes. Further reduction of the load of contaminating microbes is up to the 
antibiotics in the corneal storage solutions. 
 
Tissue evaluation 
Prior to transplantation, the corneas must be examined for the presence of biological 
characteristics that are required in order to ensure a good clinical outcome. 
The morphological and functional status of the endothelium is a key factor for the success 
of corneal grafting and therefore the most important indicator of donor cornea quality. As 
there is no direct functional test that can be used, the cornea must be evaluated by 
morphological parameters [3,4]. A cornea suitable for transplantation is required to display 
some essential biological characteristics: 
− a non interrupted epithelial layer;  
− a stroma free of opacities in the optic centre and sufficient clear zone in case of an 
arcus lipoides; 
− absence of folds of the stroma and the DM indicative for poor endothelial function; 
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− a viable (absence of cell degenerations) and regular (absence of dystrophies, no 
substantial pleomorphism or polymegathism) endothelium, with a cell density above 
2000 cells/mm² (the lowest value generally accepted by most surgeons). 
Corneas from eligible donors with local eye disease affecting the corneal endothelium, or 
previous ocular surgery that does not compromise the corneal stroma, can be used for 
lamellar (anterior, posterior) or patch grafts. 
Eye banks currently examine donor corneas by a combination of techniques. In general, 
the slit lamp biomicroscopy of the anterior segment (enucleation), or the slit lamp 
examination of the cornea (in situ excision) is combined with specular microscopy (mostly 
in the USA), or with light microscopy [4]. 
 
Slit lamp examination -  
A 10× examination with a wide slit of light for a general inspection of the corneo-scleral rim 
is performed first. A more in-depth examination allows an evaluation of the following: 
− epithelial defects; 
− corneal transparency (noting any scars, edema, or arcus lipoides); 
− infiltrates or foreign bodies; 
− Descemet‘s alterations: folds (iatrogenic, stretch striae, hypotonic folds); 
− corneal guttata; 
− evidence of technical problems during removal and or transport; 
− the corneal endothelium; and 
− adequacy of the scleral rim. 
 
Specular microscopy -  
Specular microscopy can be performed on donor eyes or corneoscleral rims by non-
contact, computerized endothelial microscopes. These instruments visualize the 
40 
 
endothelium when the cornea is optically transparent, either on the donor eye or the 
excised corneoscleral rim. Endothelial density can be estimated by a calibrated reticule, or 
calculated by built-in software. 
 
Light microscopy - 
The donor cornea is put into a sterile petri dish. The endothelial mosaic can be visualized 
by exposing the cells to a slightly hypotonic solution, which induces an enlargement of the 
intercellular spaces. The whole surface of the corneal epithelium, stroma and endothelium 
can be scanned with an inverted (tissue leaning on the scleral rim, immersed in swelling 
solution), or non-inverted phase contrast or bright-field light microscope, at a magnification 
of 50×, 100× and 200×. The number of endothelial cells is estimated at about 100×, with 
the help of a calibrated grid/reticule (10×10 mm) mounted onto one eye-piece of the 
microscope. The cells should exhibit a regular pattern of intercellular spaces swelling. 
Absent or irregular swelling, associated with a grayish appearance of the cells has been 
correlated to metabolic suffering of the corneal endothelium. 
 
The presence of dead cells is studied exposing the endothelium to trypan blue. The trypan 
blue exclusion assay is a well established method to test the endothelial cell viability or 
membrane alteration(s), despite the staining is not very specific for dead and necrotic 
cells. The presence of TBPC in corneal endothelium is usually related to post mortem 
degenerative changes or injuries during tissue manipulation. The cell morphology and 
TBPCs are shown in figure 2.   
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Figure 2: Human corneal endothelium. a) Regular pattern of the corneal endothelium 
without any trypan blue positive cells and b) damaged corneal endothelium with large area 
of disorganized cells and presence of trypan blue positive cells. 
 
Preservation of corneas 
The primary aim of corneal storage is the maintenance of endothelial viability from the 
time of corneal excision to transplantation. Currently there are two storage practices for 
the corneas, both use liquids, based on cell culture medium: the hypothermic storage at 2-
6°C, adopted by many eye banks all over the world, and organ culture at 30-37°C, the 
current method of choice for most eye banks in Europe [5]. McCarey-Kaufmann medium, 
which allowed the hypothermic storage of donor corneas for 3–4 days was a huge 
success. As a consequence, corneal transplantation became a scheduled, rather than 
emergency procedure. The storage of donor corneas for an extended period allowed 
extensive donor screening, scheduling of operations and a more rational dispatching of 
donor tissue to transplant centers. Other formulations containing chondroitin sulphate in 
addition to dextran, that retarded corneal swelling during storage, and components 
promoting tissue survival were introduced afterwards. 
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During the same period, the organ culture technique was invented in the USA, and then 
subsequently modified and enhanced with methods for the evaluation of the corneal 
endothelium. Organ culture has been widely adopted in Europe, where it still remains the 
most widely used technique for the storage of donor corneas.  
 
Hypothermic storage -  
Donor corneas are stored in serum-free tissue-culture medium at a temperature of 2-6°C. 
At this temperature the metabolic activity of endothelial cells is minimal and pumping 
function is lost. Cornea swelling may be prevented by the addition of water retentive 
compounds to the preservation medium. One of the most commonly used is the 
deturgescent compound dextran either alone or in association with the glucosaminoglycan 
chondroitin sulphate. Storage liquids also contain antibiotics (gentamicin alone or with 
streptomycin) that, together with the low temperature, prevent or limit the bacterial growth. 
Commercially available solutions are also supplemented with a number of additives 
(energy sources, antioxidants, membrane stabilizing components, growth factors), but the 
specific contribution of such compounds for corneal storage has never been clarified. 
 
During hypothermia, the cornea shows progressive degeneration of the epithelium and the 
endothelium, intercellular disruption, decreased adhesion and, eventually, cell death. Both 
apoptosis and necrosis occur in cells during hypothermic storage, with apoptosis 
appearing to predominate. The extent of endothelial loss seems to be related to the 
biological quality of the tissue, rather than the composition of the medium. Furthermore, 
the ability of a medium to prevent cornea swelling in vitro does not correlate with the 
viability and function of the endothelium. Therefore, most corneas are transplanted after 3-
5 days of storage, without displaying major alterations. 
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The hypothermic storage method does not allow time for obtaining pre-operative 
microbiology controls before distribution of the tissue for transplant. Scleral rim cultures 
are usually performed at the time of surgery, despite the recognition that bacteriologic 
contamination of donor eyes does not necessarily lead to infection. As per the data 
collected by the Veneto Eye Bank Foundation, around 12-28% of cultures are found to be 
positive for bacteria and fungi, with Staphylococcus epidermidis as the most common 
contaminant. However, ocular infections after penetrating keratoplasty are rare and, in 
most of the cases, related to the recipient eye condition or the surgical procedure. 
 
Overall, hypothermic storage seems to offer donor tissues of good quality comparable to 
that obtained by organ culture, provided that the storage time is kept short. Indeed, 
according to the literature, the risk of primary graft failure increases significantly after 
storage longer than 7 days. Furthermore, corneas stored longer than 7 days display 
epithelial alterations that may hinder the surgical procedure or delay the full recovery of 
the graft [6]. 
 
Organ culture -  
The OC storage method consists of two phases – a storage period in culture medium at 
30-37C°, and a de-swelling and transportation phase at 30-37C° and room temperature in 
the same medium supplemented with 4-8% dextran. Organ culture solutions are based on 
cell culture media. They generally consist of a base of Eagle‘s MEM or its variant 
Dulbecco‘s MEM supplemented by penicillin, streptomycin and fungicide (amphotericin B 
or nystatin) to counteract the growth of microbiological contaminants, and by 2-10 % FCS 
as a source of growth factors. A storage period of 30 days can be achieved without 
significant loss of endothelial cells. The evaluation of endothelium, which can show 
reparative phenomena during storage, is usually performed before and after storage. The 
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organ culture serves as a stress test and corneas not tolerating long term storage are 
detected by a significant endothelial cell loss and are discarded. 
 
Irrespective of the storage method used, inspection of the endothelium after a prolonged 
storage is essential to prevent transplantation of corneas of poor quality. Changes in the 
endothelium as a result of postmortem time and other variables such as cause of donor 
death, donor age, circumstances of death, may affect cell viability and result in endothelial 
death in the long run. Cultured corneas have preservation folds caused by swelling of the 
stroma in the absence of osmotic agents. These folds do not affect the quality of the 
tissue, provided that they remain covered by viable endothelium. Before transport and 
surgery the swelling is reversed by the dextran present in the transport medium. The final 
thickness is reached after about 24 hrs and is dependent on the dextran concentration. 
The deswelling phase precludes that an organ cultured cornea, contrary to a 
hypothermically stored cornea, is ready for immediate use unless specific systems and 
logistics are developed for emergencies. The dextran also protects the cornea against the 
lower ambient temperature during transport. Organ culture offers a longer storage time, a 
less restricted donor supply on beforehand, corneal endothelium with a better defined 
quality and a pre-operative sterility control. Organ cultured corneas always display an 
epithelium made up of 2-3 layers of viable cells. The 30 days storage period allows an 
efficient use of valuable donor tissue: planning of operations is easier, allowing sufficient 
time for the allocation of HLA-matched corneas. The disadvantages of this method are the 
relative technical complexity and the need for qualified staff to perform tissue culture and 
selection of the corneas [7]. 
 
Samples of the storage medium of cultured corneas are routinely tested for microbiology 
after 3-7 days in the first phase, and after 1 day in the second phase. Cultured corneas 
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are also visually inspected every day. A gradual change in color of the medium is 
expected, but any cloudiness or significant color change of the medium is indicative of 
bacterial or fungal contamination. A contaminated cornea is discarded regardless of 
whether the microbe is pathogenic or not. Identification helps to identify trends and 
opportunities for process improvement [8,9]. It is still a point of debate whether the clinical 
outcome after grafting of corneas stored by hypothermic or organ culture techniques is the 
same, although the few studies comparing the effect of the storage methods on outcome 
demonstrate similar graft survival and post-operative decline in endothelial cell density 
[10-13]. 
 
Tissue processing for specific surgical purposes 
Eye bank preparation of corneal tissue for lamellar keratoplasty - 
Lamellar keratectomy of donor corneas may be performed by eye bank technicians who 
have successfully demonstrated proficiency in sectioning the cornea using aseptic 
technique with an automated microkeratome under laminar flow. Donor selection criteria 
for corneas used in lamellar keratoplasty are the same as for penetrating keratoplasty with 
a few exceptions.  Corneas with prior laser photoablation surgery or non-infectious 
anterior stromal scars may be suitable for posterior keratoplasty, but corneas with 
previous intraocular surgery scars are not recommended for use since the cornea may 
rupture under infusion pressure while on the artificial anterior chamber [14-16]. 
 
A 3-4 mm scleral rim is needed for corneas used in lamellar keratoplasty procedures to 
ensure an adequate seal on the artificial chamber of the automated microkeratome. An 
evaluation of the cornea by slit lamp biomicroscopy and specular microscopy should be 
performed prior to lamellar keratectomy. An automated microkeratome system consists of 
a control unit, an artificial chamber, microkeratome turbine and heads. The control unit 
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should be set up in close proximity to the laminar flow cabinet. A sterile field is set up 
under the laminar flow cabinet with the artificial anterior chamber connected to an 
irrigation system and turbine connected to the control unit. The cornea is placed using 
tissue forceps centrally onto the artificial anterior chamber which has been moistened by 
activating the irrigation system and the chamber is locked into place. The system must be 
watertight to ensure a smooth cut. The cornea is pressurized by infusing PBS through the 
irrigation system. A tonometer lens is placed on the corneal surface to confirm that a 
minimum of 65 mm Hg has been established inside the artificial chamber through the 
infusion of PBS. In case of anterior lenticules, the graft desired thickness is obtained by 
the correspondent microkeratome head. For posterior lenticules, a pachymetry reading is 
obtained after the removal of the epithelium, to determine which microkeratome head to 
use to obtain a final graft thickness in a range of 120 μm to 250 μm. 
 
Resection of cornea with a swinging microkeratome - 
The corneal epithelium may be gently removed before preparation, or left in place. In the 
former case, the subsequent swelling of the stroma during preservation could be limited. 
Two points are marked on the mid-periphery of the cornea using a sterile gentian violet or 
trypan blue marker to assist with re-aligning the cap back onto the remaining stromal bed 
after the cut has been made. 
 
The blade in inserted into the microkeratome head, which is secured into the turbine and 
lubricated with PBS. The power source is then activated to begin the blade oscillation of 
the microkeratome. The microkeratome head is rotated manually across the cornea. Once 
the sectioning is completed, the free cap is removed from the microkeratome head and 
repositioned onto the corneal bed, taking care of re-aligning the marks. A wexel sponge 
spear is used to smooth out any bubbles between the cap and the graft bed. The pre-cut 
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cornea is removed from the artificial chamber using tissue forceps. Once lamellar 
keratectomy has been completed, the cornea should be re-evaluated by slit lamp 
biomicroscopy and specular/light microscopy to confirm that the tissue is suitable for the 
intended use [17]. 
 
Storage of corneal lenticules for lamellar keratoplasty - 
Anterior corneal lenticules can be either dehydrated or freeze-dried, and stored at 2-6°C 
according to the eye bank‘s validation protocol. Alternatively, anterior/posterior lenticules 
can be placed in a cornea viewing chamber filled with preservation media (hypothermic 
storage) or in the transport medium (OC). 
 
The preparation of donor sclera - 
The donor sclera is used in allografts for a variety of procedures, most commonly to 
enclose orbital implants for reconstruction of anophthalmic cavities, reconstruct eyelids, 
cover tubes used in glaucoma surgery, repair scleral thinning, correct lid retraction and 
cicatricial entropion, tumour excision. Selection criteria are the same as cited for 
penetrating keratoplasty, except that tissue with local eye disease affecting the corneal 
endothelium is acceptable for use. Being a vascularised tissue, malignancies are applied 
as additional contraindication. Post mortem interval may be extended. 
 
Donor sclera is prepared from remaining ocular tissue following excision of the 
corneoscleral button or from donor globes which have been disqualified before 
corneoscleral rim excision. Any abnormalities such as discoloration, thinning or atypical 
vessels preclude the utilization of the tissue, as well as tumors in the donor medical 
history. Since conjunctival tissue is an excellent carrier for microbes, remnants of muscles 
and conjunctiva must be removed. The intraocular material is removed by using forceps, 
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iris scissors, sterile gauze or cotton tipped applicators. The sclera is finally rinsed in PBS, 
reshaped to its original spherical form, preserved dehydrated in ethanol (70% or higher 
concentration) or glycerol, fixed in formalin, freeze dried, or frozen. 
 
Future aspects in eye banking 
Synthetic medium for corneal preservation -  
Conventional OC is typically a 3-stage protocol: the first transport medium that allows the 
corneal shipment from the morgue to the eye bank, the OC (storage) medium that helps to 
preserve the cornea for duration of 21-28 days at 31
o
C and the final transport medium 
with a deswelling agent to reduce the thickness of cornea for ease of transplantation as 
reported earlier in this chapter. The storage and the final transport medium contain serum 
of animal origin in it. Apart from serum, other nutrients of animal origin have also been 
investigated for prolongation of the endothelial metabolic activities, such as chicken 
feather, ovalbumin, and pig bone amino acids, usually used in combination with other 
sources of nutrient supplements. The significance of FCS is not well-known; however, it 
was proved that a higher rate of endothelial cell damage occurred when the porcine 
corneal endothelial cells were preserved in the OC medium without serum. It has 
previously been reported that FCS is responsible for resisting the stress levels of the cells 
in vitro, whereas other reports suggest that the serum-free medium causes higher ECL 
due to necrotic areas. Animal-derived products have the potential to introduce animal 
viruses or prions that if assimilated in the human body could be hazardous. Animal 
viruses, especially retroviruses, could integrate into the human genome and activate 
human oncogenes or oncosuppressor genes, while prions could lead to human forms of 
BSE. This is why synthetic media have been developed. However, in the literature, there 
is no document reporting the transmission of animal viruses due to the fact that animal 
serum was used and most of the safety concerns are ruled out. The potential transmission 
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of BSE primarily comes from donors who have donated their corneas and were at risk of 
having BSE (from example, UK donors at the time of mad cow disease). Theoretically, 
there could be a transmission of animal-derived viruses that could integrate in the genome 
and activate oncogenes, therefore, technically it would be safer to develop and integrate a 
totally synthetic/animal free media in the routine eye banking procedures [18,19].  
 
Pre-cut and pre-loaded tissues for Descemet Stripping Automated Endothelial 
Keratoplasty -  
Donor tissues for DSAEK can be prepared by the eye banks where the cornea is cut using 
a microkeratome and the entire tissue is delivered to the surgeon as a pre-cut lenticule. 
The anterior cap of the cornea can still be left attached to the scleral rim by its peripheral 
edge for ease of transportation and to lower any potential endothelial cell damage 
[20,21,22]. Eye bank prepared pre-cut tissues have certain advantages over those tissues 
that are prepared in the surgery. If the tissue is prepared by the surgeon in the operating 
theatre and if it fails due to irregular cut or perforation in some cases then the surgery has 
to be postponed or an extra cornea has to be kept ready for replacement which increases 
the tissue wastage in general. Moreover, technological advances like 3D (three 
dimensional) printing has helped ophthalmic field in various ways, one of which is 
designing and developing surgical tools for transplantation purposes.  
 
Device prototyping for surgical glides - 
3D printing technology can be used for initial prototyping of the surgical glides however 
depending on the requirement of the units, it can be custom built, sterilized and used in a 
surgical theatre. Initial prototyping is used in order to check the units before proceeding to 
mass production. This technique finds applications in multiple fields such as aerospace, 
art and sculpture, industrial design, engineering, medical industries, biotech (human tissue 
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replacement) and much more. This technology could be used in order to get a functional, 
inexpensive, ready to use prototype. Starting from a digital file (STL - 
STereoLithography/Standard Tessellation Language) the device is generated by adding 
multiple layers of material (plastic, resin, etc.) until the entire object is formed.  
 
Preparation of the pre-loaded lenticules - 
In order to keep the procedure easy, especially when ultra thin lenticule are prepared, the 
posterior lenticules were preserved with a support such as the anterior lenticule of the 
tissue or a synthetic support such as a contact lens. The support prevents the tissue to 
shrink and it can be used as an anchor point to avoid any endothelial damage. The pre-cut 
tissue and its support are put in a standard punching block (Moria, Antony, France) with 
the endothelial side facing up. The tissues can be trephined with a desired diameter (8-9 
mm). The posterior lenticule is picked up grasping the support and is inserted into the 
glide. The device is further filled with 1 mL tissue culture medium after removing the air 
present inside the glide in order to avoid the formation of bubbles that remain in contact 
with the endothelium during the storage time. The lid of the glide is closed and the glide is 
gently fixed in the preservation container. The container is filled with 50 mL of the 
preservation media with Dextran and all the grafts are ready to be delivered within 4 days 
from the preparation. 
 
Pre-bubbling the tissues for Descemet Membrane Endothelial Keratoplasty - 
Recently, two techniques for preserving pre-separated corneal tissues for DMEK have 
been published. Descemet‘s membrane and endothelium can be separated from the 
overlying stroma with a simple technique using air or liquid dissection. Air injection is 
usually performed with a high pressure (pneumodissection) to create the separation using 
a big-bubble technique. However, liquid requires medium to high pressure (figure 3).  
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Figure 3: Pre-bubbled tissue prepared using submerged hydro-separation (SubHyS) 
method. 
 
The tissues can then be preserved in the transport medium for 7 days. These techniques 
can be performed at the eye banks and the pre-bubbled tissues can be shipped to the 
surgical theatre allowing surgeons to reduce tissue wastage in the surgery room due to 
tissue preparation errors. An adequate size of graft tissue can be obtained without the 
need to manually handle the tissue. The technique allows storage of the tissue in tissue 
culture medium with low endothelial cell loss. However, either of the techniques has no 
significant changes seen in the endothelium apart from that the yield generated using 
liquid separation was slightly higher than air [23-25].  
 
Pre-stripping the tissues for Descemet Membrane Endothelial Keratoplasty - 
Stripping, unlike the bubble separation technique is performed by peeling the Descemet‘s 
Membrane and the endothelium away from the stroma leaving a hinge at the end of the 
52 
 
lenticule as showed in figure 4. This allows preservation of pre-separated endothelial 
grafts in the eye bank further shipped to the surgeons. This technique has showed 
minimum mortality rate as compared to the other currently performed techniques.  
 
Figure 4: Pre-stripped tissue using stripping method.  
 
Thus, Pre-loaded, pre-bubbled or pre-stripped tissues can be prepared in the eye bank 
and shipped to the surgery to ensure a validated graft by the eye bank for surgery.  
 
Human corneal endothelial cell culture -  
The field of eye banking surely requires more in depth knowledge in terms of graft 
manipulation however new technologies and culture methods for HCEC culture would 
surely prove to be a next challenge for eye banks. Considering the requirement of donor 
corneal tissues for clinical purposes, in vitro cultured cells may help to reduce the demand 
of tissues for endothelial keratoplasty. However, challenges concerning the requirement of 
clean room facilities and culture conditions along with pre-defined scaffolds or a surgical 
technique will need a thorough revision in the near future.  
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Thus, we envision that eye bank is growing not only in the field of procuring the tissues for 
transplantation but also in the field of research and development. Development in the 
preservation techniques, surgical devices, modification of tissues and designing new 
methodologies for ocular health care is now becoming a part of eye bank world. 
Standardizing the posterior lamellar graft preparation methods will reduce unnecessary 
manipulation of the tissue in the operating theatre and reduce the high surgical skill or risk 
quotient. Pre-cut tissues which would reduce the overall intervention costs and time 
seems to be the future of eye banking. The efforts by the eye banks on the final quality of 
the graft would reduce the severe efforts of manipulation by the surgeons thus providing 
better quality tissue for patients [26]. The tissues may be replaced by the in vitro cultured 
cells to reduce the demand of human corneal tissues in the near future and eye banks 
may play a dramatic role in determining the co-factors that will relate to the cellular 
pathophysiology and conditions.  
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INTRODUCTION TO CORNEAL ENDOTHELIAL CELL 
CULTURE AND TRANSPLANTATION 
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Introduction 
In recent years, corneal tissue engineering has evolved dramatically, from culturing cells in 
vitro to developing synthetic scaffolds and artificial corneas. Isolation, culturing and 
bioengineering have been studied to a limited extent and further research is on-going. 
Attempts have already been discussed in the literature for exploiting the power of native 
cells for the manufacturing of stroma-like extracellular matrix and for the production of cell 
sheets, whether it be the epithelium with amniotic membrane/fibrin or endothelial cells with 
intact basement membranes [1]. It has also been found that collagen-based engineered 
matrices support cell growth and demonstrate appropriate optical and mechanical 
properties. Current research is showing promising results in growing corneal constructs. 
The next challenge is to ensure if these constructs show appropriate thickness, 
transparency and strength in vivo. However, issues like cellular responses, wound healing 
and inflammatory responses need to be studied in detail clinically before any conclusions 
can be drawn [1].  
 
Evidence for corneal endothelial stem cells 
Both in vitro and in vivo studies have been carried out which indicates the presence of 
corneal endothelial progenitors. Some of which include: 
 
BrdU - Studies carried out using Alkaline phosphatase-Bromodeoxyuridine (AP-BrdU) 
have suggested the presence of corneal endothelial progenitors. In these studies the 
limbus was intensely stained with AP-BrdU [2,3]. This experimental method was used to 
detect the presence of dividing cells. BrdU retention was identified by alkaline 
phosphatase activity. Although this technique indicates dividing cells, it may also identify 
the presence of native, cellular alkaline phosphatise activity which is typically observed in 
both intracellular and cellular plasma membrane isoforms of this enzyme and particularly 
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in stem cells. These studies also showed that HCECs from the corneal periphery 
increased in number suggesting the presence of progenitor cells.  
 
Telomerase - In the telomerase based studies, corneas were divided into three sections, 
a) central, b) middle and c) peripheral. The authors observed telomerase activity in the 
middle and the peripheral sections whereas the central section did not show the presence 
of telomerase activity [9-12]. It was also observed that donor age may have a potential 
limitation to the human wounding response or cell division in the periphery [4-7].  
 
Schwalbe’s line cells - A novel cell type (named Schwalbe‘s line cells) was identified in 
1982 by Raviola and co-workers. These cells form a discontinuous cord that is usually 
found in the circumference beneath the Schwalbe‘s ring (transition region between the 
corneal endothelium and the anterior extension of the trabecular meshwork) [8]. An 
increase in cell division by the Schwalbe‘s ring cells after laser trabeculoplasty has been 
observed. This indicates that Schwalbe‘s line cells may hold progenitor cell-like properties. 
A four-fold increase in cell division in human laser-treated explants was also confirmed by 
Acott and co-workers [9]. It was observed that over 60% of the cell division was initially 
localized to the anterior non-filtering region of the trabecular meshwork and these 
migrated towards the burn [10-13].  
 
Corneal endothelial regeneration in vivo - It has been hypothesized that a slow, 
regeneration of HCECs starting from the corneal periphery can occur [14]. The 
microanatomy of the endothelium showed anatomic organization in the periphery of the 
human corneal endothelium, which also suggested a continuous slow centripetal migration 
throughout life of HCECs from specific niches. This further led to the understanding that 
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the corneal endothelium can be regenerated if cells are excised from the peripheral region 
[14].  
 
Isolation of human corneal endothelial progenitors  
Single cell culture: There are several methods used for HCEC isolation. Initially, 
collagenase or trypsin was used on whole corneas but as it inevitably caused 
contamination of corneal fibroblasts, a selective L-valine-free medium was used. As this 
medium had to be used for several passages to completely abolish the presence of 
fibroblast growth, L-valine free selection medium was assumed to have acted by arresting 
the growth of fibroblast-like cells rather than by killing them [15].  
 
The peel-and-digest method by Peh and co-workers has resulted in successful cultures 
[16]. Other methods include stripping or bubble techniques to separate the DM from the 
stroma and then digestion of the cells using trypsin for cell culture. Stripping of HCECs 
can also be performed with the aid of a vacuum suction holder [13]. After peeling, the DM 
and endothelial layer are finally digested enzymatically using dispase or EDTA, followed 
by gentle pipetting. However, enzymatic digestion requires a prolonged incubation time to 
detach cells from the matrix, subsequently also leading to higher cellular degeneration. 
Thus, although several potentially successful methods do exist in the literature, it is 
evident that there is still the need to standardize a specific and reproducible method to 
isolate and culture HCECs from donor corneas [17]. 
 
Explant culture method - A recent study showed remarkable growth that was achieved 
using a serial explant culture technique. The explant was transferred to 7 new plates over 
a period of 6 months, generating sheets of small, primitive cells in each plate. The findings 
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are consistent with the theory that progenitor cells for the corneal endothelium reside 
within the limbus and provide new insights to HCECs culture [18].  
 
The HCEC sphere forming assay - It is believed that the corneal endothelium is derived 
from neural crest cells during embryonic development but also has a mesenchymal origin 
[19,20]. Sphere colonies from corneal endothelial cells express neural and mesenchymal 
proteins. Mimura and Wing et al have also shown that these colonies have the potential to 
differentiate into neuronal lineages [21,22]. The sphere forming method has also been 
used to investigate cultivated HCECs with differences in telomere length, telomerase 
activity, and characteristics reflecting senescence. The sphere forming assay was 
performed to obtain precursors from cultured sixth passage (p6) HCECs. p6 and p7 
cultured HCECs were used as the controls. It was observed that precursors obtained from 
the spheres had longer telomeres and higher telomerase activity than cultured p6 cells. 
Strong positive staining for senescence-associated β-galactosidase activity was detected 
in p6 and p7 cultured HCECs, whereas little or no staining was detected in the precursors 
within spheres obtained from p6-cultured HCECs or their progeny. The progeny of 
spheres derived from cultured HCECs were small regular cells that grew at a higher 
density and contained more 5-bromo-2‘-deoxyuridine-incorporating cells compared with 
the parental cultured cells. These findings indicate that the sphere forming assay enriches 
precursors with longer telomeres, higher telomerase activity, and younger progeny than 
the original cells. Thus, the sphere forming assay may contribute to obtaining the young 
HCECs needed for regenerative medicine [21].  
 
In another study, the cultured cells partially retained the properties of neural crest and 
periocular mesenchyme which are believed to be the source of origination of corneal 
endothelium via the neural crest using serum free media. The progenitors have a high 
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proliferative potency and possess endothelial function which was checked by Ussing 
Chamber and transplantation in the rabbit cornea [20]. 
 
The culture of human corneal endothelial cells using conditioned medium 
Many human corneal endothelial cell culture media have been described earlier with a 
combination of endothelial growth factors, base medium, serum, growth factors, insulin, 
vitamins etc [17]. There have been several studies utilising conditioned medium from other 
cell types to promote HCEC proliferation. These include conditioned medium from mouse 
embryonic stem cells, human bone marrow derived mesenchymal stem cells and human 
amniotic fluid. 
 
Mouse embryonic stem cell conditioned medium –  
Studies were performed to understand if mouse embryonic stem cell conditioned medium 
had any effect on the proliferative capacity of HCECs in vitro. Primary HCECs were 
cultured in human CEM containing 25% ESC-CM for the experimental group and CEM 
alone for the control group. The results showed that HCECs in the 25% ESC-CM group 
resulted in polygonal cells on day 2, whereas those in the CEM group showed slightly 
larger cells during days 3-4. HCECs in the 25% ESC-CM group could be sub-cultured until 
6
th
 passage without increasing in cell volume whereas those in the CEM group were 
cultured and lost their polygonal appearance by passage 2. Cells in both the groups 
expressed ZO-1, Na+-Ka+ ATPase, VDAC3, SLC4A4, and CLCN3 (described further in 
the article). Ki67 positive cells and the percentage of cells entering the S and G2 phases 
were higher in the 25% ESC-CM group than in the CEM group. The 25% ESC-CM group 
showed a decrease in apoptotic cells and p21 protein expression. Furthermore, it was also 
reported that the cells cultured in 25% ESC-CM had enhanced HCEC proliferation and 
promoted HCECs into the cell cycle [23-27]. To summarise, in these studies primary 
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cultures of HCECs were cultured using 25% mouse embryonic stem cell conditioned 
medium. Compared to control cultures, these cultures showed cells with increasing 
polygonal morphology (characteristic of healthy HCECs), the cultures could be sub-
cultured further (until the 6
th
passage), had a higher number of cells expressing Ki-67 and 
fewer apoptotic cells.  
 
Human bone marrow derived mesenchymal stem cell conditioned medium –  
Human bone-marrow-derived MSCs derived conditioned medium (MSC-CM) use has also 
been suggested. It has been observed that cells cultured in MSC-CM showed regular 
morphology, functional phenotypes of intracellular junctions and pump functions as 
compared to those cells that were cultured without MSC-CM. An increase in cellular 
proliferation was also noted with double the amount of positive cells in MSC-CM cultures. 
Pump proteins such as VDAC3, CLCN3, SLC4A4 and p120 were expressed in the MSC-
CM cultured cells. It also regulated the G1 proteins of the cell cycle which are required for 
endothelial functioning [28].  
 
Human amniotic fluid – 
Another study was designed to evaluate the effects of HAF on the growth of HCECs and 
to establish an in vitro method for expanding HCECs. This showed that 20% HAF 
containing medium exhibited a greater stimulatory effect on HCEC growth and could 
represent a potential enriched supplement for HCEC regeneration studies [29].  
 
The conditioned media that have been discussed so far either have an animal origin or an 
animal derived component, mainly serum. However, a xeno-free media would be more 
suitable to reduce the chances of transmission of prions or any potential disease from the 
animal origin. Moreover, it is always required by the regulatory authorities to show the 
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minimal risks of using animal derived components for human use or use a complete 
synthetic medium. This will further be challenging but required both in terms of healthcare 
and regulatory issues.  
 
Cultivation of the primary human donor corneal cells using a dual media approach 
A study by Peh GS et al demonstrated that the outcome of culturing primary HCECs and 
proliferative potential can be successful if negatively impacted by lower, sub-optimal 
plating density. The study showed that it was possible to obtain the hexagonal morphology 
of the cells at the end of third passage and the count of up to 2.5X10
7
 cells with a seeding 
density of greater than or equal to 1X10
4
 cells per cm
2
 [30]. However, after defining the 
seeding density, the same group also described a novel dual media approach for the 
expansion of primary HCECs in vitro. Analysis of growth dynamics of the cells in 
proliferative or maintenance media was carried out. At the third passage, homogeneous 
appearance of the cells and polygonal morphology was observed using dual media 
approach. The cells also expressed endothelial associated markers. Using this method, 7 
day exposure to maintenance media showed differential gene expression associated with 
cell proliferation and wound healing which eventually confirmed that this is a reproducible 
and consistent method for the culture of HCECs [31].  
 
Human corneal endothelial cell markers 
Structural markers such as ZO-1 which is a tight junctional protein have been used widely 
to study the junctions of in vitro expanded HCECs. As the major function of the corneal 
endothelium is to prevent corneal swelling by the activity of membrane pumps, these are 
also used as functional markers for cultivated HCECs. These pumps include Na
+
-
K
+
ATPase, VDAC3, CLCN3, SLC4A4 and p120. 
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Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5), a target of Wnt 
signaling has also been identified as a potential biomarker for HCECs. LGR5 has been 
widely used as a marker of intestine, stomach and hair follicle stem cells in mice models 
however human corneal tissues were used to study functional gain and loss. The 
peripheral region of corneal endothelial cells shows a high expression of LGR5 and the 
cells that express this protein have also been shown to have stem/progenitor cell 
characteristics. It has been observed that LGR5 is the target molecule of the Hedgehog 
(HH) signaling pathway in the human corneal endothelium. More importantly, this study 
showed a repeatable expression of LGR5 that helped to maintain endothelial cell 
phenotype and the potential to inhibit mesenchymal transformation (MT) through the Wnt 
pathyway. Thus, this study highlights new findings that underline homeostatic regulation of 
human corneal endothelial stem/progenitor cells by LGR5 through the HH and Wnt 
pathways that are important for corneal endothelial cell functioning [32].  
 
Another study reported the characterization of HCECs in developmental stages. mRNA 
transcriptomes in human fetal and adult corneal endothelium were studied. High 
expression signature genes were identified for both fetal (245) and adult (284) HCECs. 
Many of these genes were identified as disease target genes in hereditary corneal 
dystrophies, consistent with their functional significance in HCEC physiology. 
Immunohistochemistry showed localization of four novel markers for fetal and adult 
HCECs such as Wnt5a, S100A4, S100A6 and IER3. This can further be used to 
characterize HCECs derived from stem cells or ex vivo expanded cells [33].  
 
As the currently used markers are not highly satisfactory due to their non-specific or co-
expression in other cell types, a published RNA-seq data of CECs and the FANTOM5 
atlas representing diverse range of cell types based on expression patterns was studied. 
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Five genes CLRN1, MRGPRX3, HTR1D and ZP4 were identified as novel markers for 
CECs. The specificities of these genes were confirmed at RNA and protein levels. These 
markers could further be used for purification of actual CECs and to evaluate the products 
derived from other cell types [34]. 
 
Wound healing of CECs 
Rho-associated protein kinase (ROCK) inhibitor helps in regulating the shape and 
movement of cells by acting on their cytoskeleton. It has been reported that ROCK 
inhibitor Y-27632 promotes adhesion, inhibits apoptosis, increases monkey CECs in vitro, 
and has also been suggested as enhancing corneal endothelial wound healing in vivo in 
animal models. HCECs did not show any toxicity or cell alterations when treated with 
ROCK inhibitor. Although it did not show any cell proliferation, ROCK inhibitor significantly 
enhanced cell adhesion and wound healing. Thus, as ROCK inhibitor did not show any 
toxicity, its benefits in corneal wound healing and adhesion may be relevant for 
therapeutic purposes [35].  
 
Tissue engineering HCEC sheets  
Scaffolds - Once the cells are cultured, it should be seeded on a transportation unit. The 
scaffolds play an important role in keeping the cells viable and transplanting the same 
being a bio-mimetic or as synthetic material. Earlier reports have shown that the cultured 
CECs have been seeded on the denuded DM scaffolds or stromal discs [36]. Human 
amniotic membranes have been used as a carrier for cultured CECs [37], but due to its 
translucent nature, it is not highly recommended for clinical applications. Gospodarowicz 
et al [38-40] tried to combine two species by seeding bovine CECs onto rabbit corneas 
denuded of their endothelium. It was reported that when corneas were transplanted back 
into rabbits, the corneal buttons showed full transparency without any edema [38-40].  
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Recently, many methods for culturing CECs on synthetic or biological grafts have been 
established. Mimura and colleagues used a network of loosely cross-linked type I collagen 
fibers for CECs [41]. Corneal edema decreased rapidly after transplantation in DSAEK 
groups [41]. Out of the many scaffolds that are described in the literature and have proven 
its efficiency in vitro or in animal models, Koizumi and colleagues cultured monkey EC 
sheets on collagen type I carriers into monkeys‘ eyes however the corneas recovered their 
clarity only six months after transplantation [42]. The scaffolds for CECs transplantation 
can be biologic or synthetic, permanent or biodegradable. Common biological materials in 
scaffolds reported so far are collagen, fibronectin, and hyaluronan. However, the next step 
forward would be to check the feasibility of the use of these scaffolds in vivo.  
 
Nanotopography - It has been reported that in the native environment, corneal endothelial 
cells interact with the nanotopography of the underlying Descemet‘s membrane. The study 
showed that nanotopography enhanced bovine corneal endothelial cell (BCEC) responses 
and created a monolayer which resembles the healthy corneal endothelium. Topographies 
of different geometries were first tested to identify those that would elicit the most 
significant responses. A BCEC monolayer was generated on both micro and nanoscale 
pillars and wells, and these topographies showed polygonal geometries with well-
developed tight junction proteins. SEM revealed that cells on pillars showed a higher 
density of microvilli, which was similar to native corneal endothelium. BCECs on 
nanopillars displayed a lower coefficient of variation of area that was within the range of 
healthy corneal endothelium. More importantly, a BCEC monolayer cultured on nanopillars 
also had enhanced Na(+)/K(+)-ATPase immunofluorescence expression and mRNA 
upregulation and a higher Na(+)/K(+)-ATPase activity. These results suggest that 
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nanopillar substrate topography may provide the relevant topographical cues, which could 
significantly enhance the formation and function of the corneal endothelium [43].  
 
Hydrogels - In a recent study, fabrication of biocompatible and biodegradable 
poly(ethylene glycol) (PEG)-based hydrogel films (PHFs) for the regeneration and 
transplantation of CECs has been described. 50-μm thin hydrogel films have similar or 
greater tensile strengths to human corneal tissue. Light transmission studies revealed that 
the films were >98% optically transparent, while in vitro degradation studies demonstrate 
their biodegradation characteristics. Cell culture studies demonstrate the regeneration of 
sheep corneal endothelium on the PHFs. Although sheep CECs do not regenerate in vivo, 
these cells proliferate on the films with natural morphology and become 100% confluent 
within 7 days. Implantation of the PHFs into live sheep corneas demonstrates the 
robustness of the films for surgical purposes. Regular slit lamp examinations and histology 
of the cornea after 28 days following surgery revealed minimal inflammatory responses 
and no toxicity, indicating that the films were benign. The results of this study suggest that 
PHFs are excellent candidates as platforms for the regeneration and transplantation of 
CECs as a result of their favourable biocompatibility, degradability, mechanical, and 
optical properties however, in vivo trials will show its real potential in the future [44]. 
 
Thermoresponsive plates - Cellular organization of foreign grafts constructed from 
cultivated cells is critical to successful graft-host integration and tissue repair. This study 
described a novel HCEC therapeutic method, where cultivated adult HCEC sheet with 
uniform orientation was prepared and transplanted to the rabbit cornea. Having a correct 
morphology and intact barriers, the HCEC sheet was made by the temperature-modulated 
detachment of monolayered HCECs from thermoresponsivepoly-N-isopropylacrylamide 
(PNIPAAm)-grafted surfaces and was delivered with proper polarity to the corneal 
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posterior surface by a bio-adhesive gelatin disc. Results of the in vivo studies, including 
the follow-up clinical observations and histological examinations, showed the laminated 
CEC sheet successfully integrated into the rabbit corneas denuded of their endothelial 
layer after the bio-degradation of gelatin carrier. More importantly, the feasibility of 
handling and delivery of a mono-singular layer of cell sheet in a clinical setting was a 
major advantage. These data indicate the feasibility of the proposed procedure in cell 
therapy for corneal endothelial cell loss [45]. 
 
HCEC transplantation 
Multiple studies have demonstrated the possibility of culturing HCECs and the current 
prospects are to study the transplantation potential of cultured cells in human and animal 
models. In one study of note, collagen sheets were used as substitute carriers for cultured 
HCECs. Pump functions showed 76%-95% of those of natural human donor corneas. 
Thickness was significantly less and no stromal edema was found post surgery in a rabbit 
model [46]. In another study the cells were injected in the anterior chamber with face down 
position in the rabbit models. Very early studies on cultured human corneal endothelial 
cells have been recently carried out on monkey models. Recently, 11 human patients 
(unpublished clinical trial) with bullous keratopathy or Fuch‘s dystrophy have been treated 
using the same technique and 20/20 vision has been attained post-operatively. Early 
stage experiments using Rho Kinase inhibitor drops have also showed promising results in 
terms of visual recovery, thickness and maintenance of intra-ocular pressure as reported 
during ASCRS 2015 symposium (S. Kinoshita).   
 
Immunosuppression 
Although there are studies carried out on transplanting the cultured corneal endothelial 
cells in human recipients, it should not be left out of consideration that immunological 
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responses may hinder the outcomes. The corneal graft has a huge immune privilege as 
compared to other transplants due to absence of blood and lymph vessels in the graft and 
its bed, absence of MHC class II
+
 antigen presenting cells in the graft, reduced expression 
of MHC-encoded alloantigens on graft cells, constitutive expression of T cell-deleting 
CD95 ligand on corneal graft endothelium, the existence of an immunosuppressive local 
microenvironment (aqueous humor), and the capacity of the graft to induce anterior 
chamber associated immune deviation (ACAID). Precisely, corneal endothelial cells have 
a distinct molecular strategy to reduce their antigenic visibility to CD4
+
 and CD8
+
 effector T 
cells, and to alter the functional program of responding T cells. This may be advantageous 
in terms of donor corneal transplantation. However, the immunological reactions of the in 
vitro cultured and transplanted corneal endothelial cells are still being studied [47].  
 
Differentiation of other cell types into HCEC 
Studies have also shown the potential to derive CEC-like cells from human embryonic 
stem cells (hESCs). The differentiation potential of hESCs to HCECs through the 
periocular mesenchymal precursor (POMP) phase has been shown using transwell co-
culture system of hESCs with differentiated human corneal stromal cells. CEC-like cells 
were derived from POMPs using lens epithelial cell-condition medium. Corneal endothelial 
differentiation marker N-cadherin and transcription factors FOXC1 and PitX2 were 
expressed within 1 week of culture. The isolated cells were seeded onto posterior acellular 
porcine corneal matrix lamellae to construct the CEC-like cell sheets. These cell sheets 
were transplanted into rabbit eyes and the transparency was found to have restored 
gradually. The cells derived from this source displayed characteristics of native human 
CECs [48].  
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Umbilical cord blood mesenchymal stem cells have also been differentiated into HCECs 
and to determine whether these MSCs can ‗home‘ to sites of corneal endothelial cell injury 
using an ex vivo corneal wound model. RNA was isolated and purified from UCB MSCs 
and HCECs. The ability of different culture media was determined and the morphology, 
immuno-localization and gene expression was determined in both tissue culture and ex 
vivo corneal endothelial wound models.  MSCs attached to damaged, but not intact, 
corneal endothelium in ex vivo corneal wounds. The results have indicated the potential 
differentiation of cord blood derived MSCs towards HCEC-like cells [28]. However, further 
studies will be required to identify the specific microenvironmental conditions that would 
permit tissue engineering of UCB MSCs to replace damaged or diseased corneal 
endothelium.  
 
ESCs and iPSCs have an extensive self-renewal capacity and the potential to differentiate 
into any tissue specific cell lineages. A study carried out using trans retinoic acid (RA) 
treatment during the embryoid body (EB) on mouse ESCs and iPSCs showed the 
promotion of neural crest cells. These cells were further differentiated into CEC-like cells 
using lens epithelial cell conditioned media. For the initial differentiation into neural crest 
cells, dose of 1 μM RA on day 4 of EB formation showed neural crest differentiation. 
Plating these cells on gelatine-coated plates further led to cell migration out of EBs. 
Further, LEC-CM enhanced the differentiation of neural crest into CEC-like cells which 
was confirmed using ICC and RT-qPCR. This study showed a potential of two-step 
inducement procedure for treatment of corneal endothelial failure [49].   
 
In conclusions, dysfunction in the corneal endothelium, which controls the hydration and 
transparency of the cornea, is one of the most common reasons of corneal 
transplantation. The current primary treatment to cure the endothelial failure is 
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replacement of the diseased corneas with a healthy donor tissue. However, globally the 
donor tissue supply is too low as compared to the requirement and therefore there is an 
enormous interest in the development of alternative treatment or therapeutic strategies to 
decline the current requirement of human donor corneas. A tissue-engineered corneal 
endothelium is of interest for corneal regeneration and for in vitro testing of ocular drugs. 
Cell therapy focuses on the culture expansion of corneal endothelial cells retrieved from 
the donor followed by transplantation to many recipients. Recently, research has focused 
on overcoming the challenge of harvesting human corneal endothelial cells and the 
generation of new bio-membranes to be used as cell scaffolds in surgical procedures. But 
a standard culture method has not been well established yet for the clinical purposes. The 
studies using telomerase activity, Schwalbe‘s line, progenitor cells indicated the presence 
of potential stem-like or progenitor cells in the periphery of the corneal endothelium. 
However, no clear evidence of corneal endothelial ‗Stem Cells‘ have been reported so far. 
The progenitors are isolated from the periphery of the corneal endothelium and have been 
exploited for the proliferative capability with early success. Till date the endothelial cell 
markers were non-specific but with the identification of novel markers, the researchers are 
one step ahead in terms of characterizing the endothelial cells. Although a few patients 
have already been treated using injection method, it is also essential to facilitate the 
validation of cell-injection therapy, or downstream development of an alternative corneal 
endothelium construct through cell-tissue engineering. This, in turn, will elicit greater 
confidence in facilitating downstream development of alternative corneal endothelium 
replacement using tissue-engineered graft materials or cell injection therapy. Current 
results highlight important emerging advances in the development of new treatment 
strategies for corneal endothelial dysfunction in humans with a better hope to treat these 
disorders with minimal clinical manipulations [50].  
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CHAPTER 3 
 
BIOCHEMICAL AND MECHANICAL BEHAVIOUR OF 
DESCEMET’S MEMBRANE 
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Before initiating the cell culture, it is important to learn the properties of the extracellular 
matrix of corneal endothelial cells which is the DM. The HCECs release the DM and 
adhere strongly on to the stroma and therefore the constituents of this material are 
important for cell adherence and proliferation. The elasticity of this membrane and 
implantation strategy at this stage would also allow exploring different possibilities to 
preserve the cells for the final transplantation. 
 
Aim 
To investigate the adhesive and stiffness properties of pre-stripped DMEK lenticules in 
different preservation conditions (with and without dextran). 
 
Introduction  
EK is a valid alternative to PK for the management of corneal endothelial failure [1-4]. 
Compared to PK, EK leaves a more secured eye with less post-operative astigmatism and 
faster visual rehabilitation with better optical quality. Different types of dissection 
techniques and instruments have been described to excise the very fragile DM and 
endothelium exclusively [5-9].  
 
Currently, organ culture is the most commonly used corneal storage method in Europe. It 
allows long storage times of approximately 4 weeks [10]. The TCM induces stromal 
swelling, reduces corneal transparency, and increases stromal and DM folding [10]. To 
facilitate surgery, the corneal graft thickness should be similar to that of the recipient‘s 
cornea while performing PK [11]. Therefore thinning the tissue is usually achieved by 
using a hyperosmolar medium (i.e. 5-6% dextran T500) for a minimum of 24 hours. As 
DMEK involves the transplantation of just a thin monolayer of endothelial cells and the 
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DM, which does not swell during TCM preservation due to the absence of stroma, it is not 
mandatory to de-swell the pre-stripped DMEK grafts [12]. Therefore, it was important to 
study the effect of the preservation conditions on corneal stiffness or adhesion of the pre-
stripped DMEK lenticules and the extent of manipulation during surgery.  
 
Adherence of the graft is an important parameter considering the re-bubbling rate during 
DMEK surgery post-operation [13,14]. Although there are many reasons that are 
correlated to re-bubbling rates such as the diameter of descemetorhexis [15] and surgical 
trauma. It has been reported that the donor characteristics may have no direct influence 
on re-bubbling rates [14] however, the preservation conditions has not been evaluated so 
far especially considering the rigidity of the graft. Therefore, to determine the optimum 
preservation media and conditions for pre-stripped DMEK lenticule, it is necessary to 
study the expression of adhesive proteins that are retained on the tissue when preserved 
in specific medium. In parallel, evaluation of the elastic properties of the tissue is needed 
to understand the extent of manipulation during the surgical procedure. The adherent 
properties can be studied using antibodies specific for adhesive proteins and the elasticity 
can be determined either using the elastic proteins or by the elastic modulus (or Young‘s 
modulus, E) of the DM, thus understanding whether the mechanical properties of the 
tissue could vary as a consequence of different preservation media. The elastic modulus 
(E) of a material can be determined from nano-indentation measurements on its surface 
[16-19]. Due to the high compliance and thinness of the investigated biological material 
(i.e. DM), the nano-indentation measurements have been performed with AFM since this 
method allows utilizing loads as low as few nN. The space resolution is also remarkable 
since the curvature radius of the probe tips is of few nanometers [16]. 
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The purpose of the reported study thus was to evaluate the effect of preservation medium 
and their cross-combinations to determine the adhesive and stiffness profiles of pre-
stripped DMEK tissues post preservation. 
 
Materials and Methods 
Ethical statement and collection of samples 
Fifteen unsuitable corneas for transplantation were collected from FBOV, Italy, with a 
written consent to be used for research from the donor‘s next of kin. The donor corneas 
did not show indications of any systemic disease, dystrophy or infections. The corneas 
were not suitable for transplant due to low endothelial cell count (<2200 cells/mm
2
).  
 
Characteristics of the samples 
The average age of the donors was 68.46 (±5.01) with male:female ratio of 13:2 and post 
mortem time of 11.96 (±5.99) hours. The tissues were preserved in TCM for 20.11 
(±10.49) days and were further transferred to the de-swelling/TM when required with 6% 
dextran T-500 for 3.5 (±1.64) days.  
 
Experimental conditions 
Different conditions of the preservation medium and their combinations that were tested 
during this study are listed in table 1.  
 Condition 1 (C1) Condition 2 (C2) Condition 3 (C3) 
Tissues collected from TCM TM TCM 
 Stripping and Loading 
Preserved in  TCM TM TM 
 Analysis 
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Table 1: Different conditions of the preservation media before and after stripping the 
DMEK lenticule. Three samples per condition were used for immunostaining to study the 
adherence and elastic properties. Two DM samples per condition were used for AFM, 
nanoindentation method to study the rigidity of the tissues.  
 
Methodology 
Stripping method 
All the corneas [n=15] were centered on the base of a trephine punch using the peripheral 
holes of the suction area as reference. The corneal tissue was secured on the base, using 
vacuum, with endothelium facing the air. A 9.5 mm diameter punch (Moria, Antony, 
France) was used to create a superficial cut by gently tapping the endothelial surface (cut-
edge) of the tissue. The endothelium was submerged with the TCM or de-swelling 
medium/TM as required in the experimental condition to create a thin film of fluid. The 
membrane was lifted using a cleavage hook throughout the circumference to limit the 
peripheral tearing of the very fragile DMEK tissue. Using acute forceps (e.janach, Como, 
Italy), the membrane was stripped with a longitudinal movement from 3 sides ensuring that 
no torsions were generated during this phase. The tissue was stripped leaving a hinge 
behind (attached at the periphery) and were re-stored to its initial place by opening the 
tissue using surgical sponges. The tissues were further preserved in their respective 
media for 4 days at room temperature.  
 
Immunofluorescence 
The tissues [n=9] were stripped leaving a hinge behind and were preserved in different 
conditions of preservation medium (n=3 per condition), as listed in table 1. The tissues 
were washed with 1X PBS and were fixed overnight using 4% PFA. Later, they were 
washed in increasing concentrations of sucrose solution (7.5%, 15% and 30% 
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respectively) and embedded in optimal cutting temperature compound (OCT) for 
microtome cutting. All the samples were immunostained with the following antibodies: anti-
fibronectin (ab2413), anti-vitronectin [VN58-1] (ab13413) and anti-laminin (ab11575) for 
adhesive proteins and anti-fibrillin (ab53076), anti-collagen VI (ab118955) and anti-elastin 
(ab21610) for elastic proteins. All the antibodies were bought from Abcam, Cambridge, 
UK. 
 
The sections were washed twice with 1X PBS for 5 minutes and permeabilized using 0.5% 
Triton-X for 30 minutes at RT. Using a blocking mix (PBS, bovine serum albumin, goat 
serum and triton-x), the sections were blocked for one hour. All the primary antibodies 
were added at 1:100 apart from anti-Elastin and anti-Fibrillin which were added at a 
concentration of 1:50 and incubated at RT for 2 hours. A FITC-conjugated secondary 
antibody was added at 1:100 and the sections were incubated for 1 hour at RT. The 
sections were mounted using Vectashield and the cover slips placed and viewed using a 
laser scanning confocal microscope LSM510 (Carl Zeiss, Milan, Italy) at 488 nM.  
 
AFM nanoindentation 
Sample preparation 
The tissues [n=6] were stripped leaving a hinge behind and shipped to the AFM center in 
different conditions of preservation medium (n=2 for each condition), as listed in table 1. A 
critical issue for the AFM analysis in liquid was to keep the membrane well opened and 
firmly adhered to a solid support (such as a cell ground) as the DM folds spontaneously in 
the liquid environment. Therefore a procedure to make the DM lenticules adhere to a solid 
support under liquid was optimized as follows. Solid support PC (Polycarbonate) slabs (1 
mm thick) were chosen for this study. These slabs were roughened with sand paper 
(P1000 grade) in order to improve adhesion of the membrane. The tissues were picked 
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from the opposite end (stripped end) of the hinge and spread out onto an Aluminium (Al) 
foil with the endothelial side facing the air. The tissue was made visible with Trypan Blue 
stain. The Al foil was used since it keeps the tissue (DM) open and allows, by just 
reversing it, to lay the tissue on the Al foil. The tissue was kept open on the foil and was 
put in contact (inverted) with the PC slab point where a glue drop (2-4 l) had been 
positioned to expose the DM to the air. After 2 minutes (adherence time), the Al foil was 
detached and the tissue was then left firmly adhered with cyanoacrilic glue on the PC 
support with the endothelial side touching the base and the DM (non-endothelial side) 
facing upwards, i.e. the cantilever AFM tip. Figure 1 shows a DM sample immobilization 
according to the procedure mentioned above. 
 
 
Figure 1: Set up of AFM nanoindentation. a) Pre-stripped DMEK on the vacuum block, as 
sent from the FBOV labs to the AFM center. Descemet Membrane (DM) was separated 
leaving a hinge behind. b) DM was placed on an Al foil with endothelial side facing the air. 
c) DM with the non-endothelial side facing the air was separated from the cornea and 
immobilized with cyanoacrylic glue on polycarbonate slab (stained with Trypan Blue), 
ready to be inserted in the liquid measurement cell once covered with deionised water. 
The membrane was stained with Trypan Blue to make it visible and make the operations 
easier. 
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AFM measurements 
Nano-indentation was performed using atomic force microscopy (AFM Ntegra from NT-
MDT) in the spectroscopy mode. In this modality, the AFM tip was pushed into the sample 
(by moving the sample upwards) until a predefined deflection was obtained comparable to 
the set-point deflection value. Once the tip reached this point, it was retracted again. 
During this complete loading-unloading cycle, the position of the tip as well as the force 
exerted on the cantilever was accurately monitored, resulting in a force–distance (height) 
curve. The tissues were analyzed in liquid environment in order to avoid any modification 
of their properties as well as to avoid any adhesion falls due to jump-in/jump-off 
phenomena in acquired force-distance curves. A CSG01 (NT-MDT) probe was utilized for 
these experiments. This was chosen as a consequence of its very low force constant 
(typical K=0.03 N/m), as suggested for very soft (biological) materials [16-21]. 
 
Deionized water was used as liquid after having verified that the storage liquids of the 
cornea samples were not suitable since they are too rich in macromolecules that adhere 
to the apparatus components.30 indentations were performed on different points of each 
tested DM sample. Some indentations were also performed under the same experimental 
conditions on the surface of the PC slab in order to acquire the force-height curve on a 
rigid (undeformable) reference. It was previously verified that this procedure allows 
obtaining expected values of elastic modulus on benchmark soft materials (polyethylene 
and polytetrafluoroethylene). 
 
Statistical analysis was performed using student‘s t-test where p<0.01 was deemed 
statistically significant.  
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Results 
Expression of adhesive proteins in dextran based medium 
Fibronectin was localized at different points on the DM in condition 1 (C1), however it was 
strongly expressed throughout in condition 2 (C2) and condition 3 (C3), which contains 
dextran. Vitronectin showed expression in all the samples from each condition on the 
basement of the DM facing towards the stroma. Laminin was expressed in all the 
conditions at the junction between the endothelial cells and the DM but was intense in C2 
(Figure 2). 
 
Figure 2: Expression of adhesive proteins on the pre-stripped DM preserved in different 
conditions of the preservation medium observed at 400X magnification. Fibronectin was 
found throughout on both, the endothelial and the stromal side of the DM apart from 
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condition C1 that did not show expression throughout (localized). Vitronectin was 
expressed on the stromal side of the DM in all the conditions. Laminin, although 
expressed on the endothelial side in all the conditions, was highly expressed in C2.  
 
Expression of elastic proteins in dextran based medium 
None of the tissues from any condition showed the expression of any elastic protein on 
the DM, as shown in figure 3. Collagen VI was expressed in all the conditions, but on the 
posterior stroma and not on the DM (figure 3). It was therefore important to study the 
rigidity of the tissues using nanoindentation to check the stiffness of the DM.  
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Figure 3: Elastic properties on the pre-stripped DM preserved in different conditions of the 
preservation medium observed at 40X magnification. None of the samples showed 
expression of the elastic proteins in either condition on the excised DM apart from 
Collagen VI that was expressed in all the conditions on the posterior stroma.  
 
Influence of dextran on stiffness properties of pre-stripped DMEK lenticules 
For the nanoindentation measurements, the deflection set point was fixed at 0.7 nA, which 
gives rise to a maximum force of about 5 nN. For the data processing and elastic modulus 
calculation unloading curves were utilized. It is worth pointing out that negligible hysteresis 
was observed during the approaching-retraction cycles, reasonably as a consequence of 
the absence of cells on this side (non endothelial side) of the membrane [21]. 
 
A sketch of the indentation process of the tissue is presented in figure 4a. The length of tip 
penetration in the sample at the highest force is the indentation depth ‗‘ which is 
measured as height difference with respect to the rigid (undeformable) reference.  
 
In figure 4b, the force-height curves obtained by these measurements are presented along 
with the curve obtained on the rigid reference. Calculation of the penetration depth () is 
thus calculated as a height difference between the sample and the reference curve at the 
maximum force (5 nN). In particular, in this diagram the curves showing a penetration 
depth corresponding to the mean penetration depth value (mean) for the three investigated 
combination is reported. 
 
From the graph in figure 4b, the indentation spans in the range of 750-1150 nm (500-800 
nm and even values higher than 1 m has been found in other curves). No interference of 
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the sample support (PC slab) is expected since the indentation depth is not higher than 
1/10 of the sample depth, as it is expected to be in nanoindentation measurements [17]. 
By analyzing the type of relation existing between F and , it has been found that the 
shape of the contact area tip-sample is conical (figure 4a). Thus the following equation 
has been used to extract the elastic modulus, E [22]: 
  
where, α is the semi-vertical angle of the tip, ν and E are the Poisson ratio and the elastic 
modulus of the indented tissue-respectively. 
 
 
Figure 4: Atomic force microscopy of DM. a) Nanoindentation of the DM lenticule by the 
tip of an atomic force microscope and b) examples of force-height curves obtained from 
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these measurements from which the elastic modulus values were derived. The curves 
reported in this diagram represent the mean values of penetration depth (mean) measured 
on membranes of the C1, C2, C3 combinations. 
 
The mean elastic modulus of the tissues from conditions 1, 2 and 3 was found to be 
0.0014, 0.0012 and 0.0031 MPa respectively. Only for condition 3, the mean E value was 
significantly different compared to the other conditions indicating a higher stiffness of the 
samples preserved according to condition 3 (figure 5). There was no significant difference 
in stiffness between C2 and C1 conditions, thus overall more flexible tissues as compared 
to C3. The difference between C1 and C2 was statistically insignificant (p=0.23); however, 
the differences between C1-C3 and C2-C3 were statistically significant [p < 0.05 
(p=2.1*10
-9
 and p=2.3*10
-8
), respectively]. 
 
Figure 5: Mean elastic modulus values from AFM nanoindentation analysis of the tissues 
from conditions 1, 2 and 3 (C1, C2, C3 in the histogram). The samples from condition C3 
are those showing the highest stiffness. Difference between C1 and C2, giving a level of 
significance p (calculated by student‘s T-test) of 0.23 is non-significant (NS); the 
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differences between C1-C3 and C2-C3 are significant both with p<0.01 (p=2.1*10
-9
 and 
p=2.3*10
-8
, respectively). 
This may highlight that when the tissues are excised and completely exposed 
(DM+Endothelium) to dextran after storage, the tissues gain stiffness as compared to 
those preserved in TCM or TM throughout. If the tissues are preserved in dextran based 
media before and after stripping, they show more compliance (C2) as compared to those 
that are preserved in TCM and then exposed to Dextran post stripping as seen in C3.  
 
Discussion 
EK has dramatically evolved as an alternative to PK in the recent years [23]. DMEK is 
becoming popular in terms of faster visual recovery, less postoperative astigmatism and 
reduced risk of transplant rejection, as compared to the other EK procedures [24-29]. 
However, it is also important to understand how the preservation techniques may play a 
role in creating a different biophysiological environment of the cornea. Failure of graft 
preparation during the learning curve has been reported in approximately ≤16% of donor 
corneas [30]. The preservation conditions may play an important role in graft preparation, 
preservation and transplantation and on the corneal biomechanics.  
 
TCM has advantages as longer times of preservation allow organizing the transplant 
better and to perform microbiological and serological tests. However, as TCM swells the 
cornea almost to its double, the tissues must be de-swelled to a more physiological 
thickness before transplantation. For this reason, tissues are preserved in a dextran based 
de-swelling medium. This de-swelling or TM allows the water-soluble macromolecule that 
produces colloid osmotic pressure to extract excess water accumulated in the stroma. The 
tissuesare usually preserved up to 4 days to manage the de-swelling and transport the 
tissues to the surgical theatre avoiding any further endothelial cell damage. A functional 
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cell layer along with a smooth DM is essential for a successful DMEK surgery, as it allows 
both quick adherence of the lenticule to the underlying stroma of the recipient eye and 
reduces the possibility of dislocation. For DMEK, however, to become more useful and be 
adopted by the surgeons, it would be important to (1) reduce the wastage during graft 
preparation; (2) excise the tissues more reproducibly and (3) have preservation conditions 
that allow the tissue to reach the theatre with minimal damages. Hence we decided to 
check the adhesive properties of the DM when preserved in different conditions to identify 
whether the DM preserves its adhesiveness post preservation, which may eventually allow 
a more successful surgery. Higher stiffness may induce a higher tendency of graft tearing 
during the DM extraction and may cause high manipulations while unscrolling the graft 
inside the recipient eye. Stiffness of the tissue can be considered an important parameter 
as higher manipulation of the tissues inside the recipient eye may danger the graft survival 
with high endothelial cell loss. 
 
Immunostaining experiments showed the expression of fibronectin throughout the tissues 
preserved in dextran based medium. Fibronectins bind cell surfaces and various 
compounds including collagen. They were expressed on both the anterior and posterior 
layer of the DM. Laminin was expressed in all the media however, it was intense in C2 
(dextran based medium). Laminin binds to the cells with a high affinity receptor and is 
thought to mediate the attachment, migration and organization of the cells into tissues 
during embryogenic development by interacting with other extracellular matrix 
components. Therefore, we believe that dextran based media would be a more 
appropriate solution for preserving pre-stripped DMEK lenticules. Intense laminin 
expression was seen in the media containing dextran which may be useful for 
preservation or for binding of the endothelial cells onto the extracellular matrix, the DM. 
This may also prevent the endothelial cells from falling-off during the preservation and 
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transplantation phases. The expression profiles are shown in figure 2. No difference was 
found in the expression of vitronectin from either condition. It may be important to note 
that dextran-based medium may have a role in cell and tissue attachment during 
preparation, preservation, transportation and surgery. However, none of the samples 
showed any expression of elastic proteins and therefore nanoindentation was required to 
check the stiffness of these tissues. It has been reported earlier that fibronectin and 
vitronectin are present only on the stromal side of the DM along with some minute 
remnants that are present on the endothelial side of the tissue [31-35]. However, our 
samples showed the presence of fibronectin on both, the stromal and the endothelial 
sides, although the expression was not uniform throughout the entire DM.  
 
The E values calculated from the force-height curves taken from six DM samples of 
different conditions were in the range of 0.001 to 0.004 MPa. Nanoindentation has 
previously been studied on different scaffolds and therefore it was determined to study the 
rigidity of the DM when preserved in different preservation media [16-19]. A higher E value 
was found in the samples from condition 3, indicating a slightly stiffer behavior of these 
samples. We assume that when the tissues are preserved in the same medium before 
and after stripping, they do not show any difference in the stiffness properties however, 
when the DM is excised and exposed from TCM to TM with dextran, the tissue adheres to 
more dextran and increases its rigidity, especially on the DM side towards the stroma. 
High rigidity may not be actually required, as it may not help to open the tissues inside the 
recipient eye during DMEK surgery. We believe that with higher flexibility the tissue can be 
manipulated easily in the recipient eye. Although there may not be any difference in the 
preparation method [12], the preservation of DMEK lenticules can be an important factor 
to manage critical surgeries.  
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It is essential to formulate strategies that improve graft adhesion after DMEK to reduce the 
re- bubbling rate. The re-bubbling rate of C1 which is similar to what is suggested by 
Melles et al has been found to be 5.2% [13] however, with C2 which is similar to what has 
been suggested by Terry et al. has been found to be around 10.6% [14]. However, Busin 
et al. have observed around 23.8% of re-bubbling rate from C2 [36]. 
 
It has been noted that the corneal donor characteristics does not have any potential 
influence on graft adhesion however, preservation of the bare DMEK lenticule has shown 
a higher flexibility (statistically insignificant) and lower endothelial cell fall-off from C2. 
Condition C3 provides a more rigid tissue, which could increase difficulties in manipulating 
or unrolling the tissue (endothelium flapped-out) during the DMEK surgery. Conditions C1 
and C2 showed comparable rigidity. We have found that the endothelial cell fall-off is 
higher in cases when the DMEK is stripped from the TCM as compared to the preparation 
from TM which is contradictory to the literature [13]. We assume that a) due to a higher 
cell fall off from TCM and b) following preservation of the lenticule in TM (C3) may have 
allowed a higher area for the dextran to stick on the DM making it more rigid. This was not 
the case with C1 (TCM to TCM and therefore no interference of dextran) and C2 
(preserved in Dextran with minimal cell fall-off). The tissue preservation systems are 
different in America (dextran based hypothermic media) and Europe (non-dextran based 
TCM followed by dextran based TM), thus the tissues obtained from TM may have a good 
preservation potential for preserving DMEK grafts.  
 
In conclusion, although the sample size is a limitation to this study, we believe that 
condition C2 (i.e., tissues collected from TM, stripped and preserved in TM) showed to be, 
among the ones investigated, a suitable preservation solution to store pre-stripped DMEK 
lenticules. Although, the re-bubbling rates and the graft survival can change with different 
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procedures and diameter of descemetorhexis [15], the laboratory investigation states that 
preservation conditions like C2 may also be advantageous. In fact, tissues in C2 
conditions showed maintenance of adhesive properties to the extra cellular matrix which 
may be useful in reducing the cell fall-off during the preservation and surgical phases. In 
addition, the higher compliance is likely to allow an easier manipulation of such tissues 
during the surgery.  
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Aim 
To evaluate the optimum preservation conditions for storing pre-loaded DMEK lenticules.  
 
Introduction  
DMEK is a type of corneal surgery, which allows the transplantation of DM and 
endothelium [1-4]. DMEK has its own advantages as compared to PK in terms of better 
optical quality, early visual rehabilitation and less post-operative astigmatism with a much 
protected eye. As it does not involve excision of the entire cornea (optic zone) from the 
patient‘s eye like PK, it is considered a safer surgery. Various techniques have been 
identified for the preparation of this highly fragile tissue [5-12].  
 
We, at the FBOV have recently started providing pre-loaded tissues for DSAEK and UT-
DSAEK surgeries, a step further to pre-cut tissues [13,14]. This reduces the time and 
efforts in surgical theatre, increases efficiency of the DSAEK surgery and allows validated 
tissue to be used. Eye bank prepared DMEK tissues are usually pre-stripped, rolled or 
pre-bubbled and shipped to the operating room [8,12]. In our institute, these tissues are 
stripped and currently preserved in TM (tissue culture medium + 6% Dextran T500) which 
is a de-swelling medium required for transportation. As the tissue is only comprised of DM 
and endothelium, the requirement of dextran is not justified for preserving DMEK lenticule. 
However, due to the properties of dextran, which may be useful to keep the cells adherent 
to the extra-cellular matrix, its evaluation therefore becomes necessary.  
 
TCM is the most commonly used corneal storage media in Europe while hypothermic-
based preservation method is pursued in America and most of the world. As the tissue 
preservation is important to keep the endothelium viable, it becomes necessary to 
investigate the optimum condition to pre-load a DMEK lenticule, which is the next 
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advancement in the field of endothelial keratoplasty [15]. Pre-loading is likely to reduce the 
undesired effects that are seen while shipping the tissues as free floating or pre-stripped 
and allows transplanting a validated tissue. Thus, the aim of this paper is to study the 
optimum preservation conditions (medium with and without dextran) and to evaluate the 
possibility to preserve the DMEK lenticules flapped (tri-folded) in a closed chamber, i.e., to 
pre-load and provide a ready-to-use tissue to the surgeons for transplantation with minimal 
manipulations. 
 
Materials and Methods 
Ethical statement 
Thirty human donor corneal tissues were collected from FBOV, Venice, Italy with a written 
consent from the donor‘s next of kin to be used for research. 
 
Media constituents 
TCM was composed of 2% newborn calf serum with MEM-Earle as a base medium along 
with 25 mM Hepes buffer, 26 mM sodium bicarbonate, 1 mM pyruvate, 2 mM glutamine, 
250 ng/mL amphotericin B, 100 IU/mL penicillin G, and 100 mg/mL streptomycin. TM was 
composed of TCM incorporated with 6% dextran T500. TCM and TM were prepared in 
house (FBOV, Mestre, Italy) with full regulatory compliance.  
 
Pre-evaluation 
All the corneas were preserved in TCM before the study. However, to load the tissues and 
study the effect of the preservation medium on the tissues, ten corneas were further 
preserved in TM. The endothelial cells were evaluated using a hypotonic sucrose solution 
and the viability was checked using trypan blue staining for 30 seconds followed by 
washing the cells with phosphate buffered saline (PBS). Corneal thickness from the TCM 
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and TM groups was recorded before peeling using Optical Coherence Tomography (OCT 
SS-1000, Tomey, Nagoya, Japan). 
 
Preservation conditions 
The tissues were collected and preserved in different conditions, as described in Table 1.  
 Condition 1 (C1) Condition 2 (C2) Condition 3 (C3) 
Tissues collected from TCM TM TCM 
 Stripping and Loading 
Preserved in  TCM TM TM 
 Analysis 
Table 1: Different conditions of preservation media to store pre-loaded DMEK lenticules 
C1; C2 and C3 = Condition 1; condition 2 and condition 3 
 
Stripping and loading 
The procedure was carried out as described in our previously published article [15]. In 
brief, the [n=30] corneas were secured on a vacuum punch base and secured. The 
corneas were gently tapped on the endothelial side and a 9.5 mm superficial cut was 
created using a Moria punch (Moria, Antony, France). The endothelium was stained using 
Trypan Blue for 20 seconds to determine the cut area. After removing the periphery, the 
central DMEK lenticule was excised and placed back on the tissue with endothelium 
facing the air. The pre-stripped membrane was punched again to excise an 8.5 mm 
(Moria, Antony, France) lenticule. The peripheral remnants were removed. The lenticule 
was folded (tri-fold) with endothelium-in position using an acute forceps. The lenticule was 
then gently moved in the preservation chamber of a 2.2 IOL cartridge (Viscoject, 
Wolfhalden, Switzerland) and was further pulled inside the funnel of the cartridge using a 
25G microincission forceps from the funnel end. The funnel was filled with the 
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preservation medium as listed in table 1 before the lenticule was inserted and was later 
filled completely. The funnel and the back entrance were closed using rubber stoppers 
and the entire system was preserved in the media as listed in table 1. The lenticules were 
preserved for 4 days at room temperature. The stopper was removed and the tissues 
were released out from the funnel pore using the microincision forceps and analyzed as 
described below.  
 
Endothelial cell evaluation 
All the lenticules [n=30] were stained after storage using trypan blue for 20 seconds and 
washed with PBS. The lenticules were exposed to sucrose solution in a petri plate. The 
ECD and mortality were counted using a 10 X 10 mm reticule (grid) inserted in the 
eyepiece of an inverted microscope (Primovert; Zeiss, Milan, Italy) at 100Xmagnification 
by masked observers.  
 
Glucose uptake of the preserved lenticules to determine the metabolic activity 
Glucose uptake was determined from the preservation media of all the samples [n=30] 
after 4 days of preservation (post-storage) in an IOL cartridge. This helped to check 
themetabolic activity of the endothelial cells when preserved in vitro. Quantitative analysis 
was performed using D-Glucose HK kit (Megazyme International Ireland Ltd, Bray 
Business Park, Bray, Co. Wicklow, Ireland) post preservation. 
 
Histological analysis to determine the presence of endothelial cells on DM, collagen fibrils 
or stromal residues  
The lenticules were opened up after storage before processing it for histological analysis. 
The presence of Descemet's Membrane, collagen fibers and endothelium was 
investigated [n=9; n=3 from each conditions]. The tissue was fixed in 4% PFA overnight 
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followed by washing it with sucrose solution at 7.5%, 15% and 30% for 15 minutes each. 
Final washing was carried out with PBS and the tissues were embedded in optimal cutting 
temperature compound (OCT) for microtome cutting. PAS staining was performed on all 
the samples and sections were viewed at 10X magnifications in order to check the 
variability and reproducibility in tissue selection and preservation performances along with 
stromal interference, if any. 
 
Antibody staining to determine the polymorphism, expression of tight junctional proteins 
and cell apoptosis study, for cellular integrity post preservation 
 
TISSUE FIXATION AND PREPARATION FOR CELL APOPTOSIS AND 
IMMUNOSTAINING: 
The tissues (n=21; n=7 from each condition) were opened up after storage before 
checking cell apoptosis and immunostaining. The preserved tissues were fixed in 4% PFA 
at 4
o
C overnight.  
 
IMMUNOSTAINING WITH ZONULA OCCLUDENS-1 (ZO-1):  
Twelve tissues [n=4 from each condition], previously treated as described above, were 
permeabilized with 0.5% Triton X-500 in PBS for 30 minutes. After blocking with 2% goat 
serum, the tissues were incubated overnight at 4
o
C with a primary antibody (Zonula 
Occludens-1 [ZO-1], 1:500 dilution). The samples were incubated with goat anti-mouse 
fluorescein isothiocyanate (FITC)-conjugated secondary antibody in 20% goat serum for 3 
hours at room temperature. Mounting medium containing DAPI was used to stain the 
nuclei. After each step, the cells were washed 3 times with 10X PBS. Cells were examined 
with an LSM 510-meta laser scanning microscope (Zeiss, Milan, Italy). Examination was 
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performed under the ultraviolet light or by excitation at 488 nm or 547 nm, and subsequent 
detection of the fluorescence was obtained.  
 
CELL APOPTOSIS USING TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE 
DEOXYURIDINE TRIPHOSPHATE NICK-END LABELING ASSAY:  
Cell apoptosis was performed as described in the manufacturer‘s protocol for TACS 2 
terminal deoxynucleotidyltransferase (TdT) diaminobenzidine (DAB) in situ apoptosis 
detection kit (Cat# 4810-30-K; Trevigen, Maryland, USA). One separate positive sample 
was induced with apoptosis using TACS nuclease and nine samples [n=3 from each Cs] 
were viewed at 100X magnifications of an inverted microscope. The images were 
analyzed using ZEN (Zeiss, Milan, Italy) software.  
 
Statistical analysis 
Student‘s T-Test and Wilcoxon paired data for non-parametric analysis was employed to 
check statistical significance between the different groups. P<0.05 was deemed 
statistically significant.  
 
Results 
Donor characteristics and pre-evaluation [n=30] 
The average age of the donor was 67.1 (±6.20) years with male:female donor ratio of 
24:6. Average post-mortem time was 14.6 (±6.45) hours. All the corneas were previously 
preserved in TCM with an average preservation time of 14.27 (±6.09) days. The tissues 
were further preserved in TM for 3.4 (±2.72) days before stripping. The average 
endothelial cell density recorded was 2203.33 (±335.52) cells/mm
2
 with initial mortality of 
0.2 (±0.54)%. Successful peeling was observed in 76% of cases when the tissues were 
collected from TCM whereas 100% tissues were peeled successfully when the tissues 
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were collected from TM. Average stripping time for C1 and C3 was 25 minutes and that 
with C2 was 19 minutes. Average loading time was5 minutes for all the tissues. The 
tissues collected from TCM had a higher thickness of 963.5 (±77.02) µm as compared to 
TM, which was 570.3 (±49.47) µm thick before stripping. The tissues from TM showed 
thickness similar to in vivo corneas as they were de-swelled. 
 
Lower endothelial cell loss in dextran based media  [n=30] 
ECD (cells/mm
2
) post preservation in C1, C2 and C3 was found to be 1130(±944.05), 
1950(±108.01) and 1970(±512.18), and the mortality (%) was 25.94(±44.23), 3.8(±7.74) 
and 21.8(±36.41), respectively. It was also observed that the cells detached from the 
lenticule during preservation and therefore the uncovered areas (%) determined for C1, 
C2 and C3 were 40.7 (±47.96), 13.0(±18.55) and 41.8(±37.77).Loading to post 
preservation in C1 showed statistically significant endothelial cell loss (p=0.0051) 
however, C2 (p=0.1092) and C3 (p=0.0819) did not show statistical significance, although 
the average ECL observed in C3 was high. Figure 1 shows how the lenticules obtained 
from corneas preserved in C1, C2 and C3, respectively, appear post-stripping (a, c, e) and 
post-preservation (b, d, f).  
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Figure 1: Endothelial cell density, mortality and uncovered areas of pre-loaded DMEK 
lenticules at 100X magnification. A, c, e) shows healthy endothelium that was found post-
stripping with minimal mortality in different conditions as listed. B, d, f) shows mortality and 
uncovered areas in each condition. C1 and C3 showed high mortality (trypan blue positive 
cells marked with arrow) and uncovered areas as compared to C2, which showed minimal 
mortality.  
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Glucose was utilized in all the media  [n=30] 
Average glucose uptake by the endothelial cells in the preservation chamber for 4 days at 
room temperature was 0.32(±0.18) mg/mL from C1, 0.43(±0.27) mg/mL from C2 and 
0.56(±0.18) mg/mL from C3, which is one third to half of the total amount of glucose 
present in the media. These results are similar to those showed in the pre-loaded DSAEK 
lenticules [13]. However, there was no statistical difference seen between either groups 
(p>0.05). 
 
Presence of DM and endothelial sheet on the excised DMEK tissues from dextran based 
media [n=9] 
The analyzed tissues (100x magnification using PAS staining) showed no presence of 
endothelial cells, but only the DM (figure 2a) in C1. This may be a reason due to high ‗fall-
off‘ rate of the cells from C1. As observed in figure 1, the cells does not maintain a 
hexagonal shape and have turned itself into circular shape (stressed) along with high 
mortality as seen using trypan blue staining. Descemet‘s membrane and endothelium 
(found in one of the tissues) without any collagen fibrils or attached stromal residues in C2 
is seen in figure 2b. However, lesser endothelial cells were found in lenticules from C3 
(figure 2c). This phenomenon can be due to the presence of dextran in the preservation 
medium after loading in the cartridge. Preservation of endothelial cells with DM was found 
in C2.  
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Figure 2: Histological analysis on pre-loaded DMEK lenticules post preservation at 100X 
magnification. a) C1 showed no presence of endothelium due to major cell fall-off, b) C2 
showed presence of endothelium and DM without any stromal remnants and c) C3 
showed limited endothelium. 
 
Expression of tight junctional proteins and polymorphism on the endothelial cells after 
preservation [n=12] 
The endothelial cells showed expression of tight junction protein (ZO-1) post preservation 
as seen in figure 3 at 400X magnification. C1 and C3 (figure 3a and 3c respectively) 
showed loss of hexagonality, most of the cells were polygonal to circular. Tight junctional 
protein was not consistent in C3 but was intense in C1 at many areas. C2 (figure 3b) 
showed endothelial cell mosaic with more hexagonal shaped cells and the conservation of 
tight junctional proteins in the pre-loaded DMEK lenticules.  
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Figure 3: Immunostaining results using ZO-1 marker for expression of tight junctional 
proteins in the pre-loaded DMEK lenticules visualized at 400X magnification. Preserved 
cells showed expression of these proteins confirming the integrity of the endothelial cells. 
However, a) and c) C1 and C3 respectively showed some areas without endothelial cell 
borders and hence loss of tight junctions whereas b) C2 expressed tight junction protein 
with less polymorphism compared to C1 and C3. Hexagonality of the cells was observed 
in C2.  
 
No cell apoptosis from dextran based media [n=9] 
Control cells were induced with apoptosis using TACS nuclease (figure 4a) to compare 
them with the samples. C1 showed apoptosis post preservation at 100X magnification 
(figure 4b). However, C2 and C3 did not show any apoptosis post preservation (figure 4c 
and 4d). C2 and C3 were preserved in dextran-based medium and we assume that may 
have prevented the cells from apoptosis.  
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Figure 4: Cell apoptosis post preservation of pre-loaded DMEK lenticules. a) Induced 
apoptosis on the control sample at 100X magnification. b) C1 showed mild apoptosis 
whereas c and d) C2 and C3 did not show any apoptosis post preservation and the 
nucleus was visible with methyl green counter stain at 100X magnification. Hence it was 
determined that the preservation of the DMEK lenticule in a cartridge for 4 days does not 
have any drastic damage on the endothelial cells.  
 
Discussion 
As indicated in the introduction, DMEK requires high surgical skills, but there are ways to 
ameliorate the quality of the tissues distributed to surgeons and help them perform an 
easier transplantation. One of the methods is to check whether the preservation technique 
may affect the quality of the tissue. Dextran has been widely used to de-swell the cornea 
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after the tissue has been swollen during the TCM preservation phase. The number of 
viable endothelial cells and a thickness that is similar to the in vivo conditions are 
important for a successful corneal transplantation.  
 
Organ culture offers several advantages in terms of sterility checks, longer duration of 
preservation and hence a proper planning of the surgery [16]. Although storage in dextran-
containing medium is not obligatory for preparing the tissues for DMEK surgery, the 
important parameters like endothelial cell density and smoothness of the DM should be 
considered before the surgery. It has been suggested that with higher number of 
functional cells, the dislocation chances of a DMEK decreases and the adherence 
increases [16]. To our knowledge, there has not been any study in the literature that 
shows the comparison of different storage media for pre-loaded DMEK preservation in a 
closed chamber like an IOL cartridge.  
 
Previously, it has been shown that the preservation medium has no effect on the rate of 
successful peeling of DMEK tissues [16]. However, we observed that when the tissues are 
thick (stromal thickness), i.e., approximately over 900µm,the success rate changes as 
compared to the normal thickness of the graft, which has re-gained its original thickness 
(approximately 550µm). We observed 76% successful peeling cases with higher thickness 
where the tissues were preserved in TCM as compared to 100% successful cases when 
the tissues were preserved in TM. Peripheral tearing that resulted into the loss of tissues 
eventually was the major reason when the tissues were excised from TCM. The stroma 
was thick and the punch for creating a superficial cut does not direct a regular cut in an 
uneven stromal base when the tissues were taken from TCM. On the contrary, when the 
tissues were obtained from TM, due to the regular thickness and a more constant cornea 
throughout, the cut obtained was precise and the excision was accurate without any 
115 
 
peripheral tears. Therefore, to standardize the peeling technique, the tissues can be 
obtained from TM or from a dextran based media for peeling.  
 
Further, the tissues are usually pre-bubbled, pre-stripped or pre-rolled and preserved in 
the respective media [8,12]. However, there has not been any study that reports about a 
completely excised and pre-loaded tissue. Therefore, we tried to pre-load the tissue in a 
closed chamber (the IOL cartridge). Tissues that were pre-loaded did not show any 
damage in terms of cellular morphology or molecular integrity. The glucose uptake study 
showed similar results as those obtained with pre-loaded DSAEK grafts, thus concluding 
that active metabolism and functional activities of the endothelium continues for at least 4 
days at RT [13]. Histology confirmed the presence of DM and endothelium without any 
stromal residues in all the cases but the presence of endothelium was definite when the 
tissues were excised from C2. The cellular apoptosis was observed inC1, it was not due to 
the pre-loading but due to the preservation medium (TCM). Cell apoptosis has been 
reported to incur in the tissues that are preserved in TCM for a long time [17]. Therefore, 
Dextran seems to play an important role in maintaining the functionality of the cells while 
pre-loading it.  
 
Endothelium, if flapped-in, does not have statistically more damage compared to 
endothelium when flapped outward (which is the natural phenomenon) [18]. However, we 
recommend that the tissues should be flapped-in, a) to avoid any possible friction between 
the endothelial cells and the cartridge during preservation, transportation and 
transplantation and b) to reduce the time of opening the graft inside the recipient eye [18]. 
The average ECL [%] (average of mortality and uncovered areas) post preservation of the 
pre-loaded DMEK lenticule was found to be 45.05(±46.61), 10.77(±15.99) and 
34.77(±37.37) in C1, C2 and C3, respectively. The endothelial cell mortality cannot be 
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considered high because 1) the tissue is punched again at the eye bank after stripping 
and is folded and loaded in the cartridge where there is some endothelial cell loss 
observed. This step is currently carried out in the surgical theatre where the surgeons do 
not check the endothelial cell loss after this step, 2) the tissue is then preserved in closed 
chamber (IOL cartridge) in the same orientation without any free movement and some 
cells may be damaged due to friction, 3) the tissues obtained for this research are not 
suitable for transplantation because of low endothelial cell count and previous mortality 
therefore it may have some additional mortality due to the health of the tissue in general. 
The results can still be extrapolated to the transplantable grade tissues as they have high 
endothelial cell density (between 1800-2000 cells/mm
2
) for research. As per our previously 
reported article, there is a learning curve to pre-load a DMEK graft and after the learning 
curve, the average endothelial cell mortality and uncovered areas post preservation in 
dextran based media was 3.55% (±5.79%) and 7.8% (±14.13%) respectively. Overall ECL 
after preservation in dextran-based medium was 4.35%, which is less than the endothelial 
cell loss observed here that is due to the learning curve [15]. Moreover, dextran is 
negatively charged and therefore the media repels the endothelial cells allowing a higher 
cell adherence to the extra cellular matrix, the DM. This property of dextran may also help 
to reduce the cell fall-off and highlight that the tissue should be preserved in dextran 
based medium. The tissues from TCM have two major disadvantages such as, a) lower 
successful peeling rate and b) higher endothelial cell loss. We have also noticed that the 
tissues preserved in C2 have a better flexibility, lower stiffness and high cell to extra-
cellular matrix adherence (data under consideration for publication) as compared to the 
other conditions.  
 
In conclusion, pre-loading a DMEK tissue may facilitate DMEK to be more successful in 
terms of transplanting a validated graft along with a comparatively short surgical 
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procedure, low costs and logistic requirements. Dextran may therefore have an important 
role during preservation, preparation and transportation, and hence it should be 
considered in the medium before pre-stripping or pre-loading a DMEK lenticule.  
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Aim 
To compare the difference between endothelium flap-in and endothelium flap-out using 
injection method for DMEK.  
 
Introduction 
Over the last few years, there has been an increase in the uptake of Descemet Membrane 
Endothelial Keratoplasty (DMEK) as a treatment for corneal endothelial disorders. During 
the years 2013-2015, our institution at the Veneto Eye Bank Foundation (Venice, Italy) 
has received a comparable increase in requests of pre-stripped tissues for DMEK. The 
Eye Bank Association of America (EBAA) reports have also shown that there is a slow 
increase in the uptake of DMEK since 2011 [Annual reports of EBAA, 2011-2014]. 
Although DMEK is a minimal invasive surgery with faster rehabilitation rate; preparation 
and transplantation techniques still remain a challenge. Out of the many preparation 
techniques that have been proposed [1-6], the stripping method has been the most widely 
adopted. In contrast, the challenges of unfolding and positioning the graft inside the eye 
have led to a wide variety in methods used to deliver the graft into the eye [7,8]. Busin et 
al recently reported a novel method to insert the graft into the eye using a pull through 
technique [9]. Injector systems for DMEK have also been evaluated [10]. The current 
approach in DMEK is based on inserting the graft with the endothelium exposed or rolled 
out. Scrolling of Descemet membrane with the endothelium out is the spontaneous form 
that the tissue takes within a liquid (Figure1a). This, however, makes the handling of the 
tissue difficult and exposes the endothelial cells to potential damage against the wall of 
the cartridge or the delivery tube, during loading and insertion [11]. If it were possible to 
roll the tissue with the endothelium on the inside, it would facilitate insertion of the tissue 
both within the introducer and also into the eye with less potential damage to the 
endothelium. One possibility is to manually roll the tissue inwards (Figure1b). The aim of 
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this study was to investigate and evaluate a technique to fold the graft with the 
endothelium on the inside (Figure 1b). We postulated that the folding of the graft with the 
endothelium inwards would be easier to achieve with larger grafts. There is already a good 
evidence that the endothelial cell density increases towards the paracentral and peripheral 
regions of the cornea [12,13] and it has been shown that larger (9.5mm and 9.00mm) 
DSAEK grafts have better survival rates [15]. 
Larger DMEK (9.5 mm) grafts therefore, were specifically used in this study and 
endothelial density measured in both the centre and periphery.   
 
Figure 1: Schematic representation of the orientation of the grafts. a) endothelium flapped 
in a natural spontaneous folding of the graft and b) Right - endothelium flapped manually 
inside. 
 
Materials and Methods 
Donor corneal tissues were obtained from The Veneto Eye Bank Foundation (Venice, 
Italy) following consent from the donor‘s next of kin. The study was conducted in the 
institutional setting, the laboratories of Veneto Eye Bank Foundation (Venice, Italy). The 
donor corneal tissue (9 tissues for each study) was randomly assigned to be used either 
for endothelium in (endo-in) or endothelium out (endo-out) technique using a coin toss.  
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Stripping method 
The corneas were centered on a punch base and fixed using a vacuum block. A 
superficial circumferential cut was created with a 9.5 mm punch [Moria, Antony, France] 
by gently tapping the trephine. The edge of the cut was visualized with trypan blue and the 
excess of peripheral membrane removed. The endothelium was kept moist during the 
procedure with a de-swelling media. The membrane was separated using a cleavage hook 
throughout the periphery and the peripheral residues were detached. The DMEK graft (9.5 
mm) was stripped leaving a small peripheral attachment hinge before being re-stored. The 
pre-stripped grafts were then preserved in the de-swelling medium at room temperature 
for 4 days. This is the procedure used for storage of pre-stripped tissue issued for 
transplantation by our eye bank.  
 
Mounting the cornea 
After removal of the DM, each cornea was mounted on the artificial anterior chamber 
(AAC, Moria, Antony, France) with continuous irrigation of saline. The pressure inside the 
AAC was controlled by adjusting the height of an infusion bottle at 20 cm (15.3 mmHg) 
[15]. At the 12 o‘clock surgical position a 3mm limbal incision was made using the slit-
knife. Three side ports were created at 10:30, 1:30 and 7:30. The orientation of the graft 
was checked after implantation using an inverted microscope [Primovert; Zeiss, Milan, 
Italy]. 
 
Endothelium-out (Endo-out) 
Following stripping of the DM the grafts were freed from the corneal hinge and 
immediately placed onto a petri-plate containing phosphate buffered saline (PBS). The 
graft, as expected, rolled with the endothelium outwards. Using a modified Jones tube, the 
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graft was aspirated inside the tube and injected into AAC. The graft was unfolded and 
attached using an air tamponade.  
 
Endothelium-in (Endo-in)  
The grafts were freed from the corneal hinge, but retained on the corneal base prior to 
folding. Using acute forceps (e.janach, Como, Italy), two opposing peripheral edges of the 
graft were grasped in turn and drawn towards the centre with the endothelial side facing 
inwards. One flap was drawn slightly beyond the centre to overly the other flap. Using the 
same acute forceps, the graft was pulled inside a 2.2 IOL (Intra Ocular Lens) cartridge 
(Viscoject, Wolfhalden, Switzerland) maintaining the graft in the same orientation 
(Descemet membrane side touching the bottom of the cartridge with the folds uppermost). 
A small drop of PBS was then added to the cartridge to keep the tissue moist prior to 
injection. Viscoelastic was not used. Using Grieshaber Revolution DSP 25 Ga + 
endgrasping forceps (Alcon, Texas, USA), the graft was pulled inside the funnel 
containing sterile PBS solution ready for delivery [9,16]. The cartridge was then inverted 
with the exposed DM side uppermost in the funnel and the folded flaps lowermost to 
facilitate opening of the graft inside the anterior chamber. The IOL cartridge was then 
inserted through one incision and the graft was injected with gentle pressure to avoid rapid 
pressure changing the orientation of the graft. Using an air bubble the unfolded graft was 
attached on the donor corneal stroma using an air tamponade. 
 
Endothelial cell count 
The corneal tissue was dismounted and the graft gently removed using PBS before 
staining with trypan blue for 20 seconds and washing with PBS. The graft was opened 
gently using PBS flow to minimize the risk of endothelial damage. With a hypotonic 
(sucrose) solution in a petri plate, the integrity of the graft and endothelium was examined 
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using an inverted microscope [Primovert; Zeiss, Milan, Italy]. The cells were manually 
counted in central and peripheral areas (combined and averaged) in triplicates using a 
10X10 eye piece reticule and the images were captured at 100X magnification. 
 
Analysis 
The following time periods were recorded. The time required to 
1. strip the tissue, 
2. prepare the tissue from dislocating the graft to either manually folding the tissue 
(endothelium inwards) and loading it into a cartridge, or aspirating it into the tube 
endothelium out, 
3. prepare the anterior chamber for insertion of the graft: mounting the cornea on 
artificial chamber, control of pressure, and preparation of limbal incision and 3 side 
ports, 
4. unfold the tissue once injected and attachment with air tamponade bubble and 
5. complete the procedure. 
 
Statistical Analysis 
A non parametric test (Wilcoxon test) was used to test for a difference between the two 
groups, endo-in and endo-out. Differences were considered statistically relevant with 
p<0.05.  
 
Results 
The average age of donors was 66.00(±6.73) years with a male:female donor ratio of 
11:7. The average post-mortem time was 13.02(±7.33) hours and preservation time of 
34.11(±12.48) days in tissue culture medium (TCM), followed by 6.22(±1.77) days in 
transport medium (TCM with 6% Dextran).  
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All the tissues were successfully peeled in one attempt (100% success rate). An average 
of 20.22(±5.54) minutes was required to prepare a pre-stripped DMEK graft. The different 
time intervals and the total time of the procedure are included in table 1. Pre, post-strip 
and post-loading endothelial cell density, mortality and uncovered areas are presented in 
table 2. 
  Endo-in Mean (± SD) Endo-out Mean (± SD) pValues 
Loading time (Minutes) 4.43(± 3.43) 1.68 (±0.57) 0.04 
Time to Inject 
(Minutes) 3.56 (±1.72) 4.89(±2.99) 0.26 
Time to Unfold 
(Minutes) 0.82(±1.04) 4.92(±4.21) 0.02 
Total time (Minutes) 8.81 (±4.54) 11.49 (±6.77) 0.34 
Table 1: Parameters which showed that time to prepare the tissues was significantly 
lesser with endo-out whereas time to unfold the graft was significantly lower with endo-in. 
Endo-in may spontaneously roll out in the eye and may help to reduce surgical 
manipulations. Loading time is when the pre-stripped lenticules are loaded in the Jones 
tube for endo-out or in a cartridge for endo-in. Time to inject is when the corneas are 
mounted and incisions are made for the delivery of the graft. Time to unfold the graft is 
when the grafts after delivery are unfolded on the stroma with DM touching the stromal 
side and air bubbled. Total time is the time required for the entire procedure using a pre-
stripped membrane.  
Table 2: Endothelial cell density, morality and uncovered areas did not show any 
statistical significance between either group before stripping, after stripping and after 
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unfolding the graft which signifies that endo-in or endo-out could be used without any 
difference in endothelial damage for DMEK surgery.  
 
The tissue preparation time for the manual folding of endo-in (4.43 ±3.43 minutes) was 
longer than for the auto-folding of endo-out (1.68 ±0.57 minutes) [p=0.04]. The time 
required to unfold the graft inside the eye, however, was significantly less for endo-in 
(0.96±1.10 minutes compared to endo-out (4.92 ±4.21 minutes) [p=0.02] (table 1). There 
was no significant difference, however, between the methods for the time for the entire 
procedure, that is, 8.94 ±4.43 minutes for endo-in and 11.49 ±6.7 minutes for endo-out 
method (p>0.05). There was similar amounts of endothelial cell loss post implantation 
(measured at center and periphery and combined) for Endo-in (10.53±2.82%) and Endo-
out (7.56 ±14.74%), (p>0.05). The cells were counted in vitro in triplicates using a larger 
area than would be obtained in vivo. We think that this would be more accurate and less 
prone to magnification error. In addition, we also measured ECD just after delivery, which 
has not been undertaken in clinical studies. There were no significant differences in 
endothelial cell density, mortality and uncovered areas between the two methods (p>0.05) 
(table 2) and as shown in figure 2a (endo-in) and figure 2b (endo-out) either before, or 
following insertion of the graft. A slightly greater number and size or grade of acellular 
areas was observed in the endo-in method after stripping and therefore it was 
extrapolated to the unfolding results. This was however, variable between different donors.  
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Figure 2: Endothelial status after implantation and removal of the graft from the cornea 
mounted on AAC. a) Endothelial cells with minimal mortality and uncovered areas from 
Endo-in and b) Endo-out, showing less damage. 
 
Discussion 
Endothelial keratoplasty using pre-cut or; pre-cut and pre-loaded grafts (DSAEK and 
DMEK) from the eye banks is gaining popularity [17]. DMEK offers a quicker rehabilitation 
rate and better visual outcomes, but requires high surgical and manipulative skills. It is 
evolving at a much slower rate due to the challenges that are faced by the surgeons in 
preparation, transplantation and managing post-operative complications. Using prepared 
tissue for DMEK may facilitate surgery. Although pre-stripped tissues from eye banks have 
been evaluated recently; unfolding the graft within the eye and dealing with post-operative 
complications is one of the reasons for the relatively slow uptakes of DMEK [18-20]. 
 
Currently DMEK grafts are aspirated inside a tube and injected with the endothelium on 
the outside of the rolled surface. This is due to the spontaneous rolling of Descemet‘s 
membrane when in fluid. The position of the endothelium increases the risk of endothelial 
damage during injection and during manipulation inside the eye, the latter being 
technically difficult. We envisioned that a DMEK roll with endothelium flap-in would unroll 
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spontaneously once inside the eye to form its natural endo-out structure. In addition, with 
endo-in, the tissue should have a minimal endothelial cell loss as the cells are not directly 
exposed to the plastic of the cartridge during the delivery of the graft. Using an IOL 
cartridge to aspirate an endo-in graft may de-orientate the graft or may lead to the graft 
folding back to an endo-out position [9]. In order to test this hypothesis we evaluated the 
method using donor corneas on an artificial anterior chamber and compared it to the 
conventional endo-out method. 
 
No significant difference in cell loss was observed with either technique.  There is a risk 
that we did not detect a difference of less than 20% with the sample size used but it was 
not feasible to increase the sample size of 100 to 400 to detect a 10% and 5% difference. 
We think that the highest cell loss from endo-in method may occur during folding of the 
graft in the preparation phase. In contrast, however, with the endo-out method, damage to 
the endothelium may be more likely during insertion and manipulation in the eye. One of 
the major advantages of endo-in is the reduced possibility of graft failure from the graft 
being placed upside down [9], which has been observed with the endothelium flapped out 
position [18]. In addition, folding of the graft endo-in may reduce damage against the wall 
of the cartridge.  This may be particularly useful for pre-loading DMEK grafts by the eye 
bank [16].  
 
There is good evidence that the endothelial cell density increases towards the paracentral 
and peripheral regions of the cornea [12,13]. In addition, it has been shown that larger 
(9.5mm and 9.00mm) DSAEK grafts have better survival likely due to an increase in 
transplanted endothelial cells. A 9.5mm grafts would also reduce the impact of zones of 
cell damage from the end-grasping forceps used to load the graft into the cartridge. It has 
been reported in DSAEK surgery that graft size is not a risk factor for the incidence of 
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rejection [15]. Although there are many factors that contribute to graft endothelial failure 
[21], the number of endothelial cells transplanted likely plays a crucial rule. It is reasonable 
to suggest, therefore, that if graft size is increased to 9.5 mm, more of the periphery will be 
included and may help in maintaining an adequate number of functional endothelial cells 
in the long term. Although subjective, we found it easier to fold and handle 9.5 mm grafts, 
and that the endo-in grafts unfolded inside the artificial chamber with minimal 
manipulation. Although this is an in vitro study it provides good evidence to undertake an 
in vivo clinical study using an endo-in technique for DMEK. 
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Busin et al. recently reported the results of an innovative surgical technique describing the 
delivery of tri-folded (endothelium-in) Descemet Membrane Endothelial Keratoplasty 
(DMEK) graft using a pull through technique [1]. We performed a similar [n=9], but in vitro 
study with larger DMEK grafts (9.5mm) in order to evaluate the surgical endothelial cell 
loss (ECL) and learning curve. We intentionally used larger DMEK grafts, because as 
previously seen with large ultra-thin Descemet Stripping Automated Endothelial 
Keratoplasty (UT-DSAEK), they increase long term graft survival [2]. Using the stripping 
method the tissue was tri-folded using acute forceps (E.Janach, Como, Italy) to 
manipulate Descemet membrane (DM) with the endothelial side facing inwards to avoid 
endothelial damage. Using the same forceps, the graft was gently pulled inside a 2.2 IOL 
(Intra Ocular Lens) cartridge (Viscoject, Wolfhalden, Switzerland) maintaining the graft in 
the same orientation (DM side touching the cartridge bottom and the endo-in on the top). 
Using a 25G end grasping forceps (Grieshaber forceps, 25G Alcon, Texas, USA), the graft 
was pulled inside the funnel of the IOL containing sterile phosphate buffered saline (PBS) 
ready for delivery [3]. After the DM-endothelium was removed, the cornea was mounted 
on an artificial anterior chamber (AAC, Moria, Antony, France). The pressure inside the 
AAC was controlled by adjusting the height of an infusion bottle at 20 cm (15.3 mmHg) [4]. 
At the 12 o‘clock surgical position, a 3mm limbal incision was made using a slit-knife. 
Three side ports were created at 10:30, 1:30 and 7:30 clock positions. The cartridge was 
inverted so that the exposed DM side was on the top of the funnel and the flaps on the 
bottom to facilitate opening the graft inside the eye. The IOL introducer cartridge was then 
inserted through one incision and the graft was pulled from the opposite side using end 
grasping forceps. An air bubble was then used to attach the unfolded graft to the donor 
corneal stroma. The cornea was then dismounted from the AAC and the graft gently 
removed using PBS and stained with trypan blue for 20 seconds followed by a wash with 
PBS. With a hypotonic (sucrose) solution in a petri plate, the endothelium was examined 
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for damage, cell loss and uncovered areas using an inverted microscope [Primovert; 
Zeiss, Milan, Italy]. The cells were counted using a 10X10 eye piece reticule. Time 
required for stripping, loading, injecting, unfolding and the total surgery time were 
recorded. All the tissues were successfully peeled in one attempt (100% success rate). An 
average of 18.78 ±5.65 minutes was required to prepare a pre-stripped DMEK graft in the 
Eye Bank. Post-stripping, post-loading and post-delivery, mean endothelial cell density, 
mortality, uncovered area, time intervals, and total time of the procedure are listed in 
Table 1. 
Endothelial cell evaluation  
Post Stripping ECD (cells/mm
2
) 2044.44±427.53 
Post Stripping Mortality (%) 0.52±0.99 
Post Stripping Uncovered Areas (%) 0.17±0.35 
  
Post Loading ECD (cells/mm
2
) 2000.00±409.27 
Post Loading Mortality (%) 0.59±0.96 
Post Loading Uncovered Areas (%) 0.29±0.43 
  
Post Delivery ECD (cells/mm
2
) 1588.89±321.89 
Post Delivery Mortality (%) 0.79±1.00 
Post Delivery Uncovered Areas (%) 17.84±24.19 
Timing  
Time to prepare (min) 1.07±0.29 
Time to inject (min) 3.51±1.00 
Time to unfold (min) 5.84±3.95 
Total time (min) 10.42±3.68 
Table 1: Endothelial cell loss and surgical timing 
 
We did not observe any de-orientation of the graft in all 9 cases. The EC loss at the end of 
the procedure was 22.28% which is less than that reported for DMEK surgery 
(endothelium out) of 35-37% at 6 months [5]. We also had similar results in a previous in 
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vitro study where we compared the ECL and total time of the surgery after injecting a 9.5 
mm DMEK graft with endothelium flapped in or rolled out [6]. In addition, a 9.5 mm DMEK 
graft will transplant increased number of cells initially and may help in maintaining an 
adequate number of functional endothelial cells in the long term. It is worth considering 
that an increase from a 8.25 mm to a 9.5 mm diameter graft would result in transplanting 
approximately 20% more cells [2,7]. Even compared to the very low ECL of 9.9% reported 
by Busin et al [1], a larger (9.5mm) graft with an ECL loss of 22.28%, would however, still 
provide a greater number of cells compared to a 8.25mm graft with a 9.9% ECL. We also 
observed that, similarly to 9.5mm UT-DSAEK, larger DMEK grafts were easier to handle in 
terms of folding and loading compared to smaller grafts. This is also highlighted by no 
significant ECL during loading time. The time required for the entire procedure was 
10.42±3.68 minutes which may give an additional advantage to the surgeons. 
  
Despite the limitations of this in vitro report, these results suggest that the described 
technique using large (9.5mm) grafts for DMEK has an acceptable ECL and learning curve 
and therefore may be useful for long term survival as compared to a smaller graft. 
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DMEK tissues are important to study for multiple reasons as it allows understanding the 
cell loss incurred during the preparation, storage, transport, implant and post-op survival. It 
is therefore important to study this to standardize the current DMEK options to treat EK 
and further enhance the transport and implantation technique of the HCECs.  
 
Aim 
To determine the feasibility of pre-loading endothelial tissues for Descemet Membrane 
Endothelial Keratoplasty (DMEK).  
 
Introduction  
Endothelial Keratoplasty (EK) is a selective transplantation technique and an effective 
alternative to Penetrating Keratoplasty (PK) for the management of corneal endothelial 
failure. Descemet Membrane Endothelial Keratoplasty (DMEK) is a sub-type of EK which 
foresees the transplantation of Descemet membrane and endothelium exclusively [1-4] 
and offers an extremely fast recovery of vision often at the 20/20 level.   
 
Similar to other lamellar keratoplasty procedures, DMEK is gaining popularity and eye 
banks are confronted with new requirements from corneal surgeons. Recently, they have 
started the preparation and transportation of pre-cut donor tissues with a desired diameter 
for Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Ultra-Thin DSAEK 
(UT-DSAEK) and pre-stripped tissues for DMEK [5-7]. 
 
As this reduces the efforts, time and cost in the surgical theatre, the popularity of pre-
cut/pre-stripped tissues is increasing rapidly. Moreover, it allows validation of the tissue to 
be grafted, a quality control that cannot be done in the surgical theater, when the 
surgeons prepare the tissue themselves. The Veneto Eye Bank Foundation has now 
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started providing pre-loaded tissues, a step further to pre-cut tissues for DSAEK and UT-
DSAEK surgeries [8]. This further reduces the time and efforts in the surgical theater, 
increases the efficiency of DSAEK surgery and allows the use of a validated tissue. DMEK 
tissues can be pre-stripped [7] or pre-bubbled [9] at the eye bank and shipped to the 
operating room with the full cornea as a base support. Instead, if the DMEK tissue is 
stored without corneal support, it rolls with the endothelium facing outwards in contact with 
the solid walls of the cartridge, thus possibly being negatively affected by the storage 
process. We have investigated the possibility of preserving DMEK tissue rolled with the 
endothelium inwards to avoid any damage caused by the contact with the cartridge wall 
and providing a ready-to-use tissue to the surgeons for direct transplantation. This study is 
a proof of concept for a pre-loaded DMEK and the clinical relevance still needs to be 
tested.  
 
Materials and Methods 
Ethical statement 
Twenty human donor corneal tissues were collected from The Veneto Eye Bank 
Foundation, Venice, Italy to be used for research with a written consent from the donor‘s 
next of kin. 
 
Donor characteristics 
The average age of the donors was 67.6(±7.47) years with Male:Female donor ratio of 
14:6. The average post-mortem time of 15.99(±5.56) hours and preservation time of 
14.5(±4.83) days in tissue culture medium [TCM] were recorded followed by 4.6(±6.27) 
days in transport medium [TM]. TCM was composed of 2% new-born calf serum with 
MEM-Earle as a base medium along with 25 mM Hepes buffer, 26 mM sodium 
bicarbonate, 1 mM pyruvate, 2 mM glutamine, 250 ng/mL amphotericin B, 100 IU/mL 
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penicillin G and 100 mg/mL streptomycin. TM was composed of TCM+6% Dextran T500. 
TCM and TM were prepared in-house (FBOV, Mestre, Italy) with full regulatory 
compliance. The endothelial cells were determined using a hypotonic sucrose solution and 
the mortality was estimated using Trypan blue staining. The endothelial cells were 
checked using an inverted microscope (Zeiss, Jena, Germany). The average endothelial 
cell density recorded was 2070(±374.31) cells/mm
2
 with no initial mortality or uncovered 
areas.  
 
Stripping method 
The [n=20] corneas were centered on a punch base of the suction. Vacuum was created 
using a syringe and the cornea was secured on the base. A 9.5 mm [Moria, Antony, 
France] trephine was used to make a superficial cut using gentle tapping method. The 
endothelium was stained with Trypan blue for about 20 seconds to determine the area of 
the cut. Excess peripheral membrane was removed using 120mm acute forceps 
(e.janach, Como, Italy). The endothelium was kept moist during the entire procedure using 
TM to create a film of fluid on the top of the corneal-scleral ring. The membrane was 
slightly lifted using a cleavage hook and the procedure was carried on along the entire 
circumference of the cut to ensure limited tearing of the very fragile DMEK tissue. The 
peripheral membrane was stripped with a longitudinal movement using a 3 quadrant 
method, ensuring no torsions were generated during this phase to limit the mortality. Once 
the tissue was stripped completely, it was re-stored on the corneal stroma.  
 
Loading method 
The pre-stripped membrane (9.5 mm) was trephined again with an 8.5 mm punch [Moria, 
Antony, France] and the excess periphery was excised maintaining the endothelial side 
facing the air. The membrane was folded manually from two ends using an acute forceps, 
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touching the Descemet side to avoid as much endothelial damage as possible (figure 1a). 
A small drop of liquid was added on the membrane to keep the tissue moist during the 
entire procedure. The purpose of the drop was only to support the moisture and not the 
opening of the membrane as this may change the orientation. The membrane was gently 
moved from the tissue base to a 2.2 IOL (Intra Ocular Lens) cartridge (Viscoject, 
Wolfhalden, Switzerland) preservation chamber (figure 1b). This step can be performed 
either using a contact lens as a scaffold as showed by Busin et al. [10] or directly from the 
cornea to the cartridge maintaining the architecture of the membrane. The membrane was 
pulled inside the funnel using a Grieshaber Revolution DSP 25 Ga + endgrasping forceps 
(Alcon, Texas, USA) from the funnel opening (figure 1c). A small amount of TM (<0.5 mL) 
was used to fill the funnel of the IOL cartridge for preservation of the DMEK membrane 
from its rear end (figure 1d). The IOL cartridge was sealed with a rubber plug both at the 
funnel and the rear exit. The entire unit was sealed with an in-house modified plastic 
clamp. The entire system was preserved in a sterile flask with TM for 4 days at room 
temperature (figure 1e). The plug was removed and the tissues were released out from 
the funnel pore using the microincision forceps and analyzed post preservation. 
Schematic representation of pre-loading the graft is shown in supplementary Figure 1 
(derived from Eye World, ASCRS, October 2016, USA). 
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Figure 1: Pre-loaded Descemet Membrane Endothelial Keratoplasty preparation 
technique. A) using acute forceps on the Descemet side, the tissue is tri-folded with 
endothelium flapped in position with a small drop of tissue culture medium supplemented 
with dextran to keep the tissue moist. The graft should be folded half-way through from 
both the ends to make a tri-fold maintaining the correct orientation, b) the graft can be 
directly transferred from the corneal base to the intra ocular lens cartridge preservation 
chamber using acute forceps which should only touch the periphery of the graft, c) using 
an endgrasping forceps, the graft is gently pulled inside the funnel (pre-filled with transport 
media) [the over-flaps should be visible on the top end and the Descemet Membrane 
should be touching the cartridge], the graft is secured in the funnel area, d) the cartridge is 
filled with the transport media from the back and closed using rubber stopper to preserve 
the membrane and its orientation inside the funnel and e)  the funnel is closed using a 
sterile rubber stopper and the graft is preserved using transport media in a 2.2 intra ocular 
lens cartridge fixed using two rubber stoppers at each end and a clamp on the top, the 
entire unit is preserved in 50 mL transport media to avoid any leakage and shipped.  
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Supplementary figure 1: Pre-loading DMEK grafts in the eye bank. a) Stripped DMEK 
tissue on vacuum block with endothelial side tri-folded inwards, b) DMEK graft is gently 
moved in the loading chamber of an IOL cartridge, c) and pulled further in the preservation 
chamber using end-grasping forceps, d) DMEK graft in the IOL cartridge filled with 
transport medium blocked from its rear and front end using rubber stoppers and e) the 
entire unit is then preserved in transport vial using transport media.   
 
Endothelial cell survival 
The membranes were stained with trypan blue for 20 seconds and washed with PBS. The 
endothelium was checked using an inverted microscope [Primovert; Zeiss, Jena, 
Germany] for endothelial cell survival and tissue integrity. The cells were counted using a 
10X10 eye piece reticule and the images were captured at 100X magnification.  
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Glucose uptake  
Glucose uptake was determined in the preservation media in which the tissues were 
preserved for 4 days. The metabolic activity of the endothelial cells was checked using this 
technique. D-Glucose HK kit (Megazyme International Ireland Ltd, Bray Business Park, 
Bray, Co. Wicklow, Ireland) was used for quantitative analysis post preservation [8]. 
 
Results 
Endothelial cells survive after preserving pre-loaded DMEK grafts [n=20] 
All the final twenty experimental tissues were stripped and loaded successfully (100% 
cases). Average stripping and loading time was recorded at 20 and 4.5 minutes 
respectively. Average endothelial cell density after stripping the tissues was 
2070(±374.31) cells/mm
2
, which did not differ from the initial count. However, the mortality 
increased to 5.08(±12.61)%. There were visible uncovered areas in the tissues post 
stripping with an average of 0.73(±1.89)% [calculated manually at a magnification of 100x 
using a 10 X 10 calibrated reticule mounted in the ocular of the microscope – fixed frame 
technique] (figure 2a). Average endothelial cell density post preservation was found to be 
1980(±278.34) cells/mm
2
 with mortality of 3.55(±5.79)% and 7.8(±14.13)% uncovered 
areas (area on the tissue without endothelial cells) (Figure 2 middle). Endothelial cell loss 
(ECL) after preservation was 4.35%. Localized uncovered areas were observed in some 
parts (Figure 2b). Apart from the areas where the endgrasping forceps get in contact with 
the endothelium for pulling the graft inside the funnel (approximately 0.25-0.5 mm
2
), other 
areas of the periphery did not show any cell loss or mortality (figure 2c). It was also 
observed that if the tissues are kept moist and folded just to orient the graft then minimal 
to no mortality can be observed.  
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Figure 2: Determination of the endothelial cell density, mortality and uncovered areas of 
the preserved grafts at 100x magnification. a) the endothelial status post stripping with 
minimal mortality and uncovered areas, b) small uncovered areas as marked in the figures 
and c) peripheral endothelium without any mortality or uncovered areas (this peripheral 
area is different than the one where the endgrasping forceps touch the endothelium)  
 
During the learning curve, morality was observed on the folds (figure 3a). The tissues 
must be handled gently as if grabbed rigorously using endgrasping forceps, the tissues 
may tear near the periphery (figure 3b). Less uncovered areas were recorded after 
learning the method using more than twenty corneas (figure 3c). The tissues should be 
handled gently to optimize results and the technique requires a learning curve.  
 
 
 
147 
 
Figure 3: Determination of the endothelial cell density, mortality and uncovered areas of 
the preserved grafts at 100X magnification during the learning curve. a) uncovered areas 
and trypan blue stained cells were observed if the tissues are rigorously handled while 
transferring them on the intra ocular lens (IOL) cartridge from the cornea base and 
preserved for 4 days at room temperature in transport media, b) a tear was observed in 
the periphery if the microincission forceps are touched tightly and when the tissue is not 
moved in the funnel gently and c) relatively lesser mortality and unvovered areas were 
observed with increased learning techniques.  
 
Pre-loaded grafts show active metabolism [n=20] 
The average glucose uptake by the endothelial cells in the preservation chamber for 4 
days at room temperature was 0.55(±0.26)mg/mL (Minimum – 0.10 mg/mL and Maximum 
– 0.882 mg/mL) which is half the total amount of glucose present in the media (1 mg/mL). 
Glucose uptake was higher as compared to the previously shown uptake from pre-loaded 
DSAEK membrane [8].  
 
Discussion 
DMEK requires high surgical skills both for the preparation and transplantation of the 
tissues. If eye banks can provide ready and validated DMEK tissues, surgeons do not 
have to engage with this time consuming phase of the procedure, thus saving time, 
eliminating possible tissue waste and facilitating surgery.  
 
It has already been determined that the cell loss in dextran based media is higher than it 
has been found without dextran for PK [11-12]. However, we have observed that corneal-
scleral rims obtained from the dextran based medium allow excising a regular DMEK graft 
with minimal endothelial cell loss. Dextran based medium helps to keep the endothelial 
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cells adhered to the DM and maintains the flexibility required for the tissues for unfolding it 
(unpublished data). Moreover, we have also obtained 100% successful peeling cases 
when the tissues were obtained from TM as compared to 76% successful peeling cases 
when the tissues were collected from TCM. Therefore we selected an inclusion criteria of 
the tissues prepared and preserved in dextran based medium.  
 
Mortality was observed near the folds or when the tissues were treated rigorously by 
making the folds tighter and stronger to maintain the orientation, which was later realized 
as not so important. A small drop of liquid that keeps the tissue moist and without any tight 
folds can be served as the best option. Majority of the uncovered areas were found near 
the periphery of the tissue where the endgrasping forceps touch the endothelium to pull 
the graft inside the funnel. In one of the cases, a peripheral tear was generated with high 
mortality and uncovered area, whereas, in other case, only uncovered areas were 
observed on the peripheral tissue without any mortality. If the graft is gently pulled in with 
minimal manipulations, then the forceps generated uncovered areas and mortality 
decreases to the level of acceptance for grafting as described by Busin et al [10]. 
 
Most of the cases showed the correct orientation and the architecture of the graft same as 
before preservation however, one case during the learning curve showed an ‗S‘ shaped 
fold where half of the corneal endothelium was exposed to the cartridge (figure 4a) and 
the cells were completely detached from that area (figure 4b) showing once again the 
importance of avoiding possible contact between endothelium and cartridge wall. A 
contact lens could be employed or the graft should be pulled gently inside the preservation 
chamber and the funnel area [10]. It was also observed that due to the thickness of the 
IOL cartridge (2.2 pore opening), the tissue does not get a chance to open up and unfold 
itself to endothelium out. The tissues open up to its maximum with endothelium-in and 
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stay in the same fashion without any further opening. The ‗S‘ shape was observed due to 
manual error while pulling the tissue inside the cartridge. If the tissue is properly inserted 
then they stay without any further damage or de-orientation. 
 
Figure 4: De-oriented graft showing ‗S‘ shape orientation. A) graphical representation of 
the tissue showing ‗S‘ shape orientation with one flap exposed to the wall of the cartridge 
and b)- the tissue showing >90% loss of the endothelial cells (uncovered areas) on the 
exposed flap.  
 
There are two transplantation strategies for DMEK, a) the injection method which is widely 
used around the world due to its simplicity and natural rolling of the graft and b) pull-
through technique that is contemporarily used for DSAEK surgery, but has been also 
introduced recently for DMEK [10]. Due to the presence of serum in the preservation 
medium, it is not advisable to inject the tissue directly in the recipient eye as the medium 
will be injected as well. Therefore, a pull through technique should be preferred for a 
successful surgery. The preserved tissue can be released out of the cartridge using a 
microincision forceps and inserted into the recipient eye using bimanual pull-through 
technique. As the endothelium is flapped-in, it reduces a direct contact or friction of the 
endothelial cells with the wall of the cartridge.  
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The DMEK membrane in its natural tendency rolls with the endothelium-out when in 
contact with liquid and therefore if they are manually flapped–in (forced against the 
nature), once inside the eye, they open up easily and try to retain its natural formation 
inside the recipient‘s eye. Therefore, this may serve as an additional advantage over the 
traditional DMEK surgical technique. Moreover, the tissue preparation and loading time 
(approximately 25 minutes) can be saved in the surgery if the tissue is pre-loaded in an 
eye bank. Simultaneously, if the injection method is supposed to be used then the TM 
from the funnel must be removed out using a cannula and filled with balanced salt solution 
(BSS) and the tissue can be injected in the eye. However, for both methods, the tissue 
can be stained inside the funnel using trypan blue for better visibility during the surgery 
[Supplementary video 2]. We have also observed that the tissue opens easily with either 
methods but only when the endothelium is flapped inwards. The tissue can be easily 
washed using BSS to aspirate the TM out however this procedure should be carried out 
gently to avoid any de-orientation of the graft inside the funnel. Alternatively, the TM can 
be removed using a 1 mL syringe and the tissue can be washed with BSS. We have found 
that using the BSS directly to remove the TM has been the best option as it avoids the 
unscrolling and de-orienting the graft. Removing the TM may suck the tissue and grab it 
on the needle of the syringe making it difficult to keep the orientation with endo-in. 
Schematic representation of the process is explained in figure 5 (derived from Eye World, 
ASCRS, October 2016, USA).  
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Figure 5: Pre-loaded DMEK graft in a clinical setting. a) Transport medium in IOL 
cartridge is replaced with BSS and the DMEK graft is stained with Trypan blue. A syringe 
is fixed at the rear end for injecting the tissue inside the recipient eye, b) the stromal side 
of the tissue should face the wall of the cartridge and on the top, facing the stroma of the 
recipient to easily open inside the recipient‘s eye and c) tri-folded DMEK opens inside the 
eye spontaneously and it is allowed adhering to the recipient stroma using air bubble with 
a cannula.  
 
It has already been proposed that the DMEK donor tissues preserved up to 2 days at 4
o
C 
does not show any significant endothelial cell loss difference [13]. However, the results 
described in this paper suggest that the DMEK tissues can be preserved in the IOL 
cartridges filled with transport media for up to 4 days at RT without a high cell loss and 
active metabolism. The surgical outcome further needs to be evaluated. The tissues used 
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in this study were obtained from relatively older donor corneas and therefore they did not 
unscroll to its natural tendency of endo-out. However, the tissues should be preserved 
around 2 mm away from the funnel pore to keep the tissue as tight as possible and avoid 
any de-orientation of the graft. DM-endothelium grafts for transplantation in DMEK 
procedures can be prepared from TM and preserved in TM for the best outcome. The 
tissues should be transplanted using a pull-through technique to reduce the possibility of 
injecting the serum inside the recipient eye, although an injection method could also be 
used if the tissue is washed inside the funnel. Injection method will reduce the chances of 
peripheral tears and uncovered areas. Pre-loading DMEK membrane will reduce surgical 
time, tissue wastage and costs. In addition, it will provide a validated tissue for 
transplantation. The study presented here is a ‗proof of concept‘ and has not undergone 
any clinical evaluation therefore the complications need to be identified before undergoing 
any surgery. 
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CHAPTER 7 
 
ISOLATION OF THE PIG AND HUMAN CORNEAL 
ENDOTHELIUM 
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Aim 
To understand the cell culture technique for pig and human corneal endothelial cells and 
determine the optimal conditions. 
 
Introduction 
There are several methods that are in use for Human Corneal Endothelial Cells (HCECs) 
isolation. Initially, Collagenase or Trypsin was used on whole corneas but as it inevitably 
caused interference of corneal fibroblasts, a selective L-valine-free medium was used as 
described earlier. Stripping the Descemet‘s Membrane (DM) and the endothelial explants 
culture in T-2 flasks have also been used. Peel and digest method by Peh et al. have 
showed successful cultures as well. The recent protocol shows scrapping of HCECs with 
the DM using enzyme digestion followed by cell scrapping. Although this method may 
eliminate fibroblast contamination, scrapping of cells using a blade has reduced the 
viability of the primary cells dramatically. Other methods can include stripping or bubble 
techniques to separate the Descemet‘s membrane from the stroma and then digest the 
cells using trypsin for cell culture. Stripping of HCECs can also be performed with the aid 
of a vacuum suction holder, as described by Peh et al [4]. After peeling, the Descemet‘s 
membrane and endothelial layer are finally digested enzymatically, using dispase or 
Ethylenediaminetetraacetic acid (EDTA), followed by pipetting. However, enzymatic 
digestion requires a prolonged incubation time to detach cells from the matrix, 
subsequently leading to higher cellular degeneration. Thus, it is evident that there is still 
room to standardize a specific and reproducible method to isolate and culture HCECs 
from the donor corneas [5].  
 
As there is no standardized protocol for isolation, two major isolation techniques were 
investigated which included, a) Accutase cell scrapping method and b) Peel and digest 
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Trypsin method. The media constituents were re-evaluated for the optimal concentrations 
from the literature.   
 
Materials and methods 
Media for culturing HCECs 
Media for HCECs 500 mL 
Ham's F12 195 mL 
DMEM 195 mL 
FBS 100 mL 
Penstrep 5 mL 
Fungizone 5 mL 
Insulin 0.5 mL 
Ascorbic acid 10 mg 
bFGF 20 microg 
 
Materials to culture pig and HCECs using ACCUTASE CELL SCRAPING METHOD and 
PEEL AND DIGEST TRYPSIN METHOD 
 
Accutase 
Trypsin-EDTA 
Tweezers 
Silicon blocks 
Sterile petri dishes 
Cell scrapers 
T 25 flasks 
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6 and 24 well tissues culture coated plastic 
plates  
Sterile PBS 1X 
PFA for histology 
30% Sucrose for wash 
H&E staining materials 
ICC antibodies for cell characterisation 
Vaccuum blocks  
8.5 mm punch 
Pierce forceps 
 
Method to culture HCECs using ACCUTASE CELL SCRAPPING METHOD 
After excising the TM, the corneas were placed in a way that the corneal epithelial side 
faces the bottom of sterile plastic bijou tube eye holders. The endothelium was covered 
with Accutase enzyme (approximately 200 µL) up to the pigmented line and the entire unit 
was incubated for 15 minutes at 37
o
C with 5% CO2 and humidified atmosphere as showed 
in figure 1a. Using a sterile cell scraper or a plastic inoculation loop, the cells were 
dislodged at the peripheral endothelium. The cells mix with Accutase and hence the cells 
can be directly pipetted out along with Accutase directly into one well of a 24 well plate 
with 1.5-2.0 mL of fresh HCECs medium and incubated at 37
o
C. The medium was 
changed after 2-3 days. During the first media change, the cells were washed using PBS 
to remove any potential debris associated with dissection. Trypan blue staining was 
carried out to judge the area of the excised tissue as showed in figure 1b. 
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Figure 1: Cell culture of HCECs using Accutase cell scrapping method. a) HCECs were 
exposed to accutase for approximately 15 minutes at 37
o
C in humidified atmosphere with 
5% CO2. The cells were excised from peripheral and central cornea and cultured 
separately and b) Trypan blue staining of the HCECs after cell scrapping from the 
peripheral region. 
 
Method to culture HCECs using PEEL AND DIGEST TRYPSIN METHOD 
The Descemet‘s membrane and endothelium can either be separated using Submerged 
Hydro Separation (SubHyS) or Stripping method (central and peripheral). However, 
Stripping method (Figure 2) was selected for this study considering its reproducibility and 
access to peripheral and central endothelium which is difficult with SubHyS method as it 
separates an entire tissue.  
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Figure 2: Stripping method using peel and digest trypsin method. a) Initial punch using 
8.5, 9 or 10 mm donor punch on vacuum block, b) identification of the central Descemet‘s 
membrane and endothelium and c) peeling the central Descemet‘s membrane and 
endothelium using Fogla forceps. The peripheral endothelium was excised using forceps 
and placed in Trypsin EDTA solution.  
 
The peripheral and the central Descemet‘s membrane and endothelium were excised and 
were used for either explant culture technique or trypsin digestion method. Peel and digest 
Trypsin method helps to lower down the stromal interference and hence limits the 
fibroblast expansion but does not eliminate completely. The Descemet‘s membrane and 
endothelium was further digested in Trypsin EDTA solution after washing the lenticule in 
1X PBS. The procedure is as follows: 
1) The Descemet‘s membrane and endothelium (central and peripheral) [Note: The 
entire cornea was used as peripheral cornea did not show a higher number of 
extractions and therefore was difficult to identify the potential co-factors] was 
transferred in a tube containing 10 mL of Trypsin EDTA solution (TE). The tube 
containing the tissue was incubated in water bath at 37
o
C for 30 minutes. The tube 
was shaken manually every 5 minutes approximately.  
160 
 
2) At the end of the incubation time, the biopsy was transferred in a new 15 mL tube 
containing 5 mL of TE and a new cycle of trypsinization was carried out.  
3) At least 5 mL of the HCECs medium was added to the tube containing the solution 
with the extracted cells to stop the Trypsin procedure. The tube was centrifuged for 
3 minutes at 800 rpm. The supernatant was aspirated gently to avoid drying of the 
cell pellet. The pellet was re-suspended in approximately 0.5 mL of the medium, 
and the final volume was verified.  
4) Approximately 50-100 µL of the sample was transferred into a 2 mL eppendorf 
tube, followed by a transfer of 50 µL to a second eppendorf tube containing 50 µL 
of Trypan blue. One or both sides of the Haemocytometer slide was filled with the 
solution and the cells were counted by 2 different drafts of the cell suspension. The 
number of extracted cells were counted, distinguishing between viable and non-
viable cells using a standard formula:  
 
‘Number of cells/number of chambers (4 or 8) X 10,000 X Trypan blue positive cells X 
Volume’ 
The entire extraction procedure was repeated until the cells are decreased drastically 
(usually 2-3 cycles). The cells were plated as soon as possible, to avoid the cells in 
suspension for long. Therefore, after each extraction cycle or when the sufficient number 
of cells was extracted, the plating of the cells in a 24 well plate was carried out. The plates 
were incubated at 37
o
C, 5% CO2 and 90% of humidity for 48 hours. Media was replaced 
every alternate day.  
 
The confluent cells were further re-suspended using Trypsin EDTA treatment for 5 
minutes incubated at 37
o
C, 5% CO2 and 90% of humidity. 50% of the suspension were re-
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cultured and the rest were used for immunocytochemistry after cyto-spinning the cells for 
5 minutes at 1000 RPM to characterize the cells.  
 
To check the density of the cells as a potential factor for human corneal endothelial cell 
culture 
10 human donor corneas (organ cultured) were pooled in together using cell scrapping 
method to excise total endothelium comprising periphery and central region. TM was 
excised and the cells were scrapped up to far periphery as described earlier. The cells 
were placed in 5 mL fresh media (HCECs medium). The cells were centrifuged at 200G 
for 4 minutes and the pellet was obtained. 3 mL of media was re-filled to collect the cells 
and were further cultured in serial dilutions. The dilution factors that were used for this 
study with cells:media were 1.5:0.5; 1:1 and 0.5:1.5 respectively.  
 
However, with peel and digest method, the cell count obtained was higher as compared to 
the Accutase cell scrapping method and therefore 4 corneas were used for the peel and 
digest method to collect different amount of cells and plated to check if the density was an 
issue for primary cells to expand and check the cell-cell communication.  
 
Explant culture method 
The lenticules were peeled off and placed in a T-25 flask with the Descemet‘s Membrane 
side touching the flask. The media was refilled every 2 days. Only stripping technique can 
be used for such culture methods.  
 
Histological analysis 
The excised Descemet‘s membrane and endothelium were used for the culture and the 
remaining tissue was fixed in 4% paraformaldehyde (PFA) for 24 hours at 4
o
C. This 
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procedure was carried out to check the absence of Descemet‘s membrane and 
endothelium from the entire tissue and verify the separation. The tissue was washed with 
PBS and was treated with 7.5%, 15% and 30% sucrose consecutively for 30 minutes 
each. The tissues were further washed in PBS and embedded in optimal cutting 
temperature compound (OCT) for 30 mins at -80
o
C before cutting. 10-25 micron thick 
sections were cut for histological analysis.  
 
Histological analysis with Hematoxylin-Eosin (H&E) staining 
The sections were brought to room temperature before H&E staining. The sections were 
dipped in Harris Hematoxylin for 3 minutes and washed briefly in Scott‘s tap water thrice to 
remove excess Hematoxylin. The section was further dipped into differentiation solution 
for 2 mins and was washed in tap water briefly followed by eosin treatment and washing 
with tap water for 2 minutes. Evaporation procedure was carried out using 70%, 90% and 
100% ethanol followed by Xylol for 1 minute each. The slides were then air dried and the 
sections were fixed and mounted using DPX mounting solution and were viewed under an 
inverted microscope at 100X magnification. The pictures were collected using Zen 
software and were analysed further.  
 
Immunostaining using Zonula Occludens-1 (ZO-1) 
The cultured cells were extracted using Trypsin treatment for 5 minutes at 37
o
C, 5% CO2 
and 90% of humidity. The extracted cells were counted and were sub-cultured as first 
passage and cyto-spinned 1:1. The cells were placed in the cyto spin chamber and were 
spinned down at 1000 rpm for 5 minutes. The collected cells were fixed with 4% PFA 
overnight. The cells were then brought to room temperature before washing them with 
PBS thrice at RT for 5 minutes. Permeabilization solution (0.5% Triton-X solution) was 
used for 30 minutes at RT and was washed briefly with PBS. The cells were further 
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blocked in a humidity chamber for 2 hours at RT using a blocking mix (10mL PBS + 150 
µL goat serum + 0.1 gm bovine serum albumin + 10 µL of Triton-X). The cells were further 
incubated overnight at 4
o
C using blocking solution and primary antibody (ZO-1, 1:100). 
PBS was used to briefly wash (three times 15 minutes each) the primary antibody off. 
Secondary antibody conjugated with FITC (1:100) was used with blocking mix for 2 hours 
at RT in dark. The cells were further washed with PBS for 5 minutes thrice in dark to avoid 
bleaching and were further mounted with Vectashield containing 4',6-diamidino-2-
phenylindole (DAPI) which is a nuclear stain which can penetrate in the intact cell 
membrane. Cells were examined using a LSM 510-meta laser scanning microscope 
(Zeiss, Milan, Italy). Examination was performed under an ultraviolet light or by excitation 
at wavelengths of either 488nm or 594nm, and subsequent detection of the fluorescence 
was obtained.  
 
Results 
Pig corneal endothelial cell culture using explants culture and cell scrapping technique. A 
higher rate of cell proliferation capability was seen from peripheral region of the explants 
and the cell scrapping method as compared to the central region which reflects the 
possibility of the presence of putative stem cells in the corneal peripheral endothelium as 
seen in figure 3.   
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Figure 3: Pig corneal endothelial cell culture using explants and cell scrapping technique 
at 100X magnification of an inverted microscope. a) the peripheral explants showed 
confluency of the cells within two weeks of the culture where as b) the central explants 
showed partial confluency in the same period. c) Accutase cell scrapping method showed 
confluent cells after 1 week of culture, whereas d) the cells from central region did not 
show any confluency. The results show that the peripheral cornea may have putative stem 
cells.  
 
The cells from one of the cadaveric donor corneas showed proliferative capability as seen 
in figure 4 at different magnifications. The TM of this cornea was not removed and the 
cells were excised from far periphery of the corneal endothelium which is presumed to be 
the corneal endothelial stem cell niche. However, out of 15 corneas that were cultured, 
only one showed proliferative capability and therefore it is necessary to further investigate 
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the co-factors. This is currently being characterized and explored further. They are 
presumed to be HCECs only on the morphological basis.  
 
Figure 4: HCECs culture using Accutase cell scrapping method at different 
magnifications, a and b) 50X, whereas c and d) 200X, Only one of the donor corneas 
showed proliferative capability as seen in the figure at different magnifications. The 
morphology was observed to be similar to HCECs as per the literature. 
 
Human corneal endothelial cell culture using explants culture technique. There was no cell 
proliferation seen using explant culture technique either from the periphery or from the 
central cornea as seen in figure 5. This also highlights that every donor behaves 
differently. None of the samples showed any proliferative capability out of five.  
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Figure 5: HCECs explants culture technique observed at 50X magnification. The cells did 
not proliferate from the a) periphery and b) central lenticule. Although the cells were 
observed on the tissues they did not show any growth after 2 weeks.  
 
H&E staining showed the absence of Descemet‘s Membrane and Endothelium from the 
entire cornea further confirming the excision of HCECs from the donor tissues as seen in 
figure 6.  
 
 
Figure 6: Histological analysis on the excised tissue observed using an inverted 
microscope at 100X magnification. a) centrally excised donor tissue without DM and 
endothelium, b) peripherally excised donor tissue without DM and endothelium and c) 
control tissue showing the presence of all the layers of a donor corneal tissue.  
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Two important characteristics were observed between the two methods: 1) Accutase does 
not allow excision of higher number of primary cells as compared to Trypsin digestion and 
2) cell scrapping hampers the viability of the cells and therefore it becomes a little difficult 
to culture them further as observed in figure 7. The cells from the Trypsin digestion 
method were further cultured as they showed proliferative capability (figure 8) and were 
characterised later.  
 
 
Figure 7: Comparison between Accutase and Trypsin digestion and isolation potential of 
each method for culturing human corneal endothelial cells at different magnifications and 
from day 0 to day 2. The figure shows that the Trypsin digestion allows a higher amount of 
cell isolation as compared to Accutase within first three days of the cell growth.  
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Figure 8: Cells isolated using Trypsin and cultured for 7 days before immunostaining at 
different magnification for better evaluation of the cell expansion in vitro.  
 
The cells obtained using Accutase cell scrapping method was too low and therefore the 
cells did not proliferate any further in either case as seen in figure 9.  
 
 
Figure 9: Density gradient experiment to verify the theory of initial requirement of the cells 
for culture as seen using a 100X magnification of an inverted microscope using Accutase 
cell scrapping method. The amount of cells isolated was too low and therefore none of the 
cells proliferated further.  
 
A higher amount of cells (countable under Hemocytometer slide) were obtained using 
Trypsin digestion method and were plated as per a higher degree of cell count obtained as 
seen in figure 9. It was observed that wells containing 12,750 cells did not show 
proliferation as compared to the one with 16,000 cells (same donor). Whereas the wells 
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with 26,000 cells and 84,000 cells showed a high proliferative capability (same donor) as 
seen in figure 10.   
 
Figure 10: Density gradient experiment to verify the theory of initial requirement of the 
cells for culture as seen using a 50X magnification of an inverted microscope using 
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Trypsin digestion method. Different amount of cells were isolated using this method and a 
higher rate of cell proliferation was observed within 3 days from the higher amount of cells 
that were isolated as compared to the ones with low amount of cell isolation.  
The cultured cells were further characterized using ZO-1 (tight junctional protein 
expressed in the corneal endothelial cell borders) immunostaining. The cells expressed 
the ZO-1 antibody as seen in figure 11.   
 
 
 
Figure 11: Immunostaining on the cyto-spinned cells using ZO-1 observed under oil 
immersion magnification. The marker stains the tight junctional proteins of the corneal 
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endothelium and therefore the presence of this marker indicates HCECs like cells from the 
culture and no interference of fibroblasts after day 7 of the culture.  
 
Discussion 
Pig corneal endothelial cells can be cultured in vitro using the culturing technique as 
described in this article however, HCECs requires further knowledge of cell extraction, 
interaction and proliferation capabilities, identification of specific media and growth factors 
that allow these cells for a controlled growth in vitro and determine a standard cell culture 
technique using functional biomarkers for specific cell types. The early observations were -  
1. Pig corneal endothelial cells can be cultured using Accutase and explants culture 
method using specific media formulation as described in the report. Peripheral 
corneal endothelium showed a high confluency as compared to the central proving 
the hypothesis of the presence of putative stem cells in the peripheral cornea.  
2. Accutase method can be used to culture HCECs, however as only one cornea 
showed the proliferative capability, therefore the method needs a further validation 
and standardization.  
3. HCECs cannot be cultured using explants culture method however other co-factors 
need to be evaluated before concluding this.  
4. Stripping method shows a precise removal of the DM and endothelium and 
therefore limiting the growth of fibroblasts, however, this needs to be further 
evaluated to understand whether the fibroblasts appear after 2
nd
 or 3
rd
 passage as 
was seen in one of the earlier cases. 
5. Trypsin digestion method showed a high amount of cell isolation, proliferation and 
confluency as compared to Accutase and therefore Trypsin digestion method was 
further used for this study.  
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6. Density gradient experiment did not show countable cells using Accutase method, 
however, the cells that were isolated using Trypsin method showed a higher 
number of cells and better proliferation rate up to confluency. It was also noted that 
cell count below 15,000 cells did not show any growth however, cell count with 
16,000; 26,000; and 84,000 cells showed cell expansion. It can be hypothesized 
that with higher cell density, chances of acquiring putative stem cells may be high 
from the periphery with better cell-cell communication higher chances of expansion.  
7. Immunostaining showed the presence of ZO-1 marker from the first passage 
however this needs to be verified with further cultures and reproducibility needs to 
be confirmed for the potential of this expansion technique.  
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CHAPTER 8 
PILOT STUDIES 
 
 
PART 1   
INTRODUCTION OF RHO-ASSOCIATED PROTEIN 
(ROCK) 
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Aim 
To evaluate the effect of ROCK inhibitor (Rho-Kinase) on the proliferation rate of HCECs 
using dual media approach. 
 
Introduction to ROCK inhibitor 
It has been thought that human corneal endothelial cells, unlike those from other species, 
are terminal and cannot proliferate. However, there is some clinical and emerging in vitro 
evidence that this is not the case. Indeed, our preliminary data shows that human 
cadaveric corneal endothelial cells can be made to expand in culture. We have already 
seen that some donor human cadaveric tissue results in incredibly successful endothelial 
cell expansion whereas other samples result in aborted growth or no growth at all. In 
addition, the initial yield of corneal endothelial cells from tissue samples can be variable.  
Many studies have shown the effect of ROCK inhibitor on corneal endothelial cell 
proliferation and therefore we set to replicate the results using old age donors which have 
been assumed to have a slow growth rate as compared to the young donors which has 
already been evaluated so far.  
Rho-associated protein kinase (ROCK) is a kinase belonging to the AGC (PKA/ 
PKG/PKC) family of serine-threonine kinases. It is involved mainly in regulating the shape 
and movement of cells by acting on the cytoskeleton. ROCKs (ROCK1 and ROCK2) occur 
in mammals (human, rat, mouse, cow), zebrafish, Xenopus, invertebrates (C. elegans, 
Mosquito, Drosophila) and chicken.  
Alternative approaches to corneal regeneration following endothelial failure include the 
use of Rho-kinase (ROCK) inhibitor eye drops to enable the proliferation and healing of 
host endothelium, or the development of allogeneic ex vivo expanded corneal endothelial 
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cells for transplantation. A major drawback for the ROCK inhibitor strategy is that in Fuchs‘ 
endothelial dystrophy, which is a common endothelial disorder, the host endothelium is 
already abnormal. It therefore requires a total replacement instead of simple proliferation. 
This will further enable to develop corneal endothelial sheets for future clinical trials. This 
may also allow the mass production of HCECs from donor cornea, thereby reducing the 
global shortage of human corneal tissues for endothelial disease.  
 
Materials and methods 
Ethical statement 
Human cadaveric donor corneas were collected with consent from the donor‘s next of kin 
to be used for research if not for transplantation and were preserved in tissue culture 
medium with age range of >60 years and endothelial cell density of <2200 cells/mm
2
. 
 
Peel and digest method  
Wash corneas in wash buffer for 5-10 minutes. Peel the Descemet‘s membrane and 
endothelium using gentle stripping method. Tear the tissue in various pieces to ensure 
higher and quicker isolation of the cells. Punching method can be used but it may release 
keratocytes and therefore unwanted contamination of the fibroblasts. Once the tissues are 
washed in the wash buffer the peeling should be carried out at the earliest. Meanwhile the 
media should be warmed up (maintenance media). The tissues are left in the collagenase 
enzyme for 4-5 hours for cell digestion.   
 
Plating  
The cells were washed and placed in a small eppendorf tube and spinned down for 5 
minutes at 1000 rpm. The supernatant was removed and TripleE was added to cut the 
clumps into single cells for 10 minutes at 37 degrees (as much as possible). The pellet 
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was mixed with the TripleE Express and the cells were dissociated. The cells were then 
spinned down. Meanwhile a 6 well plate was coated with FNC. The liquid coating was left 
in the plate for 10-30 minutes. The residual coating was removed. After removing the 
TripleX supernatant, the cells were mixed with maintenance medium (basal serum free 
media without any growth factors). 2.5 mL of maintenance media was added on the 
coated plate and 500 µL was mixed with the cells. The cell suspension was added in the 
maintenance media to make a total volume of 3 mL. The cells were preserved at 37 
degrees for 2 days. The cells were left in the maintenance media for 2 days and then 
transferred to the proliferation media for cell expansion. The cells were monitored up to 
confluence.  
 
Passaging  
The cells were dissociated in TripleE Express for 5 minutes at 31 degrees. Once the cells 
were dislodged, they were gently washed and flushed from each side of the petri to 
ensure the removal of all the cells, they were then pipetted out and centrifuged at 1500 
rpm for 5 minutes. The supernatant was removed and refilled with maintenance media 
and mixed well. The cells were counted. The plates were coated with FNC. 150k cells 
were plated in a 6 well plate with proliferation media.  
 
Antibody staining 
The small cover slips were UV sterilized and placed in the small 4 well plates. The cover 
slips were coated with FNC. The FNC was removed without touching the 7 mm cover slips 
(approximately 60 µL on each cover slip). The cells were plated on the cover slips and left 
to attach for 4-5 hours. It usually looks like a single drop on the cover slip. Once attached 
the cells were flattened by adding 1 mL of maintenance media covering the entire well. No 
growth was required if plated at high density.  
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The media was removed and the cells were washed with 1X PBS (5 minutes). Fix with 
PFA for 10 minutes and wash twice with 1X PBS. Add blocking buffer on the cells for 30 
minutes [10% Goat serum diluted in 1X PBS – Blocking buffer]. Add primary antibody [ZO-
1, GPC4, Na-K ATPase, 1A3] for 1-2 hours at RT. The cells were washed twice with PBS 
for 5 minutes each. Add secondary antibody diluted in blocking buffer and incubate the 
cells for 1 hour at RT in dark. Proceed with Hoechst staining for 5 minutes at RT in dark. 
Wash the cells in 1X PBS and mount it with Vectashield mounting medium with DAPI.  
 
Proliferation – ClickIT BrDu assay  
Proliferation of the corneal endothelial cells are assessed using a 5-ethynyl-29-deoxyuridie 
(EdU) incorporation assay, by using a Click-iT EdU Alexa Fluor 488 cell proliferation assay 
kit (Invitrogen, Carlsbad, CA, USA). Cultured HCECs were passaged using TE and 
seeded in their respective culture conditions on FNC-coated glass slides at a plating 
density of 2,000-5,000 cells/cm
2
 for 24 hours. The cells were then incubated in their 
respective medium containing EdU (10 mM) for another 24 hours. HCECs were washed 
with PBS, and fixed using 4% paraformaldehyde (PFA) for 15 minutes on ice, followed by 
a 0.1% Triton X-100 in 3% BSA block and permeabilization step for 20 minutes, all at 
room temperature. Incorporated EdU was detected by fluorescent-azide coupling Click-iT 
reaction. Briefly, cells were incubated for 30 minutes in a reaction containing azide-
conjugated Alexa Fluor 488 dye in Click-iT EdU reaction buffer supplemented with 4 mM 
CuSO4. Cells were washed twice with 1 mL 3% BSA in PBS, and mounted on glass slides 
with Vectorshield containing DAPI (Vector Laboratories, Burlingame, CA, USA). Images of 
cells were examined using a Zeiss Axioplan 2 fluorescence microscope (Carl Zeiss, 
Germany). At least 500 nuclei were analyzed per experiment and data point. 
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Live/dead/apoptosis FACS analysis  
Trypsinize the cells. Suspend and count. FITC Annexin V Apoptosis Detection Kit with PI. 
The cells were washed with cold BioLegend‘s cell staining buffer, and then resuspend the 
cells in Annexin V Binding buffer at a concentration of 0.25-1X10
7
 cells/mL. Transfer 100 
µL of cell suspension in a 5 mL test tube. Add 5 µL of FITC Annexin V. Add 10 µL of 
Propidium-Iodide solution. Gently Vortex the cells and incubate for 15 minutes at room 
temperature (25
o
C) in the dark. Add 400 µL of Annexin V binding buffer to each tube. 
Analyze by flow cytometry with proper machine settings. PI is a fluorescent dye that binds 
to DNA. When excited by 488 nm laser light, it can be detected with 562-588 nm band 
pass filter. Flow cytometry analysis was carried out.  
 
Results 
Collagenase digestion of the excised human corneal endothelial cells using stripping 
method showed total isolation of the cells within 5 hours at room temperature. The 
digestion phases at each hour were showed in figure 1. The cells were then trypsinized 
and collected as single cells from the clumps and seeded on the wells coated with FNC as 
shown in figure 1f. The cells were then left and monitored for adherence and proliferation 
with media change at every alternate day.  
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Figure 1: Collagenase digestion, a-e) at hourly basis showed that the cells were isolated 
totally within 5 hours of collagenase enzyme digestion. F) further, the cells were plated on 
the FNC coated wells and were left for attachment and further proliferation.  
 
7 pairs of donor cornea showed proliferation in P0 while one pair was contaminated with 
fibroblasts. The cells with proliferation but no further growth in P0 are showed in Figure 2a 
and 2b, however the other donors showed confluency and were further passaged to P1 
(figure 2c and 2d). The cells did not show any further confluency restricting the growth 
only up to P1.  
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Figure 2: Cultured corneas in proliferative media. a and b) the cells showed proliferation 
but no confluency in P0. c and d) The cells showed confluency and were further passaged 
to P1. The cells did not show any further confluency restricting the growth only up to P1. 
Different donors have different characteristics and growth profile.  
 
Immunostaining showed expression of different antibodies as seen in figure 3 which 
further confirmed the presence of protein profiles of cultured human corneal endothelial 
cells.  
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Figure 3: The antibody staining showed presence of pump proteins and tight junctional 
proteins. The new antibodies specifically designed for human corneal endothelium (1A3) 
also showed expression of the proteins.  
 
Proliferative cells were observed in the cultures as seen in figure 4.  
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Figure 4: Proliferation study. 5% of cultured human corneal endothelial proliferative cells 
were observed. A) shows the presence of cell nuclei using DAPI staining, b) shows the 
presence of proliferative cells using FITC and c) shows the merge of two.  
 
Discussion 
HCECs can be cultured from human cadaveric donor corneas. The donor characteristics 
are yet to be defined to understand the best suitable source for such kind of cultures. 
There are no specific corneal endothelial markers and therefore there is a need to identify 
a specific marker in order to conclude the culture results. Plating density should be 
identified and the source cells should be used accordingly. 
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CELL ADHESION AND PROLIFERATION 
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Aim 
To identify different methods of cell adhesion and coating mixture for corneal endothelial 
cell proliferation. 
 
Introduction 
Cell adhesion is an important part of cell culture. HCECs are already been suggested to 
be non proliferative especially when they are isolated from the old donor corneas. If these 
cells do not attach properly to their base then there is a high chance of cells not surviving 
in the due course. Therefore, it was important to learn the base coating and adhesion 
properties. Base coating currently is carried out using FN coating mix. There are many 
other coating mixtures but FN has been standardized earlier for HCECs cell culture. 
HCECs proliferation is another important parameter after studying cell adhesion. 
Proliferating cells are analyzed and further used for passaging. In this study, we checked 
the cell adhesion and proliferation of HCECs and the effect of ROCK inhibitor.  
 
Material and methods 
Ethical statement 
The corneas (n=10) were obtained from the eye bank in University of Szeged, Hungary. 
Five donors with age 64, 83, 66, 85 and 81 were used for this study. Corneas from each 
donor were excised from whole eye globes. The DMEK graft was excised using standard 
peeling method and the Descemet‘s membrane and endothelium from both the corneas 
were pooled together in one well. The endothelial cells were isolated from the Descemet‘s 
membrane sheet using collagenase A for approximately 2 hours. The cells were 
centrifuged at 1000 rpm. The supernatant was removed and the cells were trypsinized for 
10 minutes at 37
o
C in a humidified incubator. The cells were centrifuged again for 5 
minutes and the supernatant was removed. The cells were mixed with maintenance 
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media. The cells were mixed well and divided into two parts, a) the control well where the 
cells were plated with maintenance media without ROCK (rho-kinase inhibitor) with 
Fibronectin (FN) coating on the plastic well and b) the experiment well, where the cells 
were plated with maintenance media and ROCK on a FN coated plastic well. Media was 
replaced every 2 days and the attachment, growth and morphology was monitored 
 
Results 
Descemet‘s membrane was monitored for isolation of cells. Figure 1 shows the peeled 
Descemet‘s membrane in collagenase A for digestion.  
 
Figure 1: Descemet‘s membrane and endothelium with endothelial cells attached on it 
while collecting the initial cell count. Peeled DM in collagenase A with corneal endothelial 
cells still attached post peeling. Isolation of HCECs after 2 and 4 hours in Collagenase A. 
 
After plating the cells, the media was added and the cell growth and morphology was 
monitored. It was observed that with time, the cells cultured in ROCK inhibitor show higher 
proliferative capability as compared to the control as seen in Figure 2. The FN coating 
allows cell adhesion and hence proliferation of the cells. Moreover, the morphology of the 
cells in the early days looks polygonal out of which a few cells turned to be elongated with 
time.   
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Figure 2: Cell proliferation and comparative analysis of the corneal endothelial cells grown 
with and without ROCK inhibitor at day 1, 4, 7 and 11. It was observed that the cell 
proliferation was much higher when the endothelial cells are exposed to ROCK however 
the cells showed elongated morphology after day 11.  
 
Another two sets of corneas were used for confirmatory analysis and similar trend was 
observed when the cells were cultured on the FN coated plates with ROCK inhibitor as 
shown in figure 3. This analysis was performed as per the new protocol. The cells were 
plated on FN coated wells and after maintaining them in maintenance media for two days, 
the media was replaced with ROCK supplemented media and monitored till confluence.  
 
Figure 3 shows the attachment of the cells at day 2 in maintenance media from the 
corneas collected from set 1 and set 2 (two different donors).  
 
Figure 3: Cells showing high adherence after 2 days in maintenance media 
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At day 4 (2 days in proliferative media – media supplemented with ROCK inhibitor), the 
cells showed high proliferation capability and high percentages of hexagonality which was 
subjectively measured as seen in figure 4. Whereas, at day 6, central well showed 
confluence whereas the periphery was not confluent and the cells still looked isolated.  
 
 
Figure 4: Cells showing proliferative capability after 2 days in proliferative media. The 
cells also show hexagonality.  
 
Figure 5: Cells showing proliferative capability after 6 days in proliferative media. The 
periphery was not confluent, however the central area was confluent.  
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Discussion 
From this study, it was determined that cells grown on pre-coated wells with FN show high 
adherence capabilities. These cells further proliferate at even a higher rate when cultured 
using ROCK inhibitor. Therefore, a combination of FN and ROCK was determined to be a 
valuable solution for the next phase.  
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PART 3 
 
INTRODUCTION OF HYALURONIC ACID FOR FORCE 
ATTACHMENT 
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Aim 
To optimize a protocol for culturing HCECs using Hyaluronic acid (HA) for force 
attachment.  
 
Introduction 
Sodium hyaluronate is a naturally occurring, high molecular mass, polysaccharide found in 
the extracellular matrix of the connective tissues. Sodium hyaluronate, and other 
viscoelastic substances including methylcellulose, chondroitin sulphate, polyacrylamide, 
and collagen, have been used in intraocular surgery since 1970s.  
 
Materials and methods 
Corneas [n=6] were excised from whole eye globes using peeling method. The cells were 
isolated from the DM using collagenase A (1mg/mL) using a shaking incubator for 2 hours. 
The cells were centrifuged at 1000 rpm for 5 minutes in a 15 mL tube. The supernatant 
was removed and the cells were trypsinized for 10 minutes at humidified incubator at 
37
o
C. The cells were centrifuged again at 1000 rpm for 5 minutes and the supernatant 
was removed. The cells were then mixed well with the maintenance media and plated as 
below.  
 
The cells were mixed with 1000 mL of maintenance media and the final volume was 1200 
mL including supernatant. The cells were mixed well and 100 µL was added in each 
chamber of the slide as shown below. The glass slide was pre-coated with FNC.  
 
C V R V+R 
C V R V+R 
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C = Control (FNC coating + maintenance media) 
V = Viscoelastic (The cells were plated and viscoelastic was added on top of cells to cover 
the entire well and induce cell adherence+maintenance media) 
R = ROCK inhibitor (The cells were plated with ROCK inhibitor) 
V+R = Viscoelastic + ROCK inhibitor (The cells were covered with Visco+ROCK and 
added without maintenance media). 
 
The remaining 400 µL were added on a plastic 12 well plate coated with FNC and were 
monitored over time.  
 
Results 
It was noted that the cells that were cultured only with maintenance media did not show a 
high proliferative capability at day 1 and day 5 as seen in figure 1. However, better 
adherence was found in the condition where HA was used, but as the cells were cultured 
in maintenance media, they did not proliferate at day 1 and day 5 as seen in figure 2. It 
was observed that when the cells were cultured with ROCK on FN coated base, the cells 
showed high adherence and proliferative capability as observed in figure 3. The cells 
adhered and proliferated the most in condition where the cells were forcefully adhered 
using HA, supplemented with ROCK inhibitor on FN coated base as seen in figure 4.  
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Figure 1: HCECs on FN coated base cultured using maintenance media. 
 
Figure 2: HCECs on FN coated base cultured using maintenance media but adhered 
firmly using HA.  
194 
 
 
Figure 3: HCECs on FN coated base cultured using ROCK supplemented media. 
 
Figure 4: HCECs on FN coated base cultured using ROCK supplemented media and 
adhered firmly using HA.  
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Discussion 
From this pilot study, it was noted that it is necessary to use a base coat which allows 
adherence to the HCECs, along with inhibitors like ROCK which would allow further 
adherence to the HCECs. Viscoelastic provides a higher and faster adhesion of the cells 
on the plate and therefore allows a quick attachment and proliferative potential. Therefore, 
a full study using the results of these pilot results was carried out and detailed in the next 
chapter.  
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HUMAN CORNEAL ENDOTHELIAL CELL CULTIVATION 
FROM OLD DONOR CORNEAS WITH FORCED 
ATTACHMENT 
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Reports.  
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Aim 
To culture HCECs from old donor corneas with forced attachment using HA.  
 
Introduction 
Human cornea is made up of several layers. The endothelium that is the posterior 
monolayer is responsible for maintaining the required transparency of the cornea. An 
osmotic gradient is generated by the transmission of essential metabolites across the 
corneal endothelium, which transports water into the cornea. The corneal endothelium 
continuously pumps the water, ions and solutes out of the cornea using trans-membrane 
ion channels [1]. Increased water content in the cornea can lead to oedema and hence 
opacity which is responsible for corneal blindness [2]. Human corneal endothelial cells 
(HCECs) maintain the clarity and thickness of the cornea [3]. Endothelial failure is seen 
mostly as a cause of Fuch‘s endothelial dystrophy, which is one of the common reasons 
for corneal endothelial replacement. 
 
Penetrating keratoplasty (PK) was the most popular choice among the surgeons to treat 
endothelial disorders. However, with the recent advancements, endothelial keratoplasty 
(EK) has shown clinically relevant results like early rehabilitation rate and better visual 
outcome over PK and is gradually been accepted by the surgeons due to standardized 
procedures [4]. The only recognized treatment for endothelial disorders so far is a corneal 
replacement. However, due to the donor shortage, the transplantation options also remain 
limited. Therefore, alternative therapeutic approaches are currently explored to provide a 
worldwide solution.  
 
One of the most common approaches for therapeutic treatment and HCECs regeneration 
includes the use of Rho-Kinase (ROCK) inhibitor for the development of allogeneic ex vivo 
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expanded HCECs for transplantation [5]. It has been previously reported that ROCK 
inhibitor (Y-27632) allows adhesion of HCECs to a substrate and the inhibition of ROCK 
signalling may manipulate cell adhesion properties [6-8]. As the host endothelium is 
already abnormal in Fuch‘s dystrophy, a direct injection of ROCK inhibitor may not be 
considered as a therapeutic approach, as it needs a complete replacement. However, ex-
vivo expansion using ROCK inhibitor may allow potential cell-based therapy. It has been 
reported that despite the limited regenerative potential in vivo, HCECs have a capacity to 
proliferate in vitro [1]. Therefore, cultured HCECs could be a prospective alternative 
treatment for corneal endothelial diseases. Several methods to define the media, 
conditions, isolation techniques etc. for cultivation of HCECs have been successfully 
investigated so far [6,9]. 
 
Hyaluronic Acid (HA) binds to and protects the corneal endothelial cells. HA dissolves in 
saline and can be aspirated easily out of the endothelium. A thin layer of HA, however, 
remains on the endothelial cells [10]. The hypothesis of the present study is that the 
viscosity of HA is higher than the media used to culture the HCECs. Therefore, using 
gravitational pull and viscosity of HA [11], the isolated primary HCECs can be pushed 
towards the base and allowed to be strongly adhered for culturing HCECs when topically 
applied over the cells.  
 
Previously reported studies on culturing HCECs have been performed on younger donor 
corneas [12]. It has been observed that young donors have a high proliferative capability 
compared to older donor corneas. However, it is difficult to obtain young donors for 
culturing HCECs in vitro due to its characteristics that are suitable for transplantation. Most 
of the older donor corneas are easy to obtain for research due to its endothelial cell 
density that is less than the threshold required for transplantation. The proliferative 
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capability is also noticed to be less. It is a challenge to culture older donor corneas 
however if the HCECs from the older donors can be cultured then the availability of the 
source will be much higher compared to the younger donor corneas. The chapter thus 
highlights four different conditions to identify the role of HA and Rho kinase (ROCK 
inhibitor) for force adherence in culture of HCECs which may eventually lead to mass 
production of huge number of corneal endothelial sheets from older donor corneas, 
reducing the requirement of human corneal tissues globally.  
 
Material and Methods 
Ethical Statement 
The corneas [n=48, twenty four pairs] were collected from the Veneto Eye Bank 
Foundation (FBOV) with written consent from the donor‘s next of kin to be used for 
research. The corneas were suitable for research and unsuitable for transplantation due to 
low endothelial cell count (<2200 cells/mm
2
). No other complications or indications were 
noted in the donor corneas. All the tissues were preserved in tissue culture medium at 
31
o
C prior to use. 
 
Endothelial cell count and donor characteristics 
Endothelial cell density (ECD) and mortality before isolation was checked using trypan 
blue (TB) stain (0.25%) (Thermo Fisher Scientific (Rochester, NY, USA), which is routinely 
used in eye banks. Approximately 100 µL of TB was topically applied to stain the 
endothelial cells for 20 seconds followed by washing it with phosphate buffered saline 
(PBS). Trypan blue positive cells (TBPCs) were recorded before isolation using an in-built 
eyepiece reticule for inverted microscope (Axiovert, Zeiss, Germany). The donor 
characteristics of 48 corneas (twenty four pairs) were obtained from the FBOV database 
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to determine the age, gender, post-mortem time, cause of death, preservation time, ECD 
and mortality.  
 
Sodium Hyaluronate 
Sodium hyaluronate is a naturally occurring, high molecular mass, polysaccharide found in 
the extracellular matrix of the connective tissues. Sodium hyaluronate, and other 
viscoelastic substances including methylcellulose, chondroitin sulphate, polyacrylamide, 
and collagen, have been used in intraocular surgery since 1970s [13]. In this study, we 
used Viscoat (Alcon, Texas, USA) – 0.8 mL comprising of 3% sodium hyaluronate and 4% 
chondroitin sulphate with Resting State Viscosity of 40,000 ± 20,000 cps that is currently 
being used in corneal and cataract surgery. The viscosity of HA allows the cells to settle 
down faster and force the cells to adhere to the coated base quicker. 
 
Formulations 
The procedure of isolation and culture was slightly modified from the previously published 
article by Peh et al [12,14]. Two different types of media were used as described earlier 
[14], maintenance media and proliferative media. In brief, the maintenance medium (M5) 
contained human endothelium SFM, 5% FBS along with antibiotics. The proliferative 
medium (M4) was a mixture of HamF12, M199, 5% FBS, 1% ascorbic acid, 0.5% Insulin 
Transferrin Selenium (ITS), Rec human FGF basic (25 µg/mL), 10 µM ROCK inhibitor (Y-
27632) and antibiotics.  
 
Peel and digest method 
The method is similar to previously published article [14] with some modifications which is 
described in brief. The corneal tissues [n=48] were washed in sterile phosphate buffered 
saline (PBS) and the Descemet membrane-endothelial tissues were peeled gently (similar 
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to the stripping technique for Descemet membrane endothelial keratoplasty – DMEK 
method) in various pieces to ensure faster isolation of the cells when incubated in the 
enzyme. The excised pieces were incubated with 2mg/mL Collagenase Type 1(Thermo 
Fisher Scientific, Rochester, NY, USA) solution for 2-3 hours 31
o
C, 5% CO2. While 
peeling, the forceps was cleaned using PBS after every single encounter with Collagenase 
Type 1 solution. Once the cells were isolated from the Descemet membrane, they were 
collected with Collagenase Type 1 and centrifuged for 5 minutes at 1000 rpm in a 15 mL 
falcon tube. The supernatant was removed and the cells were re-suspended with TrypLE 
Express (1X), phenol red [Life Technologies, Monza, Italy] to cut the clumps into single 
cells for 10 minutes at 37
o
C [if the clumps were not converted to single cells then TrypLE 
Express treatment was repeated for 5 minutes]. The supernatant was removed and the 
cells were re-suspended with 400 µL of M5 after counting them with TB in a 
haemocytometer slide. The plating density was recorded for all the cultures.  
 
Plating and force attaching the cells on coated slides 
Labt-Tek II chamber slides (8 chambers, 25X75 mm, 0.7 cm
2
 culture area) from Thermo 
Fisher Scientific (Rochester, NY, USA) was used for plating the cells. All the chambers 
were coated with 50 µL FNC coating mix [Cell attachment Reagent (FNC Coating mix) 
BRFF AF-10, US Biological Life Sciences, Salem, Massachusetts, USA] for at least 30-45 
minutes at 37
o
C, 5% CO2. The residual coating was removed before the plating. 100 µL of 
the cell suspension was mixed well and added in each chamber to ensure equal 
distribution of cells and proliferative cells in all the conditions. Four chambers were used 
for each donor that was pooled together. The chamber slides were used to check four 
conditions as shown in table 1. The cells were monitored every alternate day till 
confluence.  
 
202 
 
Condition 1 Condition 2 Condition 3 Condition 4 
100µL of cell 
suspension + 200 
µL of M5 up to day 
2. 
 
The media was 
changed after day 
2 to M4 and was 
re-freshed every 
alternate day  
 
100µL of cell 
suspension + 200 
µL of M5 up to day 
2. 
 
Cells were force 
adhered using 
gentle addition of 
Viscoelastic 
(approximately 50-
100 µL) on top of 
the cell 
suspension.  
 
The media was 
changed after day 
2 to M4 and was 
re-freshed every 
alternate day  
 
100µL of cell 
suspension + 200 
µL of M4 
throughout the 
culture period. The 
media was 
refreshed every 
alternate day.  
100µL of cell 
suspension + 200 
µL of M4 
throughout the 
culture period. The 
media was 
refreshed every 
alternate day.  
 
Cells force adhered 
using gentle 
addition of 
Vicoelastic 
(approximately 50-
100 µL) on top of 
the cell 
suspension. 
 
 
 
Table 1: Description of plating conditions. Condition 1, 2, 3 and 4 shows different plating 
characteristics with and without HA and ROCK. In condition 1, no HA or ROCK was used 
to check the behaviour of the cells without the influence of these extra parameters. In 
Condition 2, only HA was added to check the adherence of the cells without ROCK. 
Condition 3 only utilized ROCK inhibitor from the day of plating to check the effect of 
ROCK inhibitor directly on the cells. Condition 4 was a mixture of HA and ROCK to 
understand the influence of both the parameters together.  
 
Morphological analysis of the cultured HCECs [n=30, fifteen pairs] 
The cells were visualized every alternate day until confluent using an inverted microscope 
(Axiovert, Zeiss, Germany) at 50X and 100X magnifications. The percentage confluency 
was monitored and recorded every alternate day manually using an eyepiece reticule.   
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Glucose uptake of the cultured HCECs for functionality checks and metabolic analysis 
[n=48, twenty four pairs] 
Glucose uptake was determined from the preservation media of all the samples at day 3 
and day 15. The amount of glucose used and lactic acid produced at day 3 (with adapting 
and proliferative cells) and day 15 (confluent cells) were recorded. The assay helps to 
check the metabolic activity of the HCECs when preserved in vitro. Quantitative analysis 
was performed using D-Glucose HK kit (Megazyme International Ireland Ltd, Bray 
Business Park, Bray, Co. Wicklow, Ireland). 
 
For Hoechst, Calcein AM and Ehidium homodimer (HEC) and, Immunostaining of Ki-67 
and Vinculin, the study was divided into two groups, a) n=6 (three pairs), to evaluate the 
early behaviour of the cells at day 3 and b) n=6 (three pairs), to evaluate the nature of 
confluent cells at the end of the study. ZO-1 was only evaluated at the end of the culture 
period (day 15).  
 
Hoechst, Calcein AM and Ehidium homodimer (HEC) staining to determine live, dead and 
dying cells [n=12, Six pairs] 
Live cells are distinguished by the presence of intracellular esterase activity, determined 
by the enzymatic conversion of the nonfluorescent cell-permeant Calcein AM to the 
intensely fluorescent Calcein. The polyanionic dye Calcein, is retained within live cells, 
producing an intense green fluorescence in live cells (ex/em 495 nm/515 nm). Ethidium 
Homodimer-1 (EthD-1) enters cells with damaged membranes and enhances 
fluorescence upon binding nucleic acids, thereby producing a bright red fluorescence in 
dead cells (ex/em 495 nm/635 nm). EthD-1 is excluded by the intact plasma membrane of 
live cells. Hoechst 33342 is a nuclear dye which stains the nucleus of the cell. Triple 
endothelial labelling with Hoechst 33342 (H), Ehidium Homodimer (E), and Calcein-AM 
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(C) showed expression of ‗E‘ in red representing the dead cells, blue represents the nuclei 
‗H‘ and green marked the living cells ‗C‘.  
 
The cells were washed with PBS prior to the assay to remove or dilute serum esterase 
activity generally present in serum-supplemented growth media such as M4 or M5. Control 
sample was prepared using a human donor cornea. Descemet membrane was peeled out 
using stripping method and the excised lenticule was washed before the assay. Some 
cells were damaged by purpose through gently scrapping and touching the endothelial 
cells using sharp forceps. 5 µL of Hoescht 33342 (H) (Thermo Fisher Scientific, 
Rochester, NY, USA), 4 µL of Ethidium Homodimer EthD-1 (E), 2 µL Calcein AM (C) 
(Live/Dead viability/cytotoxicity kit, Thermo Fisher Scientific, Rochester, NY, USA) was 
mixed in 1 mL of PBS and mixed well. 100 µL of the final solution was directly added on 
the cultured cells and incubated at room temperature in dark for 45 minutes. For the 
control tissue, the stripped lenticule was placed on the slide, cut at four peripheral sides 
for a flat mount and covered with coverslips without the mounting medium. HEC was 
viewed at 488, 495, 515 and 635 nm at 50X, 100X and 200X magnification. 
 
Immunostaining for tight junctions using Zonula Occludens-1 (ZO-1) [n=12, Six pairs], 
proliferation marker Ki-67 [n=12, Six pairs] and focal adhesion marker Vinculin [n=12, Six 
pairs] 
The cells were washed with PBS and fixed in 4% paraformaldehyde (PFA) at room 
temperature (RT) for 30 minutes. The cells were permeabilized with 0.5% Triton X-100 in 
PBS for 30 minutes. After blocking with 2% goat serum for 2 hours at RT, the tissues were 
incubated overnight at 4
o
C with primary antibodies [anti-ZO-1, 1:200 (ZO1-1A12, Thermo 
Fisher Scientific, Rochester, NY, USA); anti-Ki-67, 1:200 (MIB-1, Milan, Italy); anti-vinculin, 
1:200 (Abcam, Cambridge, Massachusetts, USA). The samples were incubated with goat 
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anti-mouse fluorescein isothiocyanate (FITC)-conjugated secondary antibody in 20% goat 
serum for 2 hours at RT. After each step, the cells were washed 3 times with 1X PBS. 
After removing the wall of the Lab-Tek slide, the cells were covered with mounting medium 
and cover slips. Cells were examined with an LSM 510-meta laser scanning microscope 
(Zeiss, Milan, Italy). Cells were examined under ultraviolet light or by excitation at 
wavelengths of either 488 nm or 594 nm where subsequent detection of the fluorescence 
was obtained. 
 
Measurement and statistical analysis 
ImageJ software was used to measure the number of endothelial cells and check the 
hexagonality and polymorphism of the cells using ZO-1. It was also used to check the 
percentage of Ki-67 positive cells in the given area and to check the number of focal 
adhesions (Vinculin positive cells).  ANNOVA and non-parametric Wilcoxon test for paired 
data using SAS statistical software was employed to check the statistical significance 
between different conditions where p<0.05 was deemed significant. 
 
Results 
Donor characteristics and plating density [n=48, twenty four pairs] 
Average age of the donors recorded was 63.94 (±13.79; Min-48, Max-79) years 
comprising of 14 Males and 10 Females. The average post mortem time was 16.71 
(±6.37; Min – 5.0 h, Max – 25.35) hours. The tissues were preserved in the tissue culture 
medium for 31.69 (±6.67; Min – 20, Max – 40) days. Average endothelial cell density 
before isolation was 1943.75 (±222.02; Min – 1800, Max – 2100) cells/mm
2
 without any 
trypan blue positive cells (TBPCs). 92,313.58 (±10,544.16; Min – 75,988, Max – 99,734.5) 
cells in average per Labt-Tek II chamber slides (8 chambers, 25X75 mm, 0.7 cm
2
 culture 
area) from Thermo Fisher Scientific (Rochester, NY, USA),  well was plated after isolation.  
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Culture of HCECs and their confluency patterns show higher proliferation from C4  [n=30, 
fifteen pairs] 
HCECs were observed at different days of culture (figure 1a). The cells were not 
passaged as only the adhesion and proliferation capability was studied and the cells were 
sacrificed for the immunostaining analysis at day 15. At day 3, the growth rate (%) 
observed in C1 (condition 1 – no HA or ROCK), C2 (condition 2 – only HA), C3 (condition 
3 – only ROCK) and C4 (condition 4 – HA + ROCK) was 15.8, 20, 29.2 and 32.5, however 
the growth rate (%) at day 7 increased to 36.6, 51.6, 65.8 and 67.5 respectively without 
any statistical significance (p<0.05). The data reveals that when the cells are adhered 
forcefully, they get a boost start. The cell attachment to the matrix or its base is highly 
important for culture and proliferation. At day 15 the cell showed (%) 90, 93.3, 99.16 and 
99.16 confluency (Figure 1b). It was observed that at day 3, C1-C4 showed statistical 
significance in growth rate (p=0.0404) and the other conditions did not show any 
significance (table 2). Although statistically insignificant (p>0.05) at day 15 (table 2), the 
cells showed faster proliferation in C4 in the first week of culture. Once the cells get 
adapted to the environment, they grow normally. It was observed that the proliferation 
capability of the cells after 7 days in C3 and C4 was the same. C1 and C2 took a longer 
time to adept and reached almost 90% confluence at day 15.  
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Figure 1: Morphological pattern and glucose analysis at different days in different 
conditions. A) It was observed that the cells attach firmly in C2, C3 and C4 and start 
proliferation within day 3. However, by day 7, C3 and C4 show a higher number of cells 
and growth rate. This is due to ROCK inhibitor in C3 and HA+ROCK in C4. By day 15, 
confluence was observed in C3 and C4 and >90% of the culture was confluent in C1 and 
C2. At day 15, the cell shape and size along with confluence is better and higher in C3 
and C4 as seen at 100 X magnification. B) The growth pattern is recorded in different 
conditions and it was determined that C3 and C4 show higher proliferation capability when 
firmly adhered to the base. Confluence of the HCECs cultured in vitro in different 
conditions shows up to 30% boost in C3 and C4 as compared to around 20% in C1 and 
C2. However, by day 15, C3 and C4 reached 99% confluence whereas C1 and C2 were at 
90%. HA is not the only reason for cell attachment, a combination of HA and ROCK suits 
the cells to adhere both mechanically and molecularly and allow higher proliferation 
capability. C and D) Higher glucose uptake was observed in C3 and C4 at day 3 and also 
at day 15 due to high number of metabolically active cells. 
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Glucose uptake showed high metabolic activity in C3 and C4 [n=48, twenty four pairs] 
It was observed that the average amount of glucose (µg/mL) that was taken up by day 3 in 
C1, C2, C3 and C4 was 0.34(±0.33), 1.13(±0.53), 2.13(±0.36) and 2.0(±0.27) respectively. 
This was statistically significant (p<0.05) between C1-C4 and C1-C3 at day 3 (figure 1c). 
No other conditions showed any statistical significance at day 3. However, glucose uptake 
was statistically significant between all the groups (p<0.05) except C1-C2 and C3-C4 at 
day 15 (table 2) where C1, C2, C3 and C4 utilized 0.94(± 0.59), 1.33(±0.58), 2.85(±0.78) 
and 2.92(±1.01) µg/mL of glucose (figure 1d). This means that the cells were functional 
throughout as the metabolism was active due to the consumption of glucose and 
production of lactic acid in all the groups. It was noticed that higher amount of glucose was 
uptaken in C3 and C4 by day 3 as compared to C1 and C2. This is because of the 
presence of HA and ROCK inhibitor. Faster cell adherence and start of proliferative phase 
was observed in C3 and C4. Both the groups have similar media composition, hence only 
the similar groups did not show any significance, which also highlights that apart from 
force adhesion using HA, ROCK is also important for higher cell adhesion and better 
proliferation.  
 
 
 
 
 
 
 
 
 
209 
 
pValues C1-C2 C2-C3 C3-C4 C1-C4 C1-C3 C2-C4 
Confluence day 3 0.2339 0.2789 0.4294 0.0404 0.1459 0.0751 
Confluence day 15 0.5495 0.5712 0.9198 0.1985 0.4922 0.5775 
              
Glucose uptake day 3 0.2379 0.1763 0.7251 0.0406 0.0381 0.2185 
Glucose uptake day 15 0.197 0.0007 0.888 0.0005 0.00009 0.0027 
              
% Hexagonality day 15 0.5077 0.3357 0.2078 0.0488 0.2122 0.0758 
% Polymorphism day 15 0.3209 0.2145 0.1239 0.0268 0.0419 0.0141 
       Ki-67 day 3 0.3371 0.4077 0.5657 0.5251 0.9003 0.7626 
Ki-67 day 15 0.9709 0.4568 0.4177 0.9248 0.3957 0.9143 
              
Vinculin day 3 0.1088 0.2598 0.7036 0.0395 0.1668 0.0609 
Vinculin day 15 0.5392 0.2743 0.7225 0.1091 0.1531 0.1889 
Table 1: Statistical data comparing different conditions and parameters. Numbers in red 
indicate statistical significant difference. C1, C2, C3 and C4 indicate conditions 1, 2, 3 and 
4.  
 
Hoechst, Calcein AM and Ehidium homodimer (HEC) staining showed higher number of 
cells at day 3 and confluency pattern at day 15 without any dead or apoptotic cells in C3 
and  C4 [n=12, Six pairs] 
HEC was observed in the control group to show the presence of all the dyes for 
comparison (figure 2a). White arrow marks the apoptotic cells, which are nucleus without 
cytoplasm (attached dying cells to the extracellular matrix). At day 3, C3 and C4 showed 
more number of cells as compared to C1 and C2. Only viable cells were observed at day 3 
(figure 2b-2e). However, at day 15, confluency was observed in C3 and C4 compared to 
C1 and C2 with no dead cells and few apoptotic cells marked in white, which were not 
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significant (figure 2f-2i). This was a qualitative analysis and therefore statistics were not 
performed.  
 
Figure 2: HEC staining to determine live/dead/apoptotic cells. A) Control cornea to show 
the presence of dead (red), live (green), apoptotic (blue without green marked with white 
arrow) and nucleus (blue). B-E) at day 3, higher number of cells was observed in C3 and 
C4 compared to C1 and C2 without any dead or apoptotic cells. F-I) at day 15 confluence 
of viable cells was observed in C3 and C4 compared to C1 and C2.  
 
Expression of Zonula Occludens-1 (ZO-1) and measurement of hexagonality and 
polymorphism showed significant data at day 15 [n=12, Six pairs] 
Zonula Occludens-1 (ZO-1) is a tight junction protein which is present in the intercellular 
borders between the cells. Apart from showing the functions of tight junction protein, it can 
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also be indirectly use to judge the hexagonality of the cells. ZO-1 has also been widely 
used in the research of HCECs. At the end of the culture at day 15, ZO-1 (figure 3a-3d) 
was expressed and showed significant difference between C1-C4 (p=0.0488). Average 
value of hexagonality (%) (yellow box in figure 3f) in C1, C2, C3 and C4 was 68.79(±4.47), 
70.58(±2.18), 72.77(±3.49) and 77.27(±5.18) whereas the polymorphism (%) (indicated as 
red box in figure 3f) in the respective combinations was found to be 8.16(±2.08), 
6.86(±1.05), 5.97(±0.66) and 4.35(±1.01). However, the cells from condition 1 and 2 
showed slightly less hexagonal cells, which were checked using ImageJ (not significant, 
p>0.05, table 2, figure 3e) for other conditions. Higher polymorphism was observed 
between C1-C3 (p=0.0419), C1-C4 (0.0268) and C2-C4 (0.0141). There was no significant 
difference between other conditions at the end stage (day 15) but as the cells were not 
fully confluent in C1 and C2, the cells showed higher polymorphism.  
 
Figure 3: ZO-1 staining for intracellular tight junctions and to determine the polymorphism 
and hexagonality of the cells in different conditions. A-D) The cultured HCECs showed 
expression of ZO-1 in all conditions. E) The image was locked in imageJ and was 
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processed to overlay masks for determination of hexagonal cells and number of cells that 
showed high polymorphism (polymegathism and pleomorphism). Yellow blocks represent 
number of hexagonal cells and red block indicate highly polymorphic cell in the determined 
area. F) Hexagonality was higher in C4 with less polymorphic cells compared to other 
conditions.  
 
Statistically insignificant expression of Ki-67 was observed in all the conditions [n=12, Six 
pairs] 
Ki-67 is a proliferative marker which is used to check the amount of proliferative cells 
present in the culture. Ki-67 was used at the initial stage to control the presence of nearly 
equal amount of proliferative cells in all the conditions and to rule out the possibility of a 
biased study with presence of higher number of cells in either condition. We performed 
this study on n=3 separate tissues to optimize our plating density. It was observed that all 
the conditions had similar amount of proliferative cells at the beginning (day 3) (figure 4a-
4d, 4i). Average Ki-67 expression (%) found on day 3 in C1, C2, C3 and C4 was 
8.25(±0.53), 7.63(±1.04), 8.34(±1.22) and 7.86(±1.02) whereas on day 15, Ki-67 
decreased to an average of 1.33(±0.58), 1.32(±0.90), 1.80(±0.82) and 1.37(±0.51) 
respectively. Number of proliferative cells or Ki-67 expression decreased in number at day 
15 (figure 4e-4h, 4j), but did not show any significance (p>0.05) (table 2) in either 
condition.  
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Figure 4: Expression of Ki-67, proliferative marker. A-D and I) Ki-67 was almost equally 
expressed in all four conditions, which highlights that the plating density of Ki-67 was 
equal in all conditions at day 3. E-H and J) at day 15, number of Ki-67 cells decreased in 
all four conditions without any statistical significance.  
 
Vinculin showed higher focal adhesion points in C4 at day 3 [n=12, Six pairs] 
Vinculin is a membrane-cytoskeletal protein in focal adhesion plaques that is involved in 
linkage of integrin adhesion molecules to the actin cytoskeleton. It is also associated with 
cell-cell and cell-matrix junctions, where it is thought to function as one of several 
interacting proteins involved in anchoring F-actin to the membrane. Vinculin was 
expressed in all the conditions at day 3 however; it was significantly expressed more in C4 
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compared to C1 and C2 (table 2). C1, C2, C3 and C4 showed 14.0(±1.83), 21.75(±6.95), 
47.0(±36.34) and 55.75(±23.96) focal adhesion spots on day 3. C3 did not show any 
statistical significance compared to any groups (figure 5a-5d). Day 15 did not show any 
significance between any groups (figure 5e-5h) (table 2) with 104.25(±31.55), 
117(±22.85), 138(±26.32) and 145.5(±30.47) focal adhesion spots on day 15. The results 
highlight that higher focal adhesions may be induced with forced adhesion especially 
when there is an involvement of mechanical pressure because of HA and molecular force 
due to ROCK inhibitor (figure 5i-5j). 
 
Figure 5: Expression of Vinculin as a focal adhesion marker. A-D and I) Number of focal 
adhesions found in C4 was statistically higher compared to C1. C3 also showed high 
number of focal adhesion points but was not significant at day 3. This highlights that 
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mechanical and molecular forces may induce higher focal adhesions and integrins for 
better cell attachment. E-H and J) at day 15, Vinculin was expressed in all the conditions 
without any significant difference.  
 
Discussion 
Corneal endothelial dysfunction is a major indication for corneal transplantation [15]. 
However, the isolation and propagation of primary HCECs have been described by 
various research groups using different approaches [16-20] to find alternative solutions 
reducing the global shortage of donor corneas. Cultivated HCECs derived from older 
donors have lower proliferative capability, a senescent cell phenotype, and cell 
morphology, which suggest less functional ability than those derived from younger donors 
[21]. If the HCECs can be cultured from old donor corneas, then the availability of donor 
corneas for isolating endothelial cells will increase and it will overcome the overall 
shortage of donor corneas available for transplantation [22,23]. 
 
Corneal endothelial dysfunction has been treated by full-thickness corneal transplantation 
(PK) since more than half a century, but more selective corneal endothelial replacement 
such as Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) and Descemet 
Membrane Endothelial Keratoplasty (DMEK) were developed in the last decade [24,25]. 
The clinically successful outcomes of DSAEK and DMEK imply that reconstruction of the 
corneal endothelium is a definitive treatment that can replace full thickness keratoplasty, 
further corneal endothelium reconstruction by cell-based therapy is a clinically relevant 
approach [26]. Currently, although HCECs are isolated from donor corneas and cultured 
for research purposes, several limitations such as limited proliferative ability, vulnerable 
transformation with loss of functions, and senescence that prohibits efficient in vitro 
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expansion for clinical use have not been answered. No protocol specifically designed for 
clinical application has been established so far. 
 
It is already known that inclusion of ROCK inhibitor Y-27632 elevates the adhesion 
property, enhances cell proliferation and suppresses apoptosis of HCECs, thus allowing 
the successful transplantation of HCECs to reconstruct functional corneal endothelium 
[27]. Another report has emphasized the effect of ROCK inhibitor in enhancing adhesion 
and wound healing of HCECs [7]. It has already been noted that Rho-ROCK signalling 
carries out a variety of cellular processes such as cell adhesion, morphogenesis, 
migration, and cell-cycle progression through mediating cytoskeletal dynamics. Rho 
regulates a variety of cytoskeletal dynamics that underlie cell morphology and adhesion 
through the activation of ROCK [28,29]. The low efficiency of engraftment and loss of 
phenotype after transplantation due to the absence of cell/cell and cell/ECM interaction in 
vivo impairs organ reconstruction in various tissues [30-32]. Researchers have therefore 
been exploring the use of various techniques, such as artificial scaffolds, biologically 
active molecules, and ECM coatings, to improve cell retention and survival [33-35]. 
 
Although the forced adhesion technique is relatively robust, the HCEC cultures can be 
affected substantially by the procurement process as well as donor variations. The 
characteristics that we have used for this study are extreme with old donor age, long 
preservation time and endothelial cell count that are less than the normal density required 
for transplantation. If these challenging cells can be cultured in the appropriate conditions 
then the cells from young donors with high cell density and proliferative capability will 
definitely show increased proliferation rate (also internally observed in one donor – 32 
year old). Donor characteristics such as health of the donor before death, the cause of 
death, as well as the duration from death to enucleation and preservation and the time 
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from preservation to the establishment of culture [14,36-38] has also shown to have a 
potential impact on the cell culture. Beyond these potential hindrances, we report herein 
that the combination of HA and ROCK (C4) [39] approach in expansion of HCECs can be 
further enhanced, in terms of high adhesion and proliferation capability. The shorter time it 
took for HCECs to reach confluence was most likely due to the increased proliferation 
rates as observed in C4 due to high adhesion rate. It has been reported that the use of Y-
27632 to increase the proliferation of HCECs may only be appropriate for cultures of 
HCECs established using younger donors, as the addition of Y-27632 were not found to 
be advantageous for cultures established using older donors [12]. Similar observation has 
been also reported that Y-27632 has no effect on the proliferative capacities on HCECs, 
which utilized corneas from donor ages 73±3 years [7]. However, forced adhesion of the 
HCECs from older donor corneas may show a potential impact in cell culture of these low 
proliferative cells.  
 
In this study, we investigated the differences in cellular phenotype in response to culture in 
different types of adherence conditions. We found that the proliferative capability of 
HCECs differed depending on the conditions used. Four conditions were selected to 
check the adhesive properties and proliferative capabilities especially for older donors. 
The isolation of HCECs is very much important as it determines the preliminary success of 
the culture. If the isolation is not performed correctly, it may lead to contamination of 
stromal fibroblasts or trabecular meshwork cells. We did observe such contaminations in 
our very first cultures (excluded from this study). Gentle peeling of Descemet membrane 
and endothelium piece-by-piece seems to be the best solution so far. We have previously 
tried using a Descemet Membrane Endothelial Keratoplasty (DMEK) donor punch (9.5 
mm). This has a great advantage in terms of excising two exclusive parts of the 
endothelium (periphery and centre) with cell loss that only occurs at the punch site. 
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However although punching method can be used, there is a possibility that increase in 
punching pressure may pierce the stroma which may then activate keratocytes leading to 
unwanted contamination of the fibroblasts. Peeling a larger diameter DMEK graft (9.0mm) 
and incubating it with Collagenase type 1 also takes longer time for the cells to digest due 
to the less available area for the enzyme to cleave between the cells. It was also noted 
that the DMEK tissue of the younger donors are firmly adhered to the stroma as compared 
to the older donors which can be peeled easily if the donors have no other 
contraindications like diabetes. Therefore manual peeling of the cells piece by piece was 
determined as a suitable protocol for this study. 
 
It has been widely reported that HCECs isolated from older donors are less proliferative 
than those established from younger donors, and this has been associated to significant 
increase of cyclin kinase inhibitors, hence resulting in an age-dependent increase in 
negative regulation of cell cycle [40]. However, using C4 i.e. HA combined with ROCK, it is 
possible to culture the older donor corneas too with a high proliferative capability. The 
presented data highlighted that the cells can reach confluence by day 10 when provided 
with conditions like C4. We used 15 pairs of older donor corneas and the confluency 
pattern seen was significant between C1 and C4 suggesting that C4 was superior in terms 
of cellular proliferation. However, C3, the condition with only ROCK did not show any 
significance in confluency with C4 or C1 but showed lesser proliferative capability than C4 
up to a week. Moreover, all the tissues that were collected for this study had an 
endothelial cell density <2200 cells/mm
2
. The plating density of younger donor corneas is 
around 550,000cells/9 cm
2
, which is less than the plating density we have used which is 
around 93,000 cells/0.7 cm
2
. Increasing the plating density for <1 cm
2 
area (optic zone) 
could also be sufficient for culturing older donor corneas.  
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We have noticed that relating culture conditions, proliferation and confluency patterns to 
donor characteristics was very difficult as some donors show good proliferation rate and 
others don‘t. However, most of the donors were cultured with success using C3 and C4. 
Morphological analysis showed hexagonal cells when cultured in different conditions and 
very less amount of cells <10% showed high polymorphism. We were able to culture 4 
wells (0.7cm
2
 each), which are similar to an optic zone by pooling low-density old age 
donor corneas and get them to confluence with good morphology and high rate of 
hexagonality. As it is difficult to obtain younger donor corneas with high-density endothelial 
cells, the technique (C4) could be of valuable importance in terms of donor availability and 
culture capacity. Moreover, if the target is to culture primary endothelium into multiple 
grafts, then high plating density in combination with C4 could be a valuable solution 
especially when the tissues are isolated from older donors. With this approach, there is a 
practical possibility of obtaining 4 grafts from 2 corneas (1 donor). 
 
The amount of utilized glucose can be determined during the culture by checking the 
metabolic activity of the cells. When the cells metabolize, they produce lactic acid from 
glucose and therefore the amount of glucose uptaken in the media by the cells can be 
evaluated. In this study we show that the amount of glucose that was utilized in the first 3 
days was significantly higher in C4. This was due to a higher number of proliferating cells 
in the first two days. However, when the cells were confluent at day 15, all the conditions 
showed insignificant amount of glucose uptake, which confirmed that majority of the cells 
were metabolically active during the culture stage and at the confluent stage. If the cells 
were stressed due to the acidity levels of HA, they would have also shown high glucose 
uptake in C2, which was not the case. It only showed in C3 and C4, which further 
highlights that HA are safe to be used for cell culture.  
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HEC staining also showed that the cell proliferation in C3 and C4 was higher compared to 
C1 and C2 at day 3 and day 15 when it was confluent. A minimum amount of apoptotic 
cells were observed with no dead cells in the culture. The cell viability was higher in all the 
conditions. ZO-1 immunostaining was used to check the hexagonality and the presence of 
tight junctional proteins. It was observed in separate conditions (data unpublished) that 
ZO-1 did not express much when the cells were packed because even though the cells 
look confluent, the time required for the development of tight junctional protein is higher. 
Therefore, the cells should be allowed to culture for an extra day after confluency just to 
ensure that they have properly developed intra-cellular tight junctions. Cell shape is 
related to various cell functions, such as the communication with other cells, regulation of 
cell movement. Polymorphism was not high in the cells cultured in either condition at the 
day of confluency as all the conditions utilize ROCK inhibitor, they all proliferate up to the 
confluence stage. Condition 4 showed lower polymorphism as compared to the other 
conditions. Force adherence helps to maintain the cell shape and size. To ensure the 
plating density of the proliferative cells is almost the same in all the conditions, we 
optimized our plating conditions in different set of corneas before the experiment. It was 
observed that the proliferative cells found in different conditions were almost the same in 
all four conditions at day 3. Proliferative cells showed a decline in number at day 15 in all 
the conditions which is already previously known that the proliferative capabilities of the 
cells decreases with time. 
 
A previous study shows that actin cytoskeleton plays a critical role in regulating the 
adhesive property through interaction between the actin cytoskeleton and integrin [41-43]. 
Another study reported that inhibition of ROCK signalling by a selective ROCK inhibitor or 
by the siRNA enhances adhesive property of HCECs and is consistent with the findings of 
those previous studies. It was also found that vinculin, which is involved in the linkage of 
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the integrin adhesion complex to the actin cytoskeleton [44-45] is upregulated in ROCK-
inhibitor treated HCECs. However, it is noted that further investigation is required to 
elucidate whether the ROCK inhibitor promotes the focal adhesions through inhibiting 
actin polymerization and induces the upregulation of cell adhesion properties on the 
extracellular matrix (ECM) [5]. Vinculin expression and HEC staining revealed the same 
thing, that C3 and C4 show higher number of cells at day 3 and day 15. C1 and C2 
showed lower number of cells when compared to C3 and C4. Vinculin expression was 
significantly higher in C4 at day 3. Therefore, it is assumed that force adherence in 
combination with ROCK may be responsible to induce more focal adhesions and hence 
integrins and expression of Vinculin.  
 
Due to the availability of young donors for research, we were only successful in culturing 
one young donor. We observed confluency on day 7 with high hexagonality 
(approximately 90%) when young donors (age 32) with high plating density were cultured 
using forced adhesion with HA and ROCK. Old donors may not have a high proliferative 
capability but if they are forced to attach and proliferate, although it may take longer to 
confluence, they do proliferate and manage to obtain the required cell size and shape.  
 
A surgical hypothesis for using HA is that it is currently used in the anterior chamber 
surgical procedures. The injection technique for introducing cultured HCECs with face 
down position is already been studied by Kinoshita and colleagues (data unpublished). 
The patients have to rest their face down for 2-3 hours which may be longer for some 
patients therefore, introducing HA after face down after introduction of HCECs may help 
the cells to adhere to the stroma faster compared to the regular adherence speed. This 
may have a potential clinical impact in the future.  
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In conclusion, the findings of this present study, which are supported by the previous data, 
indicate that ROCK inhibitor Y-27632 in combination with HA may enable the 
establishment of a cultivated-HCEC–based therapy. This novel strategy of using a force 
attachment of the HCECs combined with a ROCK inhibitor in older donor corneas with 
less proliferative and isolated cells may ultimately provide clinicians with a new therapeutic 
modality in regenerative medicine and reduce the global shortage of the donor corneas for 
the treatment of endothelial disorders.  
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Aim 
To investigate a fish scale derived scaffold for culturing HCECs 
 
Introduction 
Human cornea is the transparent, outermost tissue of the eye. It is the principal refractive 
element of the visual system and its function depends majorly on the optical clarity. 
HCECs are responsible for maintaining the transparency of the cornea with a mechanism 
known as the pump-and-leak hypothesis [1].  
 
The monolayer of hexagonal HCECs avoids corneal edema, but also allows passive 
diffusion of nutrients simultaneously. Due to their amitotic nature in vivo, the amount of 
endothelial cells only decreases throughout life. However, they can be dramatically 
accelerated by trauma or disease. When the amount of HCECs drops below a certain 
threshold, corneal edema becomes unavoidable and leads to an opaque cornea. The only 
available treatment to overcome this disorder is corneal transplantation, whether full or 
partial thickness. However, it hugely depends on the availability of the donor tissue, which 
is currently a huge limitation. It is noted that the total number of donated corneas in 2015 
distributed by US eye banks was 79,306 [Eye Bank Association of America (EBAA) 
statistical report 2015]. Of these, 39,554 were destined for full thickness penetrating 
keratoplasty (PK) and 30,710 for endothelial keratoplasty (EK) (14,472 for Fuchs‘ 
Dystrophy and 3,208 other causes of endothelial dysfunction). This means that nearly 
40% of corneal transplantations were carried out for endothelial dysfunction. Although EK 
has a high success rate in terms of visual rehabilitation and post-op visual outcomes, 
shortage of donor corneas still remain a global challenge [2]. Endothelial keratoplasty has 
been the most commonly performed keratoplasty procedure in the United States in the 
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last four years and continues to increase. This means that endothelial diseases are the 
main indication for corneal transplantation in the United States. 
Alternative medical and therapeutic approaches like ex vivo expansion of the cultured 
HCECs thus become important as well as developing a scaffold for cell culture and 
eventually as a carrier for transplantation. As patients suffering from corneal endothelial 
dysfunction take up a big proportion on the current waiting list, these tissue-engineering 
approaches could greatly reduce current waiting lists. Apart from various attempts for 
efficient endothelial cell expansion using different media [3] and inhibitors [4], different 
scaffolds have also been reported to act as a mechanical support and meanwhile sustain 
cell expansion and functionality. Among these different options, three different categories 
can be distinguished: (i) biological, (ii) synthetic and (iii) biosynthetic substrates [5].  
 
In 2010, Lin et al. proposed a collagen scaffold derived from decalcified fish scales 
(Tilapia; Oreochromis Mossambicus) for use in corneal regeneration. Until now, 
preliminary in vitro studies have shown the cytocompatibility of cells on these 
heterogeneously patterned, biological scaffolds [5]. Its architectural features have been 
suggested as an important feature for cell seeding, migration and growth. It‘s transparency 
and nature (soft-tissue) makes it a superior biocompatible material for HCEC culture and 
transplantation. Additional in vivo studies performed on rats and rabbits have 
demonstrated its potential as a DALK alternative or to seal perforated corneas, 
respectively [6,7].  
 
The design, development and preliminary evaluation of an acellular, decalcified fabricated 
scaffold that fits the need for the design of current corneal prostheses has been 
evaluated. Although, fish scale-derived collagen scaffolds have been identified as a 
potential scaffold for ocular surface, it has never been studied before for culturing the 
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HCECs. Acellularized and decalcified fish scales have appeared to favour cell proliferation 
and biosynthetic activity after 7 days of cultivation. This chapter intends to investigate the 
efficacy and efficiency of fish scales as potential scaffolds for culturing and a possibility of 
transplanting HCECs cultured ex vivo. Due to its transparent nature and wide availability, 
we investigated FSS to act as a HCECs scaffold more into detail. 
 
Materials and Methods 
Ethical Statement 
The corneas [n=30, Fifteen pairs] were collected from the Veneto Eye Bank Foundation 
(FBOV) with written consent from the donor‘s next of kin to be used for research. The 
corneas were suitable for research and unsuitable for transplantation due to its low 
endothelial cell count (<2200 cells/mm
2
). No other complications or indications were noted 
in the donor corneas. All the tissues were preserved in tissue culture medium at 31
o
C prior 
to use.   
 
Characteristics of Fish Scale Scaffolds 
Fish scale scaffolds (FSS) were shipped to the FBOV labs from Body Organ Corp. (Taipei, 
Taiwan). Tilapia fishes were cleaned and acellularized using previously reported articles 
[6-8]. To increase the pore sizes and porosity within the test samples, the acellular tissues 
were additionally treated with acetic acid. The resulting acellularized fish scales were 
rinsed extensively with and stored in sterilized phosphate-buffered saline. These scales 
were decalcified and shipped to the FBOV labs in sterile PBS.  
 
Endothelial cell count and donor characteristics 
Endothelial cell density (ECD) and mortality (on the donor cornea) before isolation was 
checked using trypan blue (TB) stain (0.25%) (Thermo Fisher Scientific (Rochester, NY, 
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USA) which is routinely used in eye banks. Approximately 100 µL of TB was topically 
applied to stain the endothelial cells for 20 seconds followed by washing it with phosphate 
buffered saline (PBS). Trypan blue positive cells (TBPCs) and endothelial cell density 
were recorded before isolation using an in-built eyepiece reticule for inverted microscope 
(Axiovert, Zeiss, Germany). The donor characteristics of 30 corneas (fifteen pairs) were 
obtained from the FBOV database to determine the age, gender, post-mortem time, cause 
of death, preservation time, ECD and mortality.  
 
Formulation of the medium for cell culture 
The proliferative medium (M4) was a mixture of HamF12, M199, 5% FBS, 1% ascorbic 
acid, 0.5% Insulin Transferrin Selenium (ITS), Rec human FGF basic (25 µg/mL), 10 µM 
ROCK inhibitor (Y-27632) and antibiotics as described earlier [3]. 
 
Peel and digest method 
The method is similar to previously published article [9] with some modifications which is 
described in brief. The corneal tissues [n=30] were washed in sterile phosphate buffered 
saline (PBS) and the Descemet membrane-endothelial tissues were peeled gently (similar 
to stripping technique for DMEK method) but, in various pieces to ensure faster isolation 
of the cells when incubated in the enzyme. The excised pieces were incubated with 
2mg/mL Collagenase Type 1 (Thermo Fisher Scientific, Rochester, NY, USA) solution for 
2-3 hours 31
o
C, 5% CO2. While peeling, the forceps was cleaned using PBS after every 
single encounter with Collagenase Type 1 solution. Once the cells were isolated from the 
DM, they were collected and centrifuged for 5 minutes at 1000 rpm in a 15 mL falcon tube. 
The supernatant was removed and the cells were re-suspended with TrypLE Express 
(1X), phenol red [Life Technologies, Monza, Italy] to dissociate the clumps into single cells 
for 10 minutes at 37
o
C [if the clumps were not converted to single cells then TrypLE 
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Express treatment was repeated]. The supernatant was removed and the cells were re-
suspended with 400 µL of M5 after counting them with TB in a haemocytometer slide. The 
plating density was recorded for all the cultures.  
 
Plating the cells on coated slides and FSS 
Labt-Tek II chamber slides (8 chambers, 25X75 mm, 0.7 cm
2
 culture area) from Thermo 
Fisher Scientific (Rochester, NY, USA) and Fish Scale scaffolds (Body Organ Corp. 
Taipei, Taiwan) were used for plating the cells. The chambers of Lab-Tek slides and the 
FSS were coated with 50 µL FNC coating mix [Cell attachment Reagent (FNC Coating 
mix) BRFF AF-10, US Biological Life Sciences, Salem, Massachusetts, USA] for at least 
30-45 minutes at 37
o
C. The residual coating was removed before the plating. 
Approximately 92,500 cells/0.7cm
2
 were plated in two wells of the Lab-Tek slides from one 
cornea of the same donor whereas, 185,000 cells/1.3 cm
2
 were plated from other cornea 
of the same donor on one FSS. As the comparison was between the base for the HCECs, 
that are the Lab-Tek, and FSS, we decided to use the same donor without pooling them to 
normalize the plating density to the area. For FSS, the cell suspension (50μL) was added 
and incubated at 37
o
C for 20 minutes allowing the cells to settle on the scaffold. Once the 
cells were settled and showed attachment, additional 150μL of the media was added and 
further incubated for 1 hour. After the cells show complete attachment and were not 
floating in the media, another 800μL of the media was added and incubated to monitor cell 
growth. For Lab-Tek slides, 50μL of cell suspension was added followed by addition of 
150μL of the media and were monitored every alternate day till confluence with media 
refreshed every alternate day. 
 
Morphological analysis and confluence of the cultured HCECs [n=30, Fifteen pairs] 
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The cells were visualized every other day until confluent using an inverted microscope 
(Axiovert, Zeiss, Germany) at 50X and 100X magnifications. The percentage confluency 
was manually counted using an in-built reticule inside the eye-piece of the microscope and 
monitored every alternate day.   
 
Glucose uptake of the cultured HCECs for functionality checks and metabolic analysis 
[n=30, Fifteen pairs] 
Glucose uptake was determined from the preserved media of all the samples every 
alternate day that were stored at -20
o
C. The amount of glucose used and lactic acid 
produced by the HCECs during the culture was recorded. This assay helps to evaluate the 
metabolic activity of the HCECs when grown in vitro. Quantitative analysis was performed 
using D-Glucose HK kit (Megazyme International Ireland Ltd, Bray Business Park, Bray, 
Co. Wicklow, Ireland). 
 
Hoechst, Calcein AM and Ehidiumhomodimer (HEC) staining to determine live, dead and 
dying cells [n=6, Three pairs] 
Live cells are distinguished by the presence of intracellular esterase activity, determined 
by the enzymatic conversion of the nonfluorescent cell-permeant Calcein AM to the 
intensely fluorescent Calcein. The polyanionic dye Calcein, is retained within live cells, 
producing an intense green fluorescence in live cells (ex/em 495 nm/515 nm). Ethidium 
Homodimer-1 (EthD-1) enters cells with damaged membranes and enhances 
fluorescence upon binding nucleic acids, thereby producing a bright red fluorescence in 
dead cells (ex/em 495 nm/635 nm). EthD-1 is excluded by the intact plasma membrane of 
live cells. Hoechst 33342 is a nuclear dye, which stains the nucleus of the cell. The cells 
were washed with PBS prior to the assay to remove or dilute serum esterase activity 
generally present in serum-supplemented growth media such as M4. Control sample was 
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prepared using a human donor cornea. Descemet membrane was peeled out using 
stripping method and the excised lenticule was washed before the assay. Some cells were 
damaged purposely by gently scrapping and touching the endothelial cells using sharp 
forceps. 5 µL of Hoescht 33342 (H) (Thermo Fisher Scientific, Rochester, NY, USA), 4 µL 
of Ethidium Homodimer EthD-1 (E), 2 µL Calcein AM (C) (Live/Dead viability/cytotoxicity 
kit, Thermo Fisher Scientific, Rochester, NY, USA) was mixed in 1 mL of PBS and mixed 
well. 100 µL of the final solution was directly added on the cultured cells and incubated at 
room temperature in dark for 45 minutes. For the control tissue, the stripped lenticule was 
placed on the slide, cut at four peripheral sides for a flat mount and covered with 
coverslips without the mounting medium. HEC staining was viewed at 488, 495, 515 and 
635 nm at 50X, 100X and 200X magnification. 
 
Immunostaining for tight junctions using Zonula Occludens-1 (ZO-1) [n=6, Three pairs], 
proliferation marker Ki-67 [n=6, Three pairs] and focal adhesion marker Vinculin [n=6, 
Three pairs]  
The cells were washed with PBS and fixed in 4% paraformaldehyde (PFA) at room 
temperature (RT) for 30 minutes. The cells were permeabilized with 0.5% Triton X-100 in 
PBS for 30 minutes. After blocking with 2% goat serum for 2 hours at RT, the tissues were 
incubated overnight at 4
o
C with primary antibodies [anti- ZO-1, 1:200 (ZO1-1A12, Thermo 
Fisher Scientific, Rochester, NY, USA); anti-Ki-67, 1:200 (MIB-1, Milan, Italy); anti-vinculin, 
anti-collagen VI, anti-laminin, 1:200 (Abcam, Cambridge, Massachusetts, USA). The 
samples were incubated with goat anti-mouse fluorescein isothiocyanate (FITC)-
conjugated secondary antibody in 20% goat serum for 2 hours at RT. After each step, the 
cells were washed 3 times with 1X PBS. After removing the media chambers of the Lab-
Tek slide, the cells were covered with mounting medium and cover slips. Cells were 
examined with an LSM 510-metalaser scanning microscope (Zeiss, Milan, Italy). Cells 
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were examined under ultraviolet light or by excitation at wavelengths of either 488 nm or 
594 nm where subsequent detection of the fluorescence was obtained. For Vinculin, focal 
adhesion points (dots) from ten cells were counted and the average number of focal 
adhesions was recorded for the analysis. 
 
Histological analysis to determine the presence of endothelial cells on FSS [n=3] 
After day 11, the FSS were washed with 1X PBS for 5 minutes and were fixed in 4% PFA 
overnight followed by washing it with sucrose solution at 7.5%, 15% and 30% for 15 
minutes each. Final washing was carried out with PBS and the tissues were embedded in 
optimal cutting temperature compound (OCT) for microtome cutting. Periodic acid–Schiff 
(PAS) staining was performed on all the samples and sections were viewed at 200X and 
400X magnifications in order to check presence of HCECs on the FSS.  
 
Measurement and statistical analysis 
ImageJ software was used to measure the number of endothelial cells and check the 
hexagonality and polymorphism of the cells using ZO-1. It was also used to check the 
percentage of Ki-67 positive cells in the given area and to check the number of focal 
adhesions (Vinculin positive cells) and the area of the cell.  Non-parametric Wilcoxon test 
for paired data was employed to check the statistical significance between Lab-Tek and 
FSS, where p<0.05 was deemed significant. 
 
Results 
Donor characteristics 
Average donor age was 60.75(±14.55) years and Male:Female ratio was 10:5. The post 
mortem time of the donors recorded was 16.54(±5.89) hours. The tissues were preserved 
in tissue culture medium for 32.33(±6.37) days before isolation of the cells. The 
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endothelial cell density before isolation was found to be 1966.67(±226.97) cells/mm
2
 
without any trypan blue positive cells (TBPCs). 
Characteristics of the fish scale scaffolds (FSS) 
Each FSS was 13 mm in diameter with an average thickness of 100-120 µm. Tensile 
stress was found to be 12.68±9.53MPa, Young's modulus was 56.4±21.91MPa with 
Elongation of 24.72±5.65 %. There was no porosity in the scales because of its structure. 
Water holding capacity of the FSS was 84.12% with initial transparency of 92.67% (380-
780 nm). 
 
Morphology, confluency and glucose uptake of the HCECs in Lab-Tek and FSS [n=30, 
fifteen pairs] 
FSS is highly transparent (figure 1a) and when observed under the confocal microscope 
showed narrow ridges (Figure 1b) and valleys (Figure 1b) in the upper left quadrant. 
Central FSS was not smooth but was relatively a flat surface compared to the other areas 
(figure 1c). The upper right (figure 1d) and lower left showed broad ridges and valleys 
(Figure 1f). However, lower right quadrant showed arc strokes (Figure 1e). FSS was highly 
transparent when observed before and after the culture of HCECs (figure 1g). It was 
noticed that when the HCECs were plated on the flat or regular surfaces, the adherence 
and proliferation capacity increased. The cells showed more adherence capability of the 
HCECs on broad ridges and in the central FSS (figure 1h). Growth rate of the cells in Lab-
Tek was higher compared to that on FSS. Confluence was observed in Lab-Tek slides 
whereas around 65% confluency was observed in FSS at day 11 (statistically insignificant, 
p=0.0883) (figure 1i). Average glucose uptake recorded from the total amount already 
present in the media (2.8 µg/mL) in Lab-Tek was (µg/mL) 1.61(±0.06), 1.74(±0.06), 
1.83(±0.07), 1.90(±0.05), 2.06(±0.11), 2.21(±0.05) at day 1,3,5,7,9,11 respectively 
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compared to 1.60(±0.05), 1.69(±0.04), 1.76(±0.02), 1.83(±0.04), 1.97(±0.11), 2.06(±0.07) 
in FSS without statistical significance (p=0.5181) (figure 1j) at day 11.  
 
Figure 1: Fish scale scaffolds (FSS) showed a) high transparency and when observed in 
bright field of the confocal microscope, it showed b) first quadrant with narrow ridges and 
valleys, c) central FSS which was rough but was relatively a flat surface compared to the 
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other areas, d and f) second and third quadrant showing broad ridges and valleys, e) 
Fourth quadrant showing arc strokes, g) highly transparent FSS before and after the 
culture of HCECs. H) Morphological analysis between Lab-Tek and FSS grown HCECs at 
different magnifications on different days of culture when observed using inverted light 
miscroscope. Most of the cells were adhered and showed outgrowth when cultured on 
broad ridges (quadrant 2 and 3) and in the central FSS. I) Growth rate of the cells in Lab-
Tek was higher compared to that on FSS. 100% Confluence was observed in Lab-Tek 
slides whereas around 65% confluency was observed in FSS at day 11. I) Glucose uptake 
was higher in Lab-Tek grown cells compared to Fish Scale Scaffolds and showed active 
metabolism of cells without any significant difference between the two conditions. 
 
HEC staining showed confluence and viability of HCECs on the Lab-Tek and cell viability 
on FSS  
Triple endothelial labelling with Hoechst 33342 (H), EhidiumHomodimer (E), and Calcein-
AM (C) showed expression of ‗E‘ in red representing the dead cells, blue represents the 
nuclei ‗H‘ and green marked the living cells ‗C‘. HEC was observed in the control group to 
show the presence of all the dyes for comparison (figure 2a). White arrow marks the dying 
cells (blue without green) without metabolic activity (attached dying cells to the 
extracellular matrix). The human cornea used as a control to demonstrate the HEC 
staining showed dead (red), nucleus (blue), live (green), dying (blue without green) and 
merge. It also showed some apoptotic cells marked in white (figure 2a). The HCECs in 
Lab-Tek showed confluence with high viability as shown in figure 2b. In compliance with 
the confluency data, HEC staining also showed that the cells were approximately 60% 
confluent (figure 2c) on the FSS with almost 100% of viability in both the conditions. The 
cell size can also be observed in FSS compared to the one in Lab-Tek.  
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Figure 2: HEC staining to determine live/dead/apoptotic cells. A) Control cornea to show 
the presence of dead (red), live (green), dying cells (blue without green marked with white 
arrow) and nucleus (blue) cells. B) HCECs from old donor corneas cultured on Lab-Tek 
showed high viability and confluency without any dead cells. C) Relatively lesser amount 
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of cells was observed when HCECs were cultured on FSS. There were no dead cells 
observed in FSS too but again, most of the cells were cultured in quadrant 2 and 3.  
 
Immunostaining showed high hexagonality and low polymorphism using Zonula 
Occludens-1 (ZO-1) in Lab-Tek slides and showed insignificant amount of Ki-67 but 
significant amount of focal adhesions and Vinculin expression between both the conditions 
ZO-1 tight junction protein was expressed in HCECs from Lab-Tek (Figure 3a) and FSS 
(Figure 3b). Using ImageJ (inserts in Figure 3a and 3b), the hexagonality and 
polymorphism was counted using overlay masks. HCECs on Lab-Tek showed 
8.13(±1.47)% polymorphism with 74.73(±6.04)% hexagonality whereas those cultured on 
FSS showed 16.68(±2.82)% polymorphism and 45.01(±6.81)% hexagonality (figure 3c). 
HCECs cultured on Lab-Tek slides showed significantly less polymorphism (p=0.0041) 
and high percentage of hexagonal cells (p=0.0006). This was presumed earlier, as Lab-
Tek has flat surface, it allows the monolayered cells to grow and spread uniformly 
compared to the cells cultured on an irregular base such as FSS which has ridges and 
valleys. It was also noted that the cells cultured in the central area, which is more uniform 
and flat, showed similar morphology as it has rough surface compared to Lab-Tek slide. 
HCECs cultured on Lab-Tek showed 4.61(±0.72)% Ki-67 positive cells (figure 3d) 
compared to 4.22(±1.11)% on FSS (figure 3e) without significant difference (p=0.5922) 
(figure 3f). Proliferative cells were almost equal in both the conditions, however, the 
confluency and morphology observed was better in Lab-Tek compared to FSS. Vinculin is 
a membrane-cytoskeletal protein in focal adhesion plaques that is involved in linkage of 
integrin adhesion molecules to the actin cytoskeleton. Using ImageJ, the binary masks of 
the focal adhesions (figure inserts of 3g and 3h) were captured and analysed. HCECs 
cultured on Lab-Tek with FNC coating mix showed 233.5(±22.63) number of focal 
adhesions (figure 3g) compared to 199.75(±12.18) number of focal adhesions from FSS 
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(figure 3h) which was statistically lower than Lab-Tek (p=0.0507) (figure 3i) at day 11. It 
was observed that HCECs took longer time for cell adherence on FSS compared to Lab-
Tek due to its surface characteristics, which is not smooth and regular. Vinculin may also 
be induced by the presence of ROCK inhibitor in the media, however, as both the 
conditions utilized ROCK and were coated with FNC mix, it is assumed that matrix 
characteristics have an effect on the adherence capability.  
 
Figure 3: Expression of different proteins in the cultured HCECs on Lab-Tek and FSS. A) 
ZO-1 staining for intracellular tight junctions to determine polymorphism and hexagonality 
of the cells in Lab-Tek and B) in FSS. Figure inserts show the overlay masks of the 
expression for calculation of hexagonality and polymorphism (polymegathism and 
pleomorphism). C) High percentage of polymorphism and low percentage of hexagonality 
was observed when HCECs were cultured on FSS compared to Lab-tek slides. D) 
Proliferative cells did not differ when the HCECs were cultured in D) Lab-Tek and E) FSS, 
and F) did not show statistical significance. G) Vinculin as a focal adhesion marker 
showed higher number of focal adhesions when HCECs were cultured on Lab-Tek 
compared to that on H) FSS which was I) statistically significant. Figure inserts show the 
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amount of vincluin expressed (number of focal adhesions) which was counted using binary 
images.  
 
Histological analysis showed presence of HCECs as a monolayer on FSS 
As controls, Periodic acid-Schiff (PAS) staining showed all the layers of a cornea including 
Descemet Membrane and Endothelium for comparison at different magnifications (figure 
4a and 4b). HCECs cultured on FSS grow as a monolayer and does not stratify. Moreover, 
it was observed that the cells are not adhered completely to the FSS due to the ridges and 
valleys present in the scaffold (figure 4c). At day 11, the cells did not show the secretion or 
presence of its own extracellular matrix (Descemet‘s membrane) but only uniform 
distribution of pure endothelium on the FSS (figure 4d). It may take extra time in the 
development of the Descemet‘s membrane. Collagen VI (figure 4e) and Laminin (figure 4f) 
did not express at day 11 which confirms that the cells did not produce the DM. The cells 
can hence be cultured on FSS but the adherence capability must be increased in order 
culture HCECs precisely and the FSS may have to be customized more to be flat and 
regular especially for HCECs.  
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Figure 4: Histological analysis using Periodic acid-Schiff (PAS) staining. A) A normal 
cornea showing the presence of Descemet Membrane and endothelial cells using PAS 
staining at 100X and B) 400X. C) FSS showing monolayer of endothelial cells at 200X 
magnification and D) at 400X magnification. Histology did not show any presence or 
development of Descmet‘s membrane on FSS by the HCECs but showed a monolayer of 
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cells attached in most of the areas. E) Collagen VI and F) Laminin as the extracellular 
markers did not express on the cells at day 11. Nucleus can be seen in red marked with 
Drac 5.  
 
Discussion 
In the recent years, development in bioengineered corneal substitutes has been designed 
to replace the full or partial thickness cornea, which is damaged or diseased [10]. They 
range from fully synthetic prostheses like keratoprosthesis or tissue engineered cell based 
constructs [11] and hydrogels [12] and have already been introduced that permit the 
integration of the implant and regeneration of the host tissues. Many therapeutic strategies 
have been adopted to reduce the global shortage of donor availability.  
Most of the previously reported studies on culturing HCECs have been performed on 
younger donor corneas [3]. It has been observed that younger donors have a high 
proliferative capability compared to older donor corneas. However, it is difficult to obtain 
young donors for culturing HCECs in vitro due to their priority use for transplantation. 
Stringent exclusion criteria, more often an inadequate endothelial cell density, make that 
most of the older donor corneas are available for research, however their proliferative 
capability is also noticed to be less. It is a challenge to culture older donor corneas, 
however if the HCECs from the old donors can be cultured then the availability of the 
source will be much higher compared to the younger donor corneas. This study therefore 
highlights the culture of HCECs from older donor corneas. The other challenge is the 
transplantation technique of these cells. Injection of the cells has already been proposed 
earlier by Kinoshita et al, however, as this technique requires a face down position, it 
becomes relatively challenging for the patients as well [13,14]. Another option that could 
have a potential clinical relevance would be development of the scaffold for culturing and 
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transplanting the HCECs, thereby creating composite grafts similar to current 
DMEK/DSAEK transplants.  
Here we describe the FSS as a potential scaffold for the culture of HCECs in vitro. Fish is 
a good source of collagen as the scales are composed of connective tissue protein and 
collagen covered with calcium salts [6]. Although it has already been proposed that the 
biomechanical stiffness is low and FSS has a rapid biodegration rate, we found that the 
subjective transparency was higher in the FSS after the culture phase with low 
biodegradation rate and biomechanical stiffness that would be more suitable for the 
transplantation techniques like EK. The flexibility of the FSS was enough to fold without 
breaking so it would be possible to insert it inside the anterior chamber similar to the 
currently used techniques like Descemet Stripping Automated Endothelial Keratoplasty 
(DSAEK) that was noted as personal observations. As a collagen multilayer structure can 
maintain water up to 84%, the use of FSS becomes more realistic for EK procedures. In 
animal models, FSS have been used so far in rat, mini pig and in rabbit models [15,16]. 
No immune response was revealed over the 6-month period of the rabbit study, while mild 
to moderate inflammation was noticed in some rats. However this model is known to be 
more sensitive for neovascularisation. Transparency of FSS was clear and it did not 
dissolve or degenerate in both of the studies [6-8].   
In an earlier reported study, the morphology of the corneal cells cultured on FSS showed 
cells spread extensively over the surface of the scaffold [6]. However, in our study we only 
observed huge number of cells on the broad ridges and more on the central region of the 
FSS. Although the cell viability did not differ in either conditions i.e. Lab-Tek and FSS, it 
was determined that the FSS is cytocompatible as HCECs did not show any toxic effect 
and showed viability when checked using HEC staining. The cells were metabolically 
active as they utilized glucose present in the media. Both the conditions showed similar 
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amount of glucose uptake. As already noticed that FSS facilitates cell attachment and cell 
migration for other corneal cells, it may not be true for HCECs as these cells might require 
different characteristic for adhesion and migration. Therefore we coated these FSS with 
FNC coating mix, although they consist mainly out of collagen. Even more, during 
investigative studies we saw no to little cell attachment when scaffolds were uncoated. 
Although the old donor corneas do not have a high proliferative potential, they still showed 
a high growth rate when cultured on Lab-Tek compared to FSS. HCECs require flat 
surfaces for the development of a monolayer with high percentage of hexagonal cells 
otherwise the polymorphism increases as seen by ZO-1 staining. Although HCECs may 
grow on the FSS, its morphology may be compromised as seen against Lab-Tek. 
Maintenance of proliferative cells in both the conditions was similar too. Actin cytoskeleton 
plays a critical role in regulating the adhesive property through interaction between the 
actin cytoskeleton and integrin [17-19]. Previous study has reported that inhibition of 
ROCK signalling by a selective ROCK inhibitor or by siRNA enhances adhesive property 
of HCECs and is consistent with the findings of those previous studies. It is also found that 
vinculin, which is involved in the linkage of the integrin adhesion complex to the actin 
cytoskeleton [20,21] is upregulated in ROCK-inhibitor treated HCECs. However, further 
investigation is needed to elucidate whether the ROCK inhibitor promotes the focal 
adhesions through inhibiting actin polymerization and induces the upregulation of cell 
adhesion properties on the extracellular matrix (ECM) [4]. Vinculin is a cytoskeletal protein 
associated with cell-cell and cell-matrix junctions, where it is thought to function as one of 
several interacting proteins involved in anchoring F-actin to the membrane. Vinculin 
expression features the number of focal adhesions or integrin presence by the cells. It 
therefore highlights the adherence capability of the cells. In our study, vinculin expression 
or number of focal adhesions was significantly higher in Lab-Tek cultured cells compared 
to FSS. We assume that this was due to the flat surface of the Lab-Tek allowing a huge 
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area of the cells to attach after incorporating ROCK inhibitor compared to FSS. FSS is 
irregular and therefore shows less flat area for the cells to attach and induce focal 
adhesions formation even after the presence of ROCK inhibitor in both the conditions.  
In conclusion, although tissue engineering is growing with the developments of 
cytocompatible and biodegradable materials, culture of HCECs and maintaining them on a 
scaffold may be challenging especially when old donor corneas are utilized. However, 
using more old donor corneas, rejected for transplantation due to their endothelial counts 
would increase the number of lab cultured corneal substitutes and decrease the global 
shortage of the available corneas. Although FSS has a huge potential in terms of culturing 
challenging cell types like primary HCECs, its characteristics and nature is suitable as a 
corneal substitute. Not only the overall costs and wide availability may attract researchers 
to culture HCECs on FSS. Also, its low immunogenic response, transparency and high 
flexibility may allow surgeons to transplant such grafts without adapting current ways of 
delivery or high dosage steroids. The study is a proof of concept for culturing HCECs from 
old donor corneas on FSS and requires further refinement before entering the pre-clinical 
phase.  
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Aim  
To study the performance of a complete synthetic organ culture preservation system 
containing recombinant human serum albumin (rHSA) for preservation of human donor 
corneas. 
  
Introduction 
Human corneas once retrieved from the cadaveric donors should be well preserved to 
maintain the viability of the cells and the transparency of the tissue which are the crucial 
parameters for corneal transplantation. Currently, there are two main preservation 
systems that are pursued: cold/hypothermic storage with preservation at 2-6
o
C mostly 
used in America and Asia, and organ culture (OC) with preservation at 31-37
o
C which is 
followed in parts of Europe [1]. OC allows long-term preservation (approximately one 
month) as compared to hypothermic preservation which is limited to two weeks. 
Hypothermic media utilizes a single vial of media for the entire preservation phase 
whereas OC requires three phases of preservation which includes a) collection of the 
tissue, b) organ culture to preserve the cornea by means of media containing serum and 
c) transport media or de-swelling media which contains dextran to regain the original 
thickness of the cornea which swells during the OC phase. OC therefore has advantages 
in terms of microbiological checks, quality assurance and gives longer preparation time for 
surgery. Commercially available OC media contain fetal calf serum (FCS) for preservation 
of the tissues. Earlier investigations have also shown that chicken feather, ovalbumin, pig-
bone amino acids etc. with other nutrients can be used for prolonging the metabolic 
activities of endothelial cells for corneal preservation in vitro [2-6]. Although the role of 
FCS is not yet clearly known, a higher amount of cell loss was reported when porcine 
corneas were preserved without serum. It has been reported that FCS helps the cells to 
resist the stress levels in vitro [7-9] although other studies suggested that serum-free 
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medium can cause higher endothelial cell loss (ECL) due to necrosis [10]. A few studies 
reported the effects of different de-swelling compounds such as poloxamer or dextran 
based medium [2,11]. Either of them could be used for de-swelling due to their synthetic 
properties.  
 
Endothelial cell viability is the most important factor for corneal preservation and 
transplantation. It is also considered as a major influential factor for acceptance or 
rejection of a cornea for grafting [2]. Media used for OC usually contain serum and since 
animal derived products have a possibility to introduce animal viruses or prions, they could 
be hazardous if assimilated in the human body. Animal viruses, especially retroviruses, 
could integrate into the human genome and activate human oncogenes or onco-supressor 
genes, while prions could lead to the human forms of Bovine Spongiform Encephalopathy 
(BSE). For this reason, as well as to decrease the variability between batches of animal 
derived serum, synthetic media have started to be developed.  
 
Therefore, to reduce the uptake of animal or animal derived components, a 
Pharmaceutical grade recombinant human serum albumin (rHSA) was tested as a 
potential replacement for serum. rHSA is a recombinant protein which is biochemically 
synthesized and used in the development of medical products. Thus, we investigated the 
possibility to use rHSA to replace serum and make a completely synthetic medium in order 
to avoid any animal derived components.  
 
Materials and Methods 
Ethical statement and donor characteristics 
Twenty-four pairs of human cadaveric donor corneal tissues unsuitable for transplantation 
and with the written consent from the donor‘s family were used to obtain the results 
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described. The average age of the corneal donors was 71.08 (±3.39) years, post-mortem 
time was 12.73 (±6.82) hours and male:female ratio was 14:10.  
 
Study design 
Each cornea from the same donor was preserved in the synthetic and serum based media 
series respectively. The corneas were transferred from each stage to the next and the 
evaluation process was carried as follows: a) before preservation [Initial – Stage I], b) after 
preservation in Cornea Trans
® 
and Cornea Prep II
® 
respectively for 6 days at room 
temperature (stage II), c) after preservation in Cornea Syn
® 
and Cornea Max
® 
for 28 days 
at 31-37
o
C (stage III) and d) after preservation in Cornea Trans
® 
and Cornea Jet
® 
for 4 
days at room temperature (RT) (stage IV). A schematic representation of the study design 
is shown in figure 1. Cornea Syn
®
 is the synthetic medium with rHSA and is based on 
similar media constituents with a recombinant serum albumin as a replacement for serum. 
Cornea Trans
® 
and Cornea Jet
® 
contain dextran. Cornea Prep II
®
 does not contain 
dextran.The other constituents of synthetic medium are not listed, as the formulation is 
confidential. Cornea Prep II
®
, Cornea Max
® 
and Cornea Jet
® 
are commercially available 
serum based media for corneal preservation marketed by Eurobio, France (control group 
for this study). 
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Figure 1: Schematic representation of the study design. The figure shows different stages 
of corneal preservation in serum based and synthetic media before preservation [Initial – 
Stage I], b) after preservation in Cornea Trans
® 
 [with dextran] and Cornea Prep II
® 
 
[without dextran] respectively for 6 days at room temperature (stage II), c) after 
preservation in Cornea Syn
® 
[with rHSA] and Cornea Max
® 
[with serum] for 28 days at 31-
37
o
C (stage III) and d) after preservation in Cornea Trans
® 
[with dextran] and Cornea Jet
® 
[with dextran] for 4 days at room temperature (RT) (stage IV).  
 
Evaluation parameters 
The parameters mentioned below were checked at stage I, II, III and IV to determine the 
quality of the tissue periodically. All the corneas were pre-checked [Stage I] using 
parameters like (a) thickness, (b) transparency (c) endothelial cell density (ECD), mortality 
and viable endothelial cell density (VECD) and (d) morphology as below: 
 
a. Central Corneal Thickness (CCT) 
The tissues were removed from the media and mounted on artificial anterior chamber 
(AAC) with an infusion of sterile phosphate buffered saline (PBS) irrigation and locked 
using AAC stopper. The CCT was measured using Optical Coherence Tomography (OCT) 
(OCT SS-1000, Tomey Corporation, Nagoya, Japan] at different stages as listed above.  
 
b. Transparency  
The corneas were dismounted from the AAC. The blank reading of the petri plate was 
recorded. The corneas were placed in the petri plate in sterility and analyzed objectively 
using a transparency device [12] at different stages. The average of 3 transparency 
readings was considered suitable to reduce the error. 
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c. Endothelial cell density (ECD) and mortality using trypan blue 
The corneas were removed from the petri plates and placed on a silicon cap with the 
endothelium side facing up. The endothelium was stained using Trypan blue (0.25%) for 
approximately 20 seconds, washed with PBS and placed in a sterile petri plate containing 
sucrose solution (1.8%) with the epithelium facing the lid. A reticule (grid) [10X10 mm] 
inserted in the eyepiece of the microscope was used for manual cell counting and 
mortality at 100X magnification [13]. Central (optic zone) and peripheral readings were 
recorded by two masked observers. The viable endothelial cell density (VECD) was 
calculated as described by Parekh et al [6].  
 
Where, CM = Central mortality; CA = Central area [πr
2
] (within optic zone = approximately 
4 mmradius); PM = Peripheral mortality; PA = Peripheral area [πr
2
] (outside optic zone = 
approximately 1.5 mm radius); TA = Total area [πr
2
] (approximately 5.5 mm radius); 
VisECD = Visual endothelial cell density (counted manually under 100X magnification). 
 
d. Morphology 
The morphology was also checked using the corneas in the same petri-plates and the 
parameters included are as described: (i) intercellular borders (IB) were checked by 
assessing disappearance, swelling or irregularity; (ii) polymorphism was checked using 
polymegathism (cell size) and pleomorphism (cell shape); (iii) the corneas were checked 
for dystrophy before preservation and (iv) degeneration was recorded by the 
disappearance of the intercellular borders and/or complete cells. After subjective 
evaluation, morphology was translated into objective numbers for statistical analysis. The 
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objective values were marked as Regular-4, Regular-Mild-3.5, Mild-3, Mild-Moderate-2.5, 
Moderate-2, Moderate-Severe-1.5, Severe-1, Severe-Poor-0.5, Poor-0 [6]. 
 
Glucose uptake 
Glucose uptake was determined in the preservation media in which the tissues were 
preserved for 4 days, as previously described by Ruzza et al [14]. The metabolic activity of 
the endothelial cells was checked using this technique. Quantitative analysis was 
performed using D-Glucose HK kit (Megazyme International Ireland Ltd, Bray Business 
Park, Bray, Co. Wicklow, Ireland) post preservation from each stage. 
 
Statistical analysis 
The data were analyzed using SAS 9.2 software for Windows (SAS Institute Inc., Cary, 
NC, USA). Non-parametric Wilcoxin test for paired data was performed at each individual 
time point. The difference between the groups was considered statistically significant 
when p<0.05. 
 
Histological analysis to determine the presence of each layer on the preserved tissues 
All the tissues were fixed in 4% paraformaldehyde (PFA) overnight and washed with 7.5%, 
15% and 30% sucrose solution progressively for 15 minutes each. The tissues were 
further washed with PBS and embedded in optimal cutting temperature compound (OCT) 
compound for microtome cutting. Periodic acid–Schiff (PAS) staining was performed on all 
the sections which were viewed at 100X magnification. 
 
Immunostaining to determine the expression of different proteins in the preserved tissues 
The tissues were fixed and cut as described above to obtain sections. The sections were 
permeabilized with 0.5% Triton X-500 in PBS for 30 minutes and blocked using blocking 
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mix (PBS, goat serum, bovine serum and triton-x). Sections were incubated overnight at 
4
o
C with primary antibodies, p63 [1:100], αSMA (1:50), ZO-1 (1:100) and CK12 (1:100). 
After washing thoroughly with PBS, the sections were incubated with fluorescein 
isothiocyanate (FITC)-conjugated secondary antibody for around two hours at room 
temperature in the dark. The sections were washed with PBS and air dried. Mounting 
medium containing 4,6-diamidino-2-phenylindole (DAPI) was used to stain the nuclei. 
Expression was examined with an LSM 510-meta laser scanning microscope (Zeiss, 
Milan, Italy). Examination was performed under an ultraviolet light or by excitation at 
wavelengths of either 488 nm or 594 nm.  
 
Cell apoptosis using terminal deoxynucleotidyltransferase deoxyuridine triphosphate nick-
end labeling assay 
The tissues were fixed and cut as described above to obtain sections. Cell apoptosis was 
performed as described in the manufacturer‘s protocol for TACS 2 terminal 
deoxynucleotidyltransferase (TdT) diaminobenzidine (DAB) in situ apoptosis detection kit 
(Cat# 4810-30-K; Trevigen, Maryland, USA). One positive sample was induced with 
apoptosis using TACS nuclease and other samples were viewed at 100X magnifications 
of an inverted microscope. The images were analyzed using ZEN (Zeiss, Milan, Italy) 
software [6].  
 
Microbiological checks 
All the samples were checked for microbiology using Bactec 9240 instrument (Becton-
Dickinson, USA) for aerobic and anaerobic microorganisms (bacteria and yeasts) using 
inoculums of the preservation medium.  
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Results 
None of the corneas assessed showed any microbial contamination. Power calculation for 
statistical analysis revealed that 24 pairs of cornea were sufficient to gain statistical 
significance. The parameters that were evaluated led to the results that are described 
below: 
 
No significant difference in thickness 
A statistically significant increase of thickness was observed when the tissues were 
preserved in Cornea Prep II
® 
as compared to Cornea Trans
® 
(p<0.001). This is due to the 
presence of dextran in Cornea Trans
® 
and not in Cornea Prep II
®
. However, no differences 
were seen in any other consecutive stage of preservation, as seen in figure 2a.  
 
Figure 2: Parametrical analysis of the tissues preserved in synthetic and serum based 
media. A) The thickness of the tissues preserved in serum based media showed a higher 
thickness as compared to the ones preserved in synthetic based with dextran in phase II; 
b) Transparency was higher in synthetic media which is inversely proportional to the 
thickness measurement; c) mortality as observed after trypan blue staining, d) visual 
endothelial cell density which showed better endothelial preservation with minimal 
mortality in synthetic medium; e) viable endothelial cell density showed better preservation 
of endothelial cells in synthetic medium f) morphology was better in synthetic medium as 
compared to serum based.  
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Key: CPII = Cornea Prep II; CT = Cornea Trans; CM = Cornea Max; CS = Cornea Syn and 
CJ = Cornea Jet  
 
No significant difference in transparency 
A statistically significant decrease of transparency was observed when the tissues were 
preserved in Cornea Prep II
® 
as compared to Cornea Trans
® 
after stage II (p<0.001) which 
also correlates with a higher thickness at this stage. No significant difference was seen at 
any other stage of preservation as seen in figure 2b.  
 
No significant difference in mortality 
After the final preservation, tissues preserved in Cornea Jet
® 
showed statistically higher 
mortality as compared to Cornea Trans
® 
as seen in figure 2C. Increased Trypan blue 
positivity was monitored when the tissues were transferred from one stage to another. 
This was further confirmed by the analysis of the apoptosis as described later. 
 
Endothelial cell density (ECD) and Viable endothelial cell density (VECD) were preserved 
better in Cornea Syn
®
 
ECD values showed higher number of endothelial cells after preservation in Cornea Syn
®
 
(p<0.05) and Cornea Trans
® 
(p<0.05) as compared to Cornea Max
®
 and Cornea Jet
®
 
respectively. No significant cell loss was observed when the tissues were preserved in 
Cornea Prep II
®
 and Cornea Trans
®
 (Figure 1d). VECD showed statistically significant 
difference at stage III (p<0.05) and stage IV (p<0.05) indicating that the endothelial cells 
are better preserved in synthetic media as compared to the serum based media series 
(Figure 1e).  
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Morphology was significantly better in Cornea Syn
®
 
Statistically, the morphology looked better after organ culture in Cornea Syn
® 
and final 
transportation in Cornea Trans
® 
as compared to Cornea Max
®
 and Cornea Jet
®
. No other 
stage showed any significant difference as seen in figure 1F. The tissues from the 
synthetic series showed clear cells as compared to hazy tissues from serum based media 
and therefore the morphology was clearly visible. The morphology, endothelial cell density 
and mortality from each medium at each stage are shown in figure 3. 
 
Figure 3: Morphological analysis. Endothelial cell density, mortality and morphological 
analysis performed at different stages of preservation in serum based and synthetic media 
(100x). 
 
Cornea Max
® 
showed higher glucose uptake 
A statistically significantly higher uptake of glucose was observed in Cornea Max
® 
as 
compared to Cornea Syn
®
. However, glucose uptake was similar in the rest of the media 
in their respective phases as seen in Figure 4. Glucose is converted to the pyruvic acid by 
producing lactic acid and ATP. In the Krebs cycle, glucose utilizes pyruvic acid and O2 to 
produce ATP. Lower but active metabolism is usually beneficial to the cornea [15]. The 
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fact that Cornea Syn
®
 consumes less glucose than Cornea Max
® 
may potentially make it 
available longer for survival. 
 
Figure 4: Glucose uptake analysis. Glucose uptake was lower in synthetic medium as 
compared to serum based when the tissues were preserved in rHSA. All the readings are 
in their original scale and unit.  
 
Histology showed presence of all the layers 
Histological analysis using PAS staining showed the presence of all the layers (epithelium, 
stroma and endothelium) without any significant damage on the tissues preserved in 
either media as seen in figure 5.  
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Figure 5: Histological analysis as observed on the sections after preservation using PAS 
staining at 100x magnification. a) tissue preserved in serum based media and b) tissue 
preserved in synthetic media, both the tissues showed all the layers of cornea without any 
damage to any layer.  
 
Immunostaining showed expression of corneal, stromal and endothelial markers 
Immunostaining using different markers showed expression of p63 (Figure 6a and 6e) 
near the limbus whereas CK12 (cytokeratin 12) was observed in the corneal epithelium 
(figure 6b and 6f) in both the media. αSMA (smooth muscle actin) was scattered and 
observed in stroma (figure 6c and 6g). ZO-1 (zonula occludens-1) was observed in the 
endothelium (figure 6d and 6h) in both the media respectively. This showed that there was 
no difference in the protein expression when the tissues were preserved in either media.  
 
Figure 6: Immunostaining of the sections to determine the protein expression in synthetic 
and serum based series after preservation. a and e) shows presence of p63 near limbal 
area, b and f) shows expression of CK12 in the corneal epithelium, c and g) shows 
presence of αSMA in the stromal region and d and h) shows the presence of ZO-1 in the 
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endothelium. DAPI staining is observed in all the respective cells. Immunostaining did not 
show any damage to the cells when preserved in synthetic or serum based media.  
 
Cell apoptosis was observed in the epithelium and not in other layers 
Mild apoptosis was observed in the epithelium in the tissues preserved in both the 
preservation media. No apoptosis was seen in any other layer of the tissue as observed in 
figure 7. Positive control is shown to compare the difference.  
 
Figure 7: Cell apoptosis analysis. a) positive control which was induced with apoptosis. 
Cell apoptosis was observed in all cells of the section, expected mild apoptosis was 
observed in the epithelium of the sections when preserved in b) synthetic and c) serum 
based media. No other cells showed apoptosis when preserved in either medium.  
 
Microbiological checks did not show any contamination 
Microbiology performed using Bactec 9240 instrument did not show any contamination in 
either media showing that the antibiotics were active and it is safe for corneal 
preservation.  
 
Discussion 
It has already been accepted that the risk of using FCS or bovine serum is minimum but 
as the corneas are in contact with the serum for almost a month, health authorities have 
huge concerns as they are intended for human grafting. There are sera that come from 
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pools of various animals; possibility of high variability between FCS batches makes the 
standardization of OC media, and its final validation, very difficult. To reduce a worldwide 
reduction in the use of animals for research and development, a three Rs (3Rs) strategy 
has been implemented. These include replacement, reduction and refinement, which also 
define the ethical guidelines for the use of animal models. It also encourages alternatives 
to animal models and in order to reduce the animal or animal derived products, a synthetic 
medium that is completely animal free product can be of high relevance. So far, there 
have been a lot of serum free media that have been analyzed but have not shown better 
endothelial cell survival as compared to the serum containing media [16-22]. Stoiber et al 
[16] tested a serum-free OC medium that derives from a medium for short-term corneal 
storage at +4
o
C (Eurosol, Bausch and Lomb, Irvive, CA). Many used several serum- free 
media for other medical purposes [10,17-19]. Whereas others kept the MEM base but 
replaced the 2% of FCS with β-FGF [20] or ovalbumin [22]. A study by Thuret et al. used 
poloxamer as the deswelling agent for animal free medium [2]. 
 
We set out for a randomized controlled study with masked observers and showed that 
Cornea Syn
®
 medium preserves endothelial cells after 38 days of OC better than standard 
serum containing media (Cornea Max
®
). The results in this article show statistical 
significance in terms of endothelial cell viability that is the major parameter of graft 
rejection. The highlights of our study were: a) huge sample size (n=24 pairs) allowing 
sincere statistical comparisons, b) paired corneas with a starting ECD greater than 1600 
cells/mm
2
, theoretically which could be extrapolated to the corneas that are used for 
transplantation, c) immersion of corneas directly in the media under test, without prior 
placement in another medium containing animal compounds, d) reproducibility and three 
batches of production were checked commercially, e) parameters that are routinely 
practiced in eye banking procedures were checked periodically. We also incorporated 
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parameters like thickness and transparency, which are not currently used by all the eye 
banks due to the lack of sophisticated instruments and devices. Triplicate reading and 
immediate measurement of cell mortality reduce the error. Apart from these parameters 
we also included a new parameter of viable endothelial cell density (VECD), which is an 
inclusion of endothelial cell density and mortality previously described [6]. This 
demonstrates the surviving and active endothelial cells and provides the actual number of 
cells that are used for transplantation for accurate post-op data.  
 
Dextran has been used widely in corneal preservation, be it hypothermic or OC. It reduces 
the thickness of the cornea and revert it back for ease of transplantation. Poloxamer has 
been used in medicine and pharmaceuticals. Zhao et al. [11] investigated the efficacy and 
tolerance of different poloxamers for deswelling human corneas. Dextran is also 
responsible for reducing the folds that are generated during the storage of the tissues, 
further leading to increased transparency. Therefore, we determined that a combination of 
preservation system that would replace the serum with rHSA and use dextran as a 
deswelling agent would show potential results. Although studies by various groups showed 
undesirable confirmation of the endothelial toxicity of using dextran [22-24], the ECD were 
also better preserved when a complete synthetic media series was used using rHSA and 
dextran based deswelling media.   
 
In our study, we observed that rHSA does not have any negative effects when replaced 
with serum. The tissues showed higher transparency and lower thickness during phase II 
due to the presence of dextran in the synthetic series. Morphology and endothelial cell 
density were highly maintained in Cornea Syn® when compared to Cornea Max®. 
Metabolism was active and the glucose uptake was statistically significantly higher in 
Cornea Max® compared to Cornea Syn®. Histology showed presence of all the layers on 
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the cornea representing no damage to any layer anatomically. Immunostaining showed 
expression of p63 (limbal stem cells marker), CK12 (corneal epithelial cells marker), αSMA 
(marker for smooth muscle actin in stroma) and ZO-1 (tight junctional protein, corneal 
endothelial cell marker). Cell apoptosis was only observed on the superior epithelial layer 
and not on any other layers of the cornea, which indicated no damage to any layer of the 
cornea in terms of apoptosis. Hence, at the anatomical and molecular level, the corneas 
did not show any significant damage. Thus, Cornea Syn
® 
may be considered equal or 
slightly better in terms of corneal health when compared to conventional serum based 
media. With Cornea Syn
®
, we have not only improved the preservation system but also 
the duration of preservation which comes to a maximum of 38 days (including transport 
and organculture). 
 
The final quality of the graft is of utmost importance and therefore the tissue selection is of 
a great concern. This study shows that the final quality of the tissue in either media 
provides a higher maintenance standard (eye bank standards) and the quality of the 
tissue. Therefore with all the benefits that are engaged with serum free media, with higher 
ECD and better morphology, rHSA containing synthetic medium Cornea Syn
®
 along with 
transport in Cornea Trans
® 
could be used for preservation of corneas in the conventional 
organ culture protocol.  
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The aim of this thesis was to study the posterior cornea which includes the DM and 
endothelium and further enhance the field of eye banking in terms of providing validated 
tissues for selective surgeries like endothelial keratoplasty, especially the DMEK. The 
second aim of the thesis was to find alternative approaches from the previous findings for 
the transplant of endothelial cells and reduce the global shortage of donor corneas by 
culturing the donor endothelium in vitro. 
 
During the studies, we noticed that by defining a new way to store and transplant a DMEK 
graft i.e. a pre-loaded DMEK inside a preservation chamber which can be used for 
transportation and transplantation, challenging surgeries like DMEK will become easily 
accessible to more surgeons, also to those with less experience or skills. Dextran 
preservation will provide a standardized and validated graft preservation method with 
required rigidity and flexibility. This in turn will reduce further manipulations during the 
surgery. Currently, the surgeons request for additional tissues that are kept as stand-by 
substitute tissues in case of any preparation error and therefore huge graft wastage of 
transplantable tissues have been recorded. The pre-loaded validated grafts will be 
prepared by the eye bankers who have skills and prepare a lot of tissues on daily basis. 
This will reduce wastage of transplantable tissues and provide a ready-to-use tissue that 
can be directly transplanted in the recipient eye. Apart from the issue of wastage, if the 
tissues are damaged during preparation in the surgical theatre with the patient on bed, 
then it becomes a serious issue. The above mentioned details are the complications that 
can be overcome by using a pre-loaded DMEK tissue however such kind of devices and 
tools can also be useful in reporting accurate post-op clinical data. Currently, the surgeons 
only receive a pre-stripped graft and they have to cut the tissue, load and transplant it in 
the eye. The last three stages mentioned are crucial in reporting the post-op ECD count 
as each stage affects the ECD significantly. Therefore, a pre-loaded graft with accurate 
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ECD count before transplantation would significantly change the scenario of reporting the 
post-op data. The only ECD damage will occur during the implantation phase and this will 
further allow the surgeons and the eye bankers to revert and evaluate the stage which 
affects the ECD the most and re-formulate the procedure accordingly for a better graft in 
the future. Apart from new products like pre-loaded tissues, it is also necessary to change 
the implantation technique like endo-in which will help the surgeons to reduce the surgical 
time and costs dramatically. Minimal endothelial cell loss and ease of unfolding due to 
endo-in method will help to reduce surgical manipulations. Hence, the new techniques and 
products described in this thesis will provide better tissues with easiness to implant which 
in turn will allow high uptake of challenging surgeries like DMEK and will reduce surgical 
time and costs for the national health system. Eye banks will play a major role in changing 
the field of DMEK transplantation and will deal with everything reducing the efforts of 
surgeons drastically.   
 
Although the pre-loading DMEK technique may be useful in terms of reducing graft 
wastage in the surgical theatre, the donor availability is a major issue. Although regions 
like northeast Italy or Spain that can account for high organ/tissue donation and USA that 
collects more than 125,000 corneas per year, the overall tissue donation rate is low. It has 
been observed that there is a high demand of donor corneas required for transplantation 
which shoots up to the requirement of 100,000 corneas/year in developing countries. 
These countries either face a huge patient waiting list ranging from kids to old age group. 
Therefore, the only possibility for these countries is to import tissues from other parts of 
the world. Many countries are also tabooed from donating corneas on religious 
backgrounds and therefore, the requirement of donated corneas keep shooting up 
dramatically. We foresee even a higher demand of corneal transplantation in the future. 
Therefore, alternative solutions like culturing the corneal endothelial cells in vitro could be 
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a possible solution for such kind of requirements. HCECs are highly challenging and the 
challenges keep rising when they have to be manipulated under GMP guidelines which 
also include the use of synthetic media. Currently, the availability of old donor corneas that 
do not pass the eligibility for transplant is high however these cells are very difficult to 
culture. The method discussed in this thesis will significantly improve the quality of the 
culture from old age corneas which will allow production of more products due to the 
available source. Although the overall costs of the final product will be high in terms of 
GMP regulations, our speculations of 4 DMEK grafts from 1 donor (2 corneas) [and even 
more with young donors] would reduce the global shortage of the donor corneas for the 
treatment of endothelial disorders which will have a huge impact clinically. The high 
flexibility and transparency of the studied scaffold may allow surgeons to transplant such 
grafts without adapting new techniques of delivery or high dosage steroids. Only the donor 
tissues will be replaced by the cultured cells in vitro, therefore, the products will become 
highly validated, with batch reproduction, total synthetic, available on requests which will 
help to plan the surgery with costs that can be justified to the current requirement.  
 
Thus, in brief, the aims were successfully achieved with further validation of the methods 
in vitro. Current EK techniques can be now modified and validated and standardized 
products will be in the surgery soon that will help the surgeons to reduce graft wastage 
and will also affect the overall time and cost of the surgery positively. Alternatives like 
tissue engineering may be useful to reduce the patient waiting list due to the availability of 
the donor corneas and will provide a more reproducible GMP validated grafts. All the 
preservation of the grafts and bioengineered tissues will be produced in a totally synthetic 
medium in the near future and therefore will reduce any potential chance of 
xenotransplants.  
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This thesis highlights important details and modifications in the field of EK which is 
deemed to be the future of corneal transplantation. Most of the data were successfully 
obtained and published in peer-reviewed journals and the others are under consideration 
for publication.  
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